BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy16044
(436 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 127 bits (319), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 130/238 (54%), Gaps = 20/238 (8%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG I + R++ G+++I +WPWQ+SLQ L R H CG LI P+ V+TAAH
Sbjct: 1 CGAPIFQPNLSARVVGGEDAIPHSWPWQISLQYL--RDNTWRHTCGGTLITPNHVLTAAH 58
Query: 74 CIHNDIFSLPIPELWTAVLGDWD-RTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKL 130
CI N + + LG + E+E + + V+ I VHE+++++ +DIAL+KL
Sbjct: 59 CISNTL-------TYRVALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKL 111
Query: 131 SRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISV 190
+ D ++ CL ++ + C TGWGR+ G + ++L+Q P+ + +
Sbjct: 112 AETVELGDT-IQVACLP-SEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVVDYAT 169
Query: 191 C--RDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C RD +G +V+ +C G DG AC GDSGGPL C DG+W + GI SFGSG
Sbjct: 170 CSQRDWWGTTVK--ETMVCAGG-DGVISACNGDSGGPLNCQ-ADGQWDVRGIVSFGSG 223
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 54/151 (35%), Positives = 83/151 (54%), Gaps = 10/151 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KL+ D ++ CL ++ + C TGWGR+ G + ++L+Q P+
Sbjct: 107 ALIKLAETVELGDT-IQVACLP-SEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPV 164
Query: 345 HNISVC--RDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
+ + C RD +G +V+ +C G DG AC GDSGGPL C DG+W + GI SF
Sbjct: 165 VDYATCSQRDWWGTTVK--ETMVCAGG-DGVISACNGDSGGPLNCQ-ADGQWDVRGIVSF 220
Query: 403 GSG--CAKSGYPDVYTKLSFYLPWIRKQINI 431
GSG C P V+T++S Y+ WI +++ +
Sbjct: 221 GSGLSCNTFKKPTVFTRVSAYIDWINQKLQL 251
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 122 bits (307), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 80/228 (35%), Positives = 125/228 (54%), Gaps = 27/228 (11%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHC--IHNDIFSLP 83
R++NG+E++ G+WPWQVSLQ + G H+CG LI+ +WVVTAAHC +D+
Sbjct: 15 RIVNGEEAVPGSWPWQVSLQ---DKTGF--HFCGGSLINENWVVTAAHCGVTTSDVV--- 66
Query: 84 IPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKLSRPTSARDKGV 141
V G++D+ + ++ + ++ + ++++ ++DI LLKLS S + V
Sbjct: 67 -------VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAAS-FSQTV 118
Query: 142 RAVCLTDADKRPVNPKQQCVATGWGRVK-PKGDLVSKLRQIRVPLHNISVCRDKYGDSVE 200
AVCL A CV TGWG + + +L+Q +PL + + C+ +G +
Sbjct: 119 SAVCLPSASDD-FAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWG--TK 175
Query: 201 LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC 248
+ +C G G S +C+GDSGGPL C K+G W L GI S+GS C
Sbjct: 176 IKDAMICAGA-SGVS-SCMGDSGGPLVCK-KNGAWTLVGIVSWGSSTC 220
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 50/145 (34%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVK-PKGDLVSKLRQIRVPL 344
LLKLS S + V AVCL A CV TGWG + + +L+Q +PL
Sbjct: 105 LLKLSTAAS-FSQTVSAVCLPSASDD-FAAGTTCVTTGWGLTRYTNANTPDRLQQASLPL 162
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ + C+ +G ++ +C G G S +C+GDSGGPL C K+G W L GI S+GS
Sbjct: 163 LSNTNCKKYWG--TKIKDAMICAGA-SGVS-SCMGDSGGPLVCK-KNGAWTLVGIVSWGS 217
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
+ P VY +++ + W+++ +
Sbjct: 218 STCSTSTPGVYARVTALVNWVQQTL 242
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 9/16 (56%), Positives = 15/16 (93%)
Query: 260 RLINGKESIRGAWPWQ 275
R++NG+E++ G+WPWQ
Sbjct: 15 RIVNGEEAVPGSWPWQ 30
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 122 bits (307), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 78/222 (35%), Positives = 113/222 (50%), Gaps = 13/222 (5%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ES G WPWQVSLQV +L H CG LI WV+TAAHC LP+ +
Sbjct: 1 IVGGTESSWGEWPWQVSLQV---KLTAQRHLCGGSLIGHQWVLTAAHCFDG----LPLQD 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
+W G + ++ K ++ I +H+ + +HDIAL+KL P +
Sbjct: 54 VWRIYSGILELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPIS 113
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
+ D + C TGWG K KG++ + L+++ +PL C+ +Y D ++
Sbjct: 114 LPSKGDTSTIYTN--CWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQD-YKITQR 170
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G +G AC GDSGGPL C +G W L GITS+G G
Sbjct: 171 MVCAGYKEGGKDACKGDSGGPLVCK-HNGMWRLVGITSWGEG 211
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 71/229 (31%), Positives = 104/229 (45%), Gaps = 26/229 (11%)
Query: 205 HLCGGQLDGFSGACIGD---SGGPLQ--CSLKDGRWYLAGITSFGSGYCGVGIRYSHRQP 259
HLCGG L G G PLQ + G L+ IT + + + H+
Sbjct: 27 HLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILELSDITK-DTPFSQIKEIIIHQNY 85
Query: 260 RLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC 319
++ G I LI + +P S KG + T+ C
Sbjct: 86 KVSEGNHDIA-------LIKLQAPLEYTEFQKPISLPSKGDTSTIYTN-----------C 127
Query: 320 VATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIG 379
TGWG K KG++ + L+++ +PL C+ +Y D ++ +C G +G AC G
Sbjct: 128 WVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQD-YKITQRMVCAGYKEGGKDACKG 186
Query: 380 DSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
DSGGPL C +G W L GITS+G GCA+ P VYTK++ Y+ WI ++
Sbjct: 187 DSGGPLVCK-HNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEK 234
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 121 bits (303), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 77/222 (34%), Positives = 113/222 (50%), Gaps = 13/222 (5%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S G WPWQVSLQV +L H CG LI WV+TAAHC LP+ +
Sbjct: 1 IVGGTNSSWGEWPWQVSLQV---KLTAQRHLCGGSLIGHQWVLTAAHCFD----GLPLQD 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
+W G + ++ K ++ I +H+ + +HDIAL+KL P + +
Sbjct: 54 VWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPIS 113
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
+ D + C TGWG K KG++ + L+++ +PL C+ +Y D ++
Sbjct: 114 LPSKGDTSTIYTN--CWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQD-YKITQR 170
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G +G AC GDSGGPL C +G W L GITS+G G
Sbjct: 171 MVCAGYKEGGKDACKGDSGGPLVCK-HNGMWRLVGITSWGEG 211
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 71/229 (31%), Positives = 104/229 (45%), Gaps = 26/229 (11%)
Query: 205 HLCGGQLDGFSGACIGD---SGGPLQ--CSLKDGRWYLAGITSFGSGYCGVGIRYSHRQP 259
HLCGG L G G PLQ + G L+ IT + + + H+
Sbjct: 27 HLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITK-DTPFSQIKEIIIHQNY 85
Query: 260 RLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC 319
++ G I LI + +P S KG + T+ C
Sbjct: 86 KVSEGNHDIA-------LIKLQAPLNYTEFQKPISLPSKGDTSTIYTN-----------C 127
Query: 320 VATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIG 379
TGWG K KG++ + L+++ +PL C+ +Y D ++ +C G +G AC G
Sbjct: 128 WVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQD-YKITQRMVCAGYKEGGKDACKG 186
Query: 380 DSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
DSGGPL C +G W L GITS+G GCA+ P VYTK++ Y+ WI ++
Sbjct: 187 DSGGPLVCK-HNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEK 234
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 79/227 (34%), Positives = 124/227 (54%), Gaps = 27/227 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHC--IHNDIFSLPI 84
++NG+E++ G+WPWQVSLQ + G H+CG LI+ +WVVTAAHC +D+
Sbjct: 1 IVNGEEAVPGSWPWQVSLQ---DKTGF--HFCGGSLINENWVVTAAHCGVTTSDVV---- 51
Query: 85 PELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVR 142
V G++D+ + ++ + ++ + ++++ ++DI LLKLS S + V
Sbjct: 52 ------VAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAAS-FSQTVS 104
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVK-PKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
AVCL A CV TGWG + + +L+Q +PL + + C+ +G ++
Sbjct: 105 AVCLPSASDD-FAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWG--TKI 161
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC 248
+C G G S +C+GDSGGPL C K+G W L GI S+GS C
Sbjct: 162 KDAMICAGA-SGVS-SCMGDSGGPLVCK-KNGAWTLVGIVSWGSSTC 205
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 50/145 (34%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVK-PKGDLVSKLRQIRVPL 344
LLKLS S + V AVCL A CV TGWG + + +L+Q +PL
Sbjct: 90 LLKLSTAAS-FSQTVSAVCLPSASDD-FAAGTTCVTTGWGLTRYTNANTPDRLQQASLPL 147
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ + C+ +G ++ +C G G S +C+GDSGGPL C K+G W L GI S+GS
Sbjct: 148 LSNTNCKKYWG--TKIKDAMICAGA-SGVS-SCMGDSGGPLVCK-KNGAWTLVGIVSWGS 202
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
+ P VY +++ + W+++ +
Sbjct: 203 STCSTSTPGVYARVTALVNWVQQTL 227
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 8/15 (53%), Positives = 14/15 (93%)
Query: 261 LINGKESIRGAWPWQ 275
++NG+E++ G+WPWQ
Sbjct: 1 IVNGEEAVPGSWPWQ 15
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 75/225 (33%), Positives = 114/225 (50%), Gaps = 13/225 (5%)
Query: 24 QPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLP 83
+PR++ G S+RG WPWQV+L P H CG +I W++TAAHC + +
Sbjct: 385 KPRIVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHC----FYGVE 437
Query: 84 IPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGV 141
P++ G +++E ++ V+ I +H+++ +DIALLKL + D
Sbjct: 438 SPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQ- 496
Query: 142 RAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
R +CL R V C TGWG K + + + L++ ++PL C+ +Y
Sbjct: 497 RPICLPSKGDRNV-IYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT 555
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
H +C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 556 H-KMICAGYREGGKDACKGDSGGPLSCK-HNEVWHLVGITSWGEG 598
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 53/144 (36%), Positives = 74/144 (51%), Gaps = 4/144 (2%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
ALLKL + D R +CL R V C TGWG K + + + L++ ++PL
Sbjct: 482 ALLKLETTVNYTDSQ-RPICLPSKGDRNV-IYTDCWVTGWGYRKLRDKIQNTLQKAKIPL 539
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
C+ +Y H +C G +G AC GDSGGPL C + W+L GITS+G
Sbjct: 540 VTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSCK-HNEVWHLVGITSWGE 597
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQ 428
GCA+ P VYT + Y+ WI ++
Sbjct: 598 GCAQRERPGVYTNVVEYVDWILEK 621
Score = 32.3 bits (72), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 10/18 (55%), Positives = 14/18 (77%)
Query: 258 QPRLINGKESIRGAWPWQ 275
+PR++ G S+RG WPWQ
Sbjct: 385 KPRIVGGTASVRGEWPWQ 402
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 120 bits (300), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 83/234 (35%), Positives = 119/234 (50%), Gaps = 19/234 (8%)
Query: 20 YSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDI 79
+S R++NG++++ +W WQVSLQ + + G H CG LI P WVVTA HCI
Sbjct: 5 FSRPSSRVVNGEDAVPYSWSWQVSLQ--YEKDGAFHHTCGGSLIAPDWVVTAGHCISTS- 61
Query: 80 FSLPIPELWTAVLGDWDRTEEEKSEVRIPVER--IRVHEEFHNY----HHDIALLKLSRP 133
+ VLG++DR+ + SE IP+ + VH +++ +DIAL+KLSR
Sbjct: 62 ------RTYQVVLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRS 115
Query: 134 TSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRD 193
DK A D P + C +GWGR+ G L KL++ +P+ + C
Sbjct: 116 AQLGDKVQLANLPPAGDILP--NEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQ 173
Query: 194 KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGY 247
+ + +C G D SG C GDSGGPL C DG W + G+TSF S +
Sbjct: 174 YDWWGITVKKTMVCAGG-DTRSG-CDGDSGGPLNCPAADGSWQVHGVTSFVSAF 225
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 53/147 (36%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KLSR DK A D P + C +GWGR+ G L KL++ +P+
Sbjct: 108 ALVKLSRSAQLGDKVQLANLPPAGDILP--NEAPCYISGWGRLYTGGPLPDKLQEALLPV 165
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ C + + +C G D SG C GDSGGPL C DG W + G+TSF S
Sbjct: 166 VDYEHCSQYDWWGITVKKTMVCAGG-DTRSG-CDGDSGGPLNCPAADGSWQVHGVTSFVS 223
Query: 405 --GCAKSGYPDVYTKLSFYLPWIRKQI 429
GC P V+T++S ++ WI + I
Sbjct: 224 AFGCNTIKKPTVFTRVSAFIDWINETI 250
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 81/237 (34%), Positives = 125/237 (52%), Gaps = 23/237 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ +WPWQVSLQ + G H CG L+ SWV+TAAHCI +
Sbjct: 1 VVGGEDARPNSWPWQVSLQ--YDSSGQWRHTCGGTLVDQSWVLTAAHCISSS-------R 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH----HDIALLKLSRPTSARDKGVR 142
+ VLG + E + + V ++ VH+++++ +DIALLKL+ P S DK ++
Sbjct: 52 TYRVVLGRHSLSTNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDK-IQ 110
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDK--YGDSVE 200
CL A N C TGWGR++ G L+Q ++ + + + C +G +V+
Sbjct: 111 LGCLPAAGTILPN-NYVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWGSTVK 169
Query: 201 LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
+ +C G DG +C GDSGGPL C +G+W + GI SFGS +G Y H+
Sbjct: 170 TN--MICAGG-DGIISSCNGDSGGPLNCQGANGQWQVHGIVSFGS---SLGCNYYHK 220
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/158 (36%), Positives = 84/158 (53%), Gaps = 9/158 (5%)
Query: 276 NLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS 335
N +++ ALLKL+ P S DK ++ CL A N C TGWGR++ G
Sbjct: 86 NQLSNGNDIALLKLASPVSLTDK-IQLGCLPAAGTILPN-NYVCYVTGWGRLQTNGASPD 143
Query: 336 KLRQIRVPLHNISVCRDK--YGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGR 393
L+Q ++ + + + C +G +V+ + +C G DG +C GDSGGPL C +G+
Sbjct: 144 ILQQGQLLVVDYATCSKPGWWGSTVKTN--MICAGG-DGIISSCNGDSGGPLNCQGANGQ 200
Query: 394 WYLAGITSFGS--GCAKSGYPDVYTKLSFYLPWIRKQI 429
W + GI SFGS GC P V+T++S Y+ WI I
Sbjct: 201 WQVHGIVSFGSSLGCNYYHKPSVFTRVSNYIDWINSVI 238
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 117 bits (294), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 81/220 (36%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E G WPWQ SLQ H CGA LI+ +W+V+AAHC + P
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGS------HRCGATLINATWLVSAAHCF----TTYKNPA 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHD--IALLKLSRPTSARDKGVRAV 144
WTA G + S+++ + RI VHE++ + HD I+L +LS P + V V
Sbjct: 51 RWTASFG----VTIKPSKMKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTN-AVHRV 105
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
CL DA P TG+G +K G + LRQ +V L + + C + + +
Sbjct: 106 CLPDASYE-FQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPR 164
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
LC G L+G + AC GDSGGPL S WYLAGI S+G
Sbjct: 165 MLCAGSLEGKTDACQGDSGGPLVSSDARDIWYLAGIVSWG 204
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 55/147 (37%), Positives = 74/147 (50%), Gaps = 2/147 (1%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
+L +LS P + V VCL DA P TG+G +K G + LRQ +V L
Sbjct: 88 SLAELSSPVPYTN-AVHRVCLPDASYE-FQPGDVMFVTGFGALKNDGYSQNHLRQAQVTL 145
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ + C + + + LC G L+G + AC GDSGGPL S WYLAGI S+G
Sbjct: 146 IDATTCNEPQAYNDAITPRMLCAGSLEGKTDACQGDSGGPLVSSDARDIWYLAGIVSWGD 205
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQINI 431
CAK P VYT+++ WI + I
Sbjct: 206 ECAKPNKPGVYTRVTALRDWITSKTGI 232
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 115 bits (289), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 73/222 (32%), Positives = 111/222 (50%), Gaps = 13/222 (5%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
+ G +++E ++ V+ I +H+++ +DIALLKL + D R +
Sbjct: 54 ILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQ-RPI 112
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
CL R V C TGWG K + + + L++ ++PL C+ +Y H
Sbjct: 113 CLPSKGDRNV-IYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK- 170
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 54/152 (35%), Positives = 76/152 (50%), Gaps = 4/152 (2%)
Query: 277 LITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK 336
+ S ALLKL + D R +CL R V C TGWG K + + +
Sbjct: 87 MAESGYDIALLKLETTVNYTDSQ-RPICLPSKGDRNV-IYTDCWVTGWGYRKLRDKIQNT 144
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
L++ ++PL C+ +Y H +C G +G AC GDSGGPL C + W+L
Sbjct: 145 LQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHL 202
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 203 VGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 115 bits (288), Expect = 5e-26, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 112/231 (48%), Gaps = 31/231 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLS---------RPTS 135
+ G +++E ++ V+ I +H+++ +DIALLKL RP S
Sbjct: 54 ILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPIS 113
Query: 136 ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKY 195
KG R V TD C TGWG K + + + L++ ++PL C+ +Y
Sbjct: 114 LPSKGERNVIYTD-----------CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY 162
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
H +C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 163 RGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 57/161 (35%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 277 LITSFLSAALLKLS---------RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRV 327
+ S ALLKL RP S KG R V TD C TGWG
Sbjct: 87 MAESGYDIALLKLETTVNYTDSQRPISLPSKGERNVIYTD-----------CWVTGWGYR 135
Query: 328 KPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQC 387
K + + + L++ ++PL C+ +Y H +C G +G AC GDSGGPL C
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSC 194
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
+ W+L GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 195 KHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 115 bits (288), Expect = 5e-26, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 112/231 (48%), Gaps = 31/231 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLS---------RPTS 135
+ G +++E ++ V+ I +H+++ +DIALLKL RP S
Sbjct: 54 ILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPIS 113
Query: 136 ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKY 195
KG R V TD C TGWG K + + + L++ ++PL C+ +Y
Sbjct: 114 LPSKGDRNVIYTD-----------CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY 162
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
H +C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 163 RGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/161 (35%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 277 LITSFLSAALLKLS---------RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRV 327
+ S ALLKL RP S KG R V TD C TGWG
Sbjct: 87 MAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTD-----------CWVTGWGYR 135
Query: 328 KPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQC 387
K + + + L++ ++PL C+ +Y H +C G +G AC GDSGGPL C
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSC 194
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
+ W+L GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 195 KHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 115 bits (288), Expect = 5e-26, Method: Compositional matrix adjust.
Identities = 83/225 (36%), Positives = 113/225 (50%), Gaps = 19/225 (8%)
Query: 29 NGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELW 88
NG++++ +W WQVSLQ + + G H CG LI P WVVTA HCI +
Sbjct: 1 NGEDAVPYSWSWQVSLQ--YEKDGAFHHTCGGSLIAPDWVVTAGHCISTS-------RTY 51
Query: 89 TAVLGDWDRTEEEKSEVRIPVER--IRVHEEFHNY----HHDIALLKLSRPTSARDKGVR 142
VLG++DR+ E SE IP+ + VH +++ +DIAL+KLSR DK
Sbjct: 52 QVVLGEYDRSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQL 111
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
A D P + C +GWGR+ G L KL+Q +P + C + +
Sbjct: 112 ANLPPAGDILP--NEAPCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQWDWWGITVK 169
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGY 247
+C G D SG C GDSGGPL C DG W + G+TSF S +
Sbjct: 170 KTMVCAGG-DTRSG-CNGDSGGPLNCPAADGSWQVHGVTSFVSAF 212
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 54/147 (36%), Positives = 72/147 (48%), Gaps = 6/147 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KLSR DK A D P + C +GWGR+ G L KL+Q +P
Sbjct: 95 ALVKLSRSAQLGDKVQLANLPPAGDILP--NEAPCYISGWGRLYTGGPLPDKLQQALLPT 152
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ C + + +C G D SG C GDSGGPL C DG W + G+TSF S
Sbjct: 153 VDYEHCSQWDWWGITVKKTMVCAGG-DTRSG-CNGDSGGPLNCPAADGSWQVHGVTSFVS 210
Query: 405 --GCAKSGYPDVYTKLSFYLPWIRKQI 429
GC P V+T++S ++ WI + I
Sbjct: 211 AFGCNTIKKPTVFTRVSAFIDWIDETI 237
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 115 bits (287), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 73/222 (32%), Positives = 110/222 (49%), Gaps = 13/222 (5%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
+ G ++ E ++ V+ I +H+++ +DIALLKL + D R +
Sbjct: 54 ILRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQ-RPI 112
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
CL R V C TGWG K + + + L++ ++PL C+ +Y H
Sbjct: 113 CLPSKGDRNV-IYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK- 170
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 54/152 (35%), Positives = 76/152 (50%), Gaps = 4/152 (2%)
Query: 277 LITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK 336
+ S ALLKL + D R +CL R V C TGWG K + + +
Sbjct: 87 MAESGYDIALLKLETTVNYADSQ-RPICLPSKGDRNV-IYTDCWVTGWGYRKLRDKIQNT 144
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
L++ ++PL C+ +Y H +C G +G AC GDSGGPL C + W+L
Sbjct: 145 LQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHL 202
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 203 VGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 114 bits (286), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 80/225 (35%), Positives = 116/225 (51%), Gaps = 15/225 (6%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDI-FSLPIP 85
++ G ++ G WPWQVSL L H CGA LI P+W+V+AAHC +D F P
Sbjct: 1 VVGGTDADEGEWPWQVSLHALG-----QGHICGASLISPNWLVSAAHCYIDDRGFRYSDP 55
Query: 86 ELWTAVLGDWDRTEEEKSEVRIP-VERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVR 142
WTA LG D+++ V+ ++RI H F+++ +DIALL+L +P VR
Sbjct: 56 TQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSM-VR 114
Query: 143 AVCLTDADKRPVNPKQQCV-ATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+CL DA V P + + TGWG + G L++ + + N + C + +
Sbjct: 115 PICLPDASH--VFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITP 172
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L G +C GDSGGPL DGR + AG+ S+G G
Sbjct: 173 R--MMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDG 215
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 53/160 (33%), Positives = 78/160 (48%), Gaps = 6/160 (3%)
Query: 273 PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCV-ATGWGRVKPKG 331
P+ N T ALL+L +P VR +CL DA V P + + TGWG + G
Sbjct: 87 PFFNDFTFDYDIALLELEKPAEYSSM-VRPICLPDASH--VFPAGKAIWVTGWGHTQYGG 143
Query: 332 DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKD 391
L++ + + N + C + + +C G L G +C GDSGGPL D
Sbjct: 144 TGALILQKGEIRVINQTTCENLLPQQITPR--MMCVGFLSGGVDSCQGDSGGPLSSVEAD 201
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQINI 431
GR + AG+ S+G GCA+ P VYT+L + WI++ +
Sbjct: 202 GRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV 241
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 114 bits (286), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 111/231 (48%), Gaps = 31/231 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLS---------RPTS 135
+ G ++ E ++ V+ I +H+++ +DIALLKL RP S
Sbjct: 54 ILRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPIS 113
Query: 136 ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKY 195
KG R V TD C TGWG K + + + L++ ++PL C+ +Y
Sbjct: 114 LPSKGDRNVIYTD-----------CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY 162
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
H +C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 163 RGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/161 (35%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 277 LITSFLSAALLKLS---------RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRV 327
+ S ALLKL RP S KG R V TD C TGWG
Sbjct: 87 MAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTD-----------CWVTGWGYR 135
Query: 328 KPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQC 387
K + + + L++ ++PL C+ +Y H +C G +G AC GDSGGPL C
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSC 194
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
+ W+L GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 195 KHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 114 bits (286), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 111/231 (48%), Gaps = 31/231 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLS---------RPTS 135
+ G +++E + V+ I +H+++ +DIALLKL RP S
Sbjct: 54 ILRVYSGILNQSEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPIS 113
Query: 136 ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKY 195
KG R V TD C TGWG K + + + L++ ++PL C+ +Y
Sbjct: 114 LPSKGDRNVIYTD-----------CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY 162
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
H +C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 163 RGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/161 (35%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 277 LITSFLSAALLKLS---------RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRV 327
+ S ALLKL RP S KG R V TD C TGWG
Sbjct: 87 MAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTD-----------CWVTGWGYR 135
Query: 328 KPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQC 387
K + + + L++ ++PL C+ +Y H +C G +G AC GDSGGPL C
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSC 194
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
+ W+L GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 195 KHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 73/222 (32%), Positives = 109/222 (49%), Gaps = 13/222 (5%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
+ G ++ E + V+ I +H+++ +DIALLKL + D R +
Sbjct: 54 ILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQ-RPI 112
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
CL R V C TGWG K + + + L++ ++PL C+ +Y H
Sbjct: 113 CLPSKGDRNV-IYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK- 170
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 54/152 (35%), Positives = 76/152 (50%), Gaps = 4/152 (2%)
Query: 277 LITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK 336
+ S ALLKL + D R +CL R V C TGWG K + + +
Sbjct: 87 MAESGYDIALLKLETTVNYADSQ-RPICLPSKGDRNV-IYTDCWVTGWGYRKLRDKIQNT 144
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
L++ ++PL C+ +Y H +C G +G AC GDSGGPL C + W+L
Sbjct: 145 LQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHL 202
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 203 VGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 84/231 (36%), Positives = 112/231 (48%), Gaps = 25/231 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ R WPWQVSL+V P H+CG LIHP WV+TAAHC+ D+ L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWM---HFCGGSLIHPQWVLTAAHCVGPDVKDL---- 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
A+ + +PV RI VH +F+ DIALL+L P V V
Sbjct: 54 --AALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSH-VHTV 110
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVS--KLRQIRVPLHNISVCRDKY------G 196
L A + P C TGWG V L L+Q++VP+ +C KY G
Sbjct: 111 TLPPASET-FPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTG 169
Query: 197 DSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
D V + LC G + +C GDSGGPL C + +G W AG+ S+G G
Sbjct: 170 DDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKV-NGTWLQAGVVSWGEG 217
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 55/154 (35%), Positives = 76/154 (49%), Gaps = 14/154 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRV 342
ALL+L P V V L A + P C TGWG V L L+Q++V
Sbjct: 93 ALLELEEPVKVSSH-VHTVTLPPASET-FPPGMPCWVTGWGDVDNDERLPPPFPLKQVKV 150
Query: 343 PLHNISVCRDKY------GDSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 395
P+ +C KY GD V + LC G + +C GDSGGPL C + +G W
Sbjct: 151 PIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKV-NGTWL 207
Query: 396 LAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
AG+ S+G GCA+ P +YT++++YL WI +
Sbjct: 208 QAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV 241
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 110/231 (47%), Gaps = 31/231 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLS---------RPTS 135
+ G ++ E + V+ I +H+++ +DIALLKL RP S
Sbjct: 54 ILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPIS 113
Query: 136 ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKY 195
KG R V TD C TGWG K + + + L++ ++PL C+ +Y
Sbjct: 114 LPSKGDRNVIYTD-----------CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY 162
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
H +C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 163 RGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/161 (35%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 277 LITSFLSAALLKLS---------RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRV 327
+ S ALLKL RP S KG R V TD C TGWG
Sbjct: 87 MAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTD-----------CWVTGWGYR 135
Query: 328 KPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQC 387
K + + + L++ ++PL C+ +Y H +C G +G AC GDSGGPL C
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSC 194
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
+ W+L GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 195 KHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 110/231 (47%), Gaps = 31/231 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLS---------RPTS 135
+ G ++ E + V+ I +H+++ +DIALLKL RP S
Sbjct: 54 ILRVYSGILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPIS 113
Query: 136 ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKY 195
KG R V TD C TGWG K + + + L++ ++PL C+ +Y
Sbjct: 114 LPSKGDRNVIYTD-----------CWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY 162
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
H +C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 163 RGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/161 (35%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 277 LITSFLSAALLKLS---------RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRV 327
+ S ALLKL RP S KG R V TD C TGWG
Sbjct: 87 MAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTD-----------CWVTGWGYR 135
Query: 328 KPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQC 387
K + + + L++ ++PL C+ +Y H +C G +G AC GDSGGPL C
Sbjct: 136 KLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSC 194
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
+ W+L GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 195 KHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 84/231 (36%), Positives = 112/231 (48%), Gaps = 25/231 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ R WPWQVSL+V P H+CG LIHP WV+TAAHC+ D+ L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWM---HFCGGSLIHPQWVLTAAHCVGPDVKDL---- 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
A+ + +PV RI VH +F+ DIALL+L P V V
Sbjct: 54 --AALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSH-VHTV 110
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVS--KLRQIRVPLHNISVCRDKY------G 196
L A + P C TGWG V L L+Q++VP+ +C KY G
Sbjct: 111 TLPPASET-FPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTG 169
Query: 197 DSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
D V + LC G + +C GDSGGPL C + +G W AG+ S+G G
Sbjct: 170 DDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKV-NGTWLQAGVVSWGEG 217
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 55/154 (35%), Positives = 76/154 (49%), Gaps = 14/154 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRV 342
ALL+L P V V L A + P C TGWG V L L+Q++V
Sbjct: 93 ALLELEEPVKVSSH-VHTVTLPPASET-FPPGMPCWVTGWGDVDNDERLPPPFPLKQVKV 150
Query: 343 PLHNISVCRDKY------GDSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 395
P+ +C KY GD V + LC G + +C GDSGGPL C + +G W
Sbjct: 151 PIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKV-NGTWL 207
Query: 396 LAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
AG+ S+G GCA+ P +YT++++YL WI +
Sbjct: 208 QAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV 241
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 84/231 (36%), Positives = 112/231 (48%), Gaps = 25/231 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ R WPWQVSL+V P H+CG LIHP WV+TAAHC+ D+ L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWM---HFCGGSLIHPQWVLTAAHCVGPDVKDL---- 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
A+ + +PV RI VH +F+ DIALL+L P V V
Sbjct: 54 --AALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSH-VHTV 110
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVS--KLRQIRVPLHNISVCRDKY------G 196
L A + P C TGWG V L L+Q++VP+ +C KY G
Sbjct: 111 TLPPASET-FPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTG 169
Query: 197 DSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
D V + LC G + +C GDSGGPL C + +G W AG+ S+G G
Sbjct: 170 DDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKV-NGTWLQAGVVSWGEG 217
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 55/154 (35%), Positives = 76/154 (49%), Gaps = 14/154 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRV 342
ALL+L P V V L A + P C TGWG V L L+Q++V
Sbjct: 93 ALLELEEPVKVSSH-VHTVTLPPASET-FPPGMPCWVTGWGDVDNDERLPPPFPLKQVKV 150
Query: 343 PLHNISVCRDKY------GDSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 395
P+ +C KY GD V + LC G + +C GDSGGPL C + +G W
Sbjct: 151 PIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKV-NGTWL 207
Query: 396 LAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
AG+ S+G GCA+ P +YT++++YL WI +
Sbjct: 208 QAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV 241
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 75/223 (33%), Positives = 115/223 (51%), Gaps = 14/223 (6%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G +P+Q+S Q +G H+CGA + + ++ +TA HC++ D + P
Sbjct: 1 IVGGTDATLGEFPYQLSFQ--ETFIGFSFHFCGASIYNENYAITAGHCVYGDDYEN--PS 56
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH---HDIALLKLSRPTSARDKGVRA 143
V G+ D + E SE I V +I +HE F +Y+ +DI+LLKLS + D V
Sbjct: 57 GLQIVAGELDMSVNEGSEQIITVSKIILHENF-DYNLLDNDISLLKLSGSLTFNDN-VAP 114
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
+ L + + TGWG G+ L+++ VPL + CR YG + E+
Sbjct: 115 IALPEQGHTATG---DVIVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYG-ADEILD 170
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G +G +C GDSGGPL S G YLAGI S+G G
Sbjct: 171 SMICAGVPEGGKDSCQGDSGGPLAAS-DTGSTYLAGIVSWGYG 212
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 57/153 (37%), Positives = 82/153 (53%), Gaps = 8/153 (5%)
Query: 276 NLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS 335
NL+ + +S LLKLS + D V + L + + TGWG G+
Sbjct: 91 NLLDNDIS--LLKLSGSLTFNDN-VAPIALPEQGHTATG---DVIVTGWGTTSEGGNTPD 144
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 395
L+++ VPL + CR YG + E+ +C G +G +C GDSGGPL S G Y
Sbjct: 145 VLQKVTVPLVSDEDCRADYG-ADEILDSMICAGVPEGGKDSCQGDSGGPLAAS-DTGSTY 202
Query: 396 LAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
LAGI S+G GCA+ GYP VYT++S+++ WI+
Sbjct: 203 LAGIVSWGYGCARPGYPGVYTEVSYHVDWIKAN 235
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 86/232 (37%), Positives = 117/232 (50%), Gaps = 27/232 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ R WPWQVSL+V R H+CG LIHP WV+TAAHC+ D+ L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRV---RDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDL---- 53
Query: 87 LWTAVLGDWDRTEEEKSEVR-IPVERIRVHEEFHNYHH--DIALLKLSRPTSARDKGVRA 143
A L R + + + +PV RI VH +F+ DIALL+L P + + V
Sbjct: 54 ---ATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSR-VHT 109
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS--KLRQIRVPLHNISVCRDKY------ 195
V L A + P C TGWG V L L+Q++VP+ +C KY
Sbjct: 110 VMLPPASET-FPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYT 168
Query: 196 GDSVE-LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
GD V + LC G + +C GDSGGPL C + +G W AG+ S+G G
Sbjct: 169 GDDVRIIRDDMLCAG--NSQRDSCKGDSGGPLVCKV-NGTWLQAGVVSWGEG 217
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 56/162 (34%), Positives = 81/162 (50%), Gaps = 14/162 (8%)
Query: 277 LITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK 336
+I + ALL+L P + + V V L A + P C TGWG V L
Sbjct: 85 IIQTGADIALLELEEPVNISSR-VHTVMLPPASET-FPPGMPCWVTGWGDVDNDEPLPPP 142
Query: 337 --LRQIRVPLHNISVCRDKY------GDSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQC 387
L+Q++VP+ +C KY GD V + LC G + +C GDSGGPL C
Sbjct: 143 FPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCKGDSGGPLVC 200
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+ +G W AG+ S+G GCA+ P +YT++++YL WI +
Sbjct: 201 KV-NGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV 241
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 86/232 (37%), Positives = 117/232 (50%), Gaps = 27/232 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ R WPWQVSL+V R H+CG LIHP WV+TAAHC+ D+ L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRV---RDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDL---- 53
Query: 87 LWTAVLGDWDRTEEEKSEVR-IPVERIRVHEEFHNYHH--DIALLKLSRPTSARDKGVRA 143
A L R + + + +PV RI VH +F+ DIALL+L P + + V
Sbjct: 54 ---ATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSR-VHT 109
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS--KLRQIRVPLHNISVCRDKY------ 195
V L A + P C TGWG V L L+Q++VP+ +C KY
Sbjct: 110 VMLPPASET-FPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYT 168
Query: 196 GDSVE-LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
GD V + LC G + +C GDSGGPL C + +G W AG+ S+G G
Sbjct: 169 GDDVRIIRDDMLCAG--NSQRDSCQGDSGGPLVCKV-NGTWLQAGVVSWGEG 217
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 56/162 (34%), Positives = 81/162 (50%), Gaps = 14/162 (8%)
Query: 277 LITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK 336
+I + ALL+L P + + V V L A + P C TGWG V L
Sbjct: 85 IIQTGADIALLELEEPVNISSR-VHTVMLPPASET-FPPGMPCWVTGWGDVDNDEPLPPP 142
Query: 337 --LRQIRVPLHNISVCRDKY------GDSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQC 387
L+Q++VP+ +C KY GD V + LC G + +C GDSGGPL C
Sbjct: 143 FPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCQGDSGGPLVC 200
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+ +G W AG+ S+G GCA+ P +YT++++YL WI +
Sbjct: 201 KV-NGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYV 241
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 113 bits (282), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 72/222 (32%), Positives = 109/222 (49%), Gaps = 13/222 (5%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G S+RG WPWQV+L P H CG +I W++TAAHC + + P+
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSP---TQRHLCGGSIIGNQWILTAAHCF----YGVESPK 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
+ G ++ E ++ V+ I +H+++ +DIALLKL + D R +
Sbjct: 54 ILRVYSGILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQ-RPI 112
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
CL R V C TGWG + + + L++ ++PL C+ +Y H
Sbjct: 113 CLPSKGDRNV-IYTDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHK- 170
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G +G AC GDSGGPL C + W+L GITS+G G
Sbjct: 171 MICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEG 211
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 53/152 (34%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 277 LITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK 336
+ S ALLKL + D R +CL R V C TGWG + + +
Sbjct: 87 MAESGYDIALLKLETTVNYADSQ-RPICLPSKGDRNV-IYTDCWVTGWGYRALRDKIQNT 144
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
L++ ++PL C+ +Y H +C G +G AC GDSGGPL C + W+L
Sbjct: 145 LQKAKIPLVTNEECQKRYRGHKITHK-MICAGYREGGKDACKGDSGGPLSCKHNE-VWHL 202
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
GITS+G GCA+ P VYT + Y+ WI ++
Sbjct: 203 VGITSWGEGCAQRERPGVYTNVVEYVDWILEK 234
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 112 bits (280), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 79/225 (35%), Positives = 115/225 (51%), Gaps = 15/225 (6%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDI-FSLPIP 85
++ G ++ G WPWQVSL L H CGA LI P+W+V+AAHC +D F P
Sbjct: 1 VVGGTDADEGEWPWQVSLHALG-----QGHICGASLISPNWLVSAAHCYIDDRGFRYSDP 55
Query: 86 ELWTAVLGDWDRTEEEKSEVRIP-VERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVR 142
WTA LG D+++ V+ ++RI H F+++ +DIALL+L +P VR
Sbjct: 56 TQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSM-VR 114
Query: 143 AVCLTDADKRPVNPKQQCV-ATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+CL DA V P + + TGWG + G L++ + + + C + +
Sbjct: 115 PICLPDASH--VFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLLPQQITP 172
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L G +C GDSGGPL DGR + AG+ S+G G
Sbjct: 173 R--MMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDG 215
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 6/160 (3%)
Query: 273 PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCV-ATGWGRVKPKG 331
P+ N T ALL+L +P VR +CL DA V P + + TGWG + G
Sbjct: 87 PFFNDFTFDYDIALLELEKPAEYSSM-VRPICLPDASH--VFPAGKAIWVTGWGHTQYGG 143
Query: 332 DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKD 391
L++ + + + C + + +C G L G +C GDSGGPL D
Sbjct: 144 TGALILQKGEIRVIQQTTCENLLPQQITPR--MMCVGFLSGGVDSCQGDSGGPLSSVEAD 201
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQINI 431
GR + AG+ S+G GCA+ P VYT+L + WI++ +
Sbjct: 202 GRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV 241
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 111 bits (277), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 83/236 (35%), Positives = 115/236 (48%), Gaps = 20/236 (8%)
Query: 13 DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTA 71
DCG + P R++ G + +WPWQVSL+ R G+ H+CG LI P WV+TA
Sbjct: 6 DCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT---RFGM--HFCGGTLISPEWVLTA 60
Query: 72 AHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLS 131
AHC+ P P + +LG E I V R+ + DIALLKLS
Sbjct: 61 AHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT----RKDIALLKLS 112
Query: 132 RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVPLHNISV 190
P DK + A CL + V + +C TGWG +G L++ ++P+ V
Sbjct: 113 SPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGET--QGTFGAGLLKEAQLPVIENKV 168
Query: 191 CRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G G
Sbjct: 169 CNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLG 223
Score = 82.8 bits (203), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 53/143 (37%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L++ ++P
Sbjct: 107 ALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGETQ--GTFGAGLLKEAQLP 162
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G
Sbjct: 163 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWG 221
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 222 LGCARPNKPGVYVRVSRFVTWIE 244
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 111 bits (277), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 83/236 (35%), Positives = 115/236 (48%), Gaps = 20/236 (8%)
Query: 13 DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTA 71
DCG + P R++ G + +WPWQVSL+ R G+ H+CG LI P WV+TA
Sbjct: 3 DCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT---RFGM--HFCGGTLISPEWVLTA 57
Query: 72 AHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLS 131
AHC+ P P + +LG E I V R+ + DIALLKLS
Sbjct: 58 AHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT----RKDIALLKLS 109
Query: 132 RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVPLHNISV 190
P DK + A CL + V + +C TGWG +G L++ ++P+ V
Sbjct: 110 SPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGET--QGTFGAGLLKEAQLPVIENKV 165
Query: 191 CRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G G
Sbjct: 166 CNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLG 220
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 53/143 (37%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L++ ++P
Sbjct: 104 ALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGETQ--GTFGAGLLKEAQLP 159
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G
Sbjct: 160 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWG 218
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 219 LGCARPNKPGVYVRVSRFVTWIE 241
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 111 bits (277), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 79/225 (35%), Positives = 115/225 (51%), Gaps = 15/225 (6%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDI-FSLPIP 85
++ G ++ G WPWQVSL L H CGA LI P+W+V+AAHC +D F P
Sbjct: 1 VVGGTDADEGEWPWQVSLHALG-----QGHICGASLISPNWLVSAAHCYIDDRGFRYSDP 55
Query: 86 ELWTAVLGDWDRTEEEKSEVRIP-VERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVR 142
WTA LG D+++ V+ ++RI H F+++ +DIALL+L +P VR
Sbjct: 56 TQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSM-VR 114
Query: 143 AVCLTDADKRPVNPKQQCV-ATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+ L DA V P + + TGWG + G L++ + + N + C + +
Sbjct: 115 PISLPDASH--VFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITP 172
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L G +C GDSGGPL DGR + AG+ S+G G
Sbjct: 173 R--MMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDG 215
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 6/160 (3%)
Query: 273 PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCV-ATGWGRVKPKG 331
P+ N T ALL+L +P VR + L DA V P + + TGWG + G
Sbjct: 87 PFFNDFTFDYDIALLELEKPAEYSSM-VRPISLPDASH--VFPAGKAIWVTGWGHTQYGG 143
Query: 332 DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKD 391
L++ + + N + C + + +C G L G +C GDSGGPL D
Sbjct: 144 TGALILQKGEIRVINQTTCENLLPQQITPR--MMCVGFLSGGVDSCQGDSGGPLSSVEAD 201
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQINI 431
GR + AG+ S+G GCA+ P VYT+L + WI++ +
Sbjct: 202 GRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV 241
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 77/222 (34%), Positives = 115/222 (51%), Gaps = 15/222 (6%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ +WPWQ+SLQ L + H CG LI ++V+TAAHCI N
Sbjct: 1 VVGGEDARPHSWPWQISLQYL--KNDTWRHTCGGTLIASNFVLTAAHCISN------TRT 52
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVRAV 144
AV + E+E+ + + V+ I VH+ ++ +DIAL+KL+ D ++
Sbjct: 53 YRVAVGKNNLEVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDT-IQVA 111
Query: 145 CLTDADKRPVNPKQQ-CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
CL + D + PK C TGWGR+ G + KL+Q P+ + + C +
Sbjct: 112 CLPEKDS--LLPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFRVKK 169
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
+C G DG AC GDSGGPL C L++G W + GI SFGS
Sbjct: 170 TMVCAGG-DGVISACNGDSGGPLNCQLENGSWEVFGIVSFGS 210
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 55/150 (36%), Positives = 79/150 (52%), Gaps = 7/150 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQ-CVATGWGRVKPKGDLVSKLRQIRVP 343
AL+KL+ D ++ CL + D + PK C TGWGR+ G + KL+Q P
Sbjct: 94 ALIKLAEHVELSDT-IQVACLPEKDS--LLPKDYPCYVTGWGRLWTNGPIADKLQQGLQP 150
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ + + C + +C G DG AC GDSGGPL C L++G W + GI SFG
Sbjct: 151 VVDHATCSRIDWWGFRVKKTMVCAGG-DGVISACNGDSGGPLNCQLENGSWEVFGIVSFG 209
Query: 404 S--GCAKSGYPDVYTKLSFYLPWIRKQINI 431
S GC P VYT++S Y+ WI +++ +
Sbjct: 210 SRRGCNTRKKPVVYTRVSAYIDWINEKMQL 239
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 85/232 (36%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ R WPWQVSL+V R H+CG LIHP WV+TAAHC+ D+ L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRV---RDRYWMHFCGGSLIHPQWVLTAAHCLGPDVKDL---- 53
Query: 87 LWTAVLGDWDRTEEEKSEVR-IPVERIRVHEEFHNYHH--DIALLKLSRPTSARDKGVRA 143
A L R + + + +PV RI VH +F+ DIALL+L P + + V
Sbjct: 54 ---ATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSR-VHT 109
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS--KLRQIRVPLHNISVCRDKY------ 195
V L A + P C TGWG V L L+Q++VP+ +C KY
Sbjct: 110 VMLPPASET-FPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYT 168
Query: 196 GDSVE-LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
GD V + LC G + +C GDSGGPL C + +G W AG+ S+ G
Sbjct: 169 GDDVRIIRDDMLCAG--NSQRDSCKGDSGGPLVCKV-NGTWLQAGVVSWDEG 217
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 55/162 (33%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 277 LITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK 336
+I + ALL+L P + + V V L A + P C TGWG V L
Sbjct: 85 IIQTGADIALLELEEPVNISSR-VHTVMLPPASET-FPPGMPCWVTGWGDVDNDEPLPPP 142
Query: 337 --LRQIRVPLHNISVCRDKY------GDSVEL-HGGHLCGGQLDGFSGACIGDSGGPLQC 387
L+Q++VP+ +C KY GD V + LC G + +C GDSGGPL C
Sbjct: 143 FPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDSCKGDSGGPLVC 200
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+ +G W AG+ S+ GCA+ P +YT++++YL WI +
Sbjct: 201 KV-NGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYLDWIHHYV 241
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 86/251 (34%), Positives = 120/251 (47%), Gaps = 23/251 (9%)
Query: 1 MINLCDTVTFAR---DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPH 56
+ + CD A DCG + P R++ G + +WPWQVSL+ R G+ H
Sbjct: 532 LYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT---RFGM--H 586
Query: 57 WCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHE 116
+CG LI P WV+TAAHC+ P P + +LG E I V R+ +
Sbjct: 587 FCGGTLISPEWVLTAAHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEP 642
Query: 117 EFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-V 175
DIALLKLS P DK + A CL + V + +C TGWG +G
Sbjct: 643 T----RKDIALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGET--QGTFGA 694
Query: 176 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRW 235
L++ ++P+ VC + + LC G L G + +C GDSGGPL C KD ++
Sbjct: 695 GLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KY 753
Query: 236 YLAGITSFGSG 246
L G+TS+G G
Sbjct: 754 ILQGVTSWGLG 764
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 53/143 (37%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L++ ++P
Sbjct: 648 ALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGETQ--GTFGAGLLKEAQLP 703
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G
Sbjct: 704 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWG 762
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 763 LGCARPNKPGVYVRVSRFVTWIE 785
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 110 bits (275), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 82/236 (34%), Positives = 115/236 (48%), Gaps = 20/236 (8%)
Query: 13 DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTA 71
DCG + P R++ G + +WPWQVSL+ R G+ H+CG LI P WV+TA
Sbjct: 6 DCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT---RFGM--HFCGGTLISPEWVLTA 60
Query: 72 AHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLS 131
AHC+ P P + +LG E I V R+ + DIALLKLS
Sbjct: 61 AHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT----RKDIALLKLS 112
Query: 132 RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVPLHNISV 190
P DK + A CL + V + +C TGWG +G L++ ++P+ V
Sbjct: 113 SPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGET--QGTFGAGLLKEAQLPVIENKV 168
Query: 191 CRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C + + LC G L G + +C GD+GGPL C KD ++ L G+TS+G G
Sbjct: 169 CNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLG 223
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 52/143 (36%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L++ ++P
Sbjct: 107 ALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGETQ--GTFGAGLLKEAQLP 162
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GD+GGPL C KD ++ L G+TS+G
Sbjct: 163 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWG 221
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 222 LGCARPNKPGVYVRVSRFVTWIE 244
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 110 bits (275), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 82/236 (34%), Positives = 115/236 (48%), Gaps = 20/236 (8%)
Query: 13 DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTA 71
DCG + P R++ G + +WPWQVSL+ R G+ H+CG LI P WV+TA
Sbjct: 5 DCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT---RFGM--HFCGGTLISPEWVLTA 59
Query: 72 AHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLS 131
AHC+ P P + +LG E I V R+ + DIALLKLS
Sbjct: 60 AHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT----RKDIALLKLS 111
Query: 132 RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVPLHNISV 190
P DK + A CL + V + +C TGWG +G L++ ++P+ V
Sbjct: 112 SPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGET--QGTFGAGLLKEAQLPVIENKV 167
Query: 191 CRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C + + LC G L G + +C GD+GGPL C KD ++ L G+TS+G G
Sbjct: 168 CNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLG 222
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 52/143 (36%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L++ ++P
Sbjct: 106 ALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGETQ--GTFGAGLLKEAQLP 161
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GD+GGPL C KD ++ L G+TS+G
Sbjct: 162 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWG 220
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 221 LGCARPNKPGVYVRVSRFVTWIE 243
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 110 bits (275), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 82/236 (34%), Positives = 115/236 (48%), Gaps = 20/236 (8%)
Query: 13 DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTA 71
DCG + P R++ G + +WPWQVSL+ R G+ H+CG LI P WV+TA
Sbjct: 4 DCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT---RFGM--HFCGGTLISPEWVLTA 58
Query: 72 AHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLS 131
AHC+ P P + +LG E I V R+ + DIALLKLS
Sbjct: 59 AHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT----RKDIALLKLS 110
Query: 132 RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVPLHNISV 190
P DK + A CL + V + +C TGWG +G L++ ++P+ V
Sbjct: 111 SPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGET--QGTFGAGLLKEAQLPVIENKV 166
Query: 191 CRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C + + LC G L G + +C GD+GGPL C KD ++ L G+TS+G G
Sbjct: 167 CNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLG 221
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 52/143 (36%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L++ ++P
Sbjct: 105 ALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGETQ--GTFGAGLLKEAQLP 160
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GD+GGPL C KD ++ L G+TS+G
Sbjct: 161 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWG 219
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 220 LGCARPNKPGVYVRVSRFVTWIE 242
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 110 bits (274), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 82/236 (34%), Positives = 115/236 (48%), Gaps = 20/236 (8%)
Query: 13 DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTA 71
DCG + P R++ G + +WPWQVSL+ R G+ H+CG LI P WV+TA
Sbjct: 3 DCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT---RFGM--HFCGGTLISPEWVLTA 57
Query: 72 AHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLS 131
AHC+ P P + +LG E I V R+ + DIALLKLS
Sbjct: 58 AHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT----RKDIALLKLS 109
Query: 132 RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVPLHNISV 190
P DK + A CL + V + +C TGWG +G L++ ++P+ V
Sbjct: 110 SPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGET--QGTFGAGLLKEAQLPVIENKV 165
Query: 191 CRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C + + LC G L G + +C GD+GGPL C KD ++ L G+TS+G G
Sbjct: 166 CNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLG 220
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 52/143 (36%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L++ ++P
Sbjct: 104 ALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGETQ--GTFGAGLLKEAQLP 159
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GD+GGPL C KD ++ L G+TS+G
Sbjct: 160 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWG 218
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 219 LGCARPNKPGVYVRVSRFVTWIE 241
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 109 bits (273), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 83/236 (35%), Positives = 114/236 (48%), Gaps = 20/236 (8%)
Query: 13 DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTA 71
DCG + P R++ G + +WPWQVSL+ R G H+CG LI P WV+TA
Sbjct: 2 DCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT---RFGQ--HFCGGTLISPEWVLTA 56
Query: 72 AHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLS 131
AHC+ P P + +LG E I V R+ + DIALLKLS
Sbjct: 57 AHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT----RKDIALLKLS 108
Query: 132 RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVPLHNISV 190
P DK + A CL + V + +C TGWG +G L++ ++P+ V
Sbjct: 109 SPAVITDKVIPA-CLPSPNYM-VADRTECFITGWGET--QGTFGAGLLKEAQLPVIENKV 164
Query: 191 CRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G G
Sbjct: 165 CNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLG 219
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 53/143 (37%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L++ ++P
Sbjct: 103 ALLKLSSPAVITDKVIPA-CLPSPNYM-VADRTECFITGWGETQ--GTFGAGLLKEAQLP 158
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G
Sbjct: 159 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWG 217
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 218 LGCARPNKPGVYVRVSRFVTWIE 240
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 109 bits (272), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 82/238 (34%), Positives = 119/238 (50%), Gaps = 27/238 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
LI+GK + RG PWQV L +L CGAVLIHPSWV+TAAHC+ L
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLA-----CGAVLIHPSWVLTAAHCMDESKKLL---- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG++D EK E+ + ++ + VH + +DIALL L++P + + + +
Sbjct: 52 ---VRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATL-SQTIVPI 107
Query: 145 CLTD---ADKRPVNPKQQCVATGWG-----RVKPKGDLVSKLRQIRVPLHNISVCRDKYG 196
CL D A++ Q+ + TGWG + K + L I++P+ + C +
Sbjct: 108 CLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMS 167
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRY 254
+ V LC G L AC GDSGGP+ S G W+L G+ S+G G CG+ Y
Sbjct: 168 NMVS--ENMLCAGILGDRQDACEGDSGGPMVASFH-GTWFLVGLVSWGEG-CGLLHNY 221
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 51/153 (33%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTD---ADKRPVNPKQQCVATGWG-----RVKPKGDLVSK 336
ALL L++P + + + +CL D A++ Q+ + TGWG + K +
Sbjct: 90 ALLHLAQPATL-SQTIVPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFV 148
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
L I++P+ + C + + V LC G L AC GDSGGP+ S G W+L
Sbjct: 149 LNFIKIPVVPHNECSEVMSNMVS--ENMLCAGILGDRQDACEGDSGGPMVASFH-GTWFL 205
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G+ S+G GC VYTK+S YL WI I
Sbjct: 206 VGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHI 238
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 109 bits (272), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 82/238 (34%), Positives = 119/238 (50%), Gaps = 27/238 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
LI+GK + RG PWQV L +L CGAVLIHPSWV+TAAHC+ L
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLA-----CGAVLIHPSWVLTAAHCMDESKKLL---- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG++D EK E+ + ++ + VH + +DIALL L++P + + + +
Sbjct: 52 ---VRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATL-SQTIVPI 107
Query: 145 CLTD---ADKRPVNPKQQCVATGWG-----RVKPKGDLVSKLRQIRVPLHNISVCRDKYG 196
CL D A++ Q+ + TGWG + K + L I++P+ + C +
Sbjct: 108 CLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMS 167
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRY 254
+ V LC G L AC GDSGGP+ S G W+L G+ S+G G CG+ Y
Sbjct: 168 NMVS--ENMLCAGILGDRQDACEGDSGGPMVASFH-GTWFLVGLVSWGEG-CGLLHNY 221
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 51/153 (33%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTD---ADKRPVNPKQQCVATGWG-----RVKPKGDLVSK 336
ALL L++P + + + +CL D A++ Q+ + TGWG + K +
Sbjct: 90 ALLHLAQPATL-SQTIVPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFV 148
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
L I++P+ + C + + V LC G L AC GDSGGP+ S G W+L
Sbjct: 149 LNFIKIPVVPHNECSEVMSNMVS--ENMLCAGILGDRQDACEGDSGGPMVASFH-GTWFL 205
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G+ S+G GC VYTK+S YL WI I
Sbjct: 206 VGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHI 238
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 108 bits (271), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 82/236 (34%), Positives = 113/236 (47%), Gaps = 20/236 (8%)
Query: 13 DCGVGIRYSHRQP-RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTA 71
DCG + P ++ G + +WPWQVSL+ R G+ H+CG LI P WV+TA
Sbjct: 3 DCGKPQVEPKKCPGAVVGGCVAYPHSWPWQVSLRT---RFGM--HFCGGTLISPEWVLTA 57
Query: 72 AHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLS 131
AHC+ P P + +LG E I V R+ + DIALLKLS
Sbjct: 58 AHCLEKS----PRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT----RKDIALLKLS 109
Query: 132 RPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVPLHNISV 190
P DK + A CL + V + +C TGWG +G L + ++P+ V
Sbjct: 110 SPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGET--QGTFGAGLLMEAQLPVIENKV 165
Query: 191 CRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G G
Sbjct: 166 CNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLG 220
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 53/143 (37%), Positives = 75/143 (52%), Gaps = 6/143 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL-VSKLRQIRVP 343
ALLKLS P DK + A CL + V + +C TGWG + G L + ++P
Sbjct: 104 ALLKLSSPAVITDKVIPA-CLPSPNYV-VADRTECFITGWGETQ--GTFGAGLLMEAQLP 159
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ VC + + LC G L G + +C GDSGGPL C KD ++ L G+TS+G
Sbjct: 160 VIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWG 218
Query: 404 SGCAKSGYPDVYTKLSFYLPWIR 426
GCA+ P VY ++S ++ WI
Sbjct: 219 LGCARPNKPGVYVRVSRFVTWIE 241
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 104 bits (260), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 81/272 (29%), Positives = 124/272 (45%), Gaps = 26/272 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + GAWPW VSLQ+ H CG +L++ WV+TAAHC N
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTD--- 57
Query: 87 LWTAVLGDWDRTEEEKSEVRIP-----VERIRVHEEFHN--YHHDIALLKLSRPTSARDK 139
W + G + V+ P VE I +HE++ + +DIAL+K++ P
Sbjct: 58 -WRLIFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPC-GP 115
Query: 140 GVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCRDKYGDS 198
+ CL P Q C TGWG +K KG S L++ RV L ++ +C +
Sbjct: 116 FIGPGCLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYN 175
Query: 199 VELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK-DGRWYLAGITSFGSGYCGVGIRYSHR 257
+ ++C G G C GDSGGPL C + + + + GITS+G G C +
Sbjct: 176 GRIRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVG-CA-----RAK 229
Query: 258 QPRLINGKESIRGAWPWQNLITSFLSAALLKL 289
+P + WP+ N I S + + L++
Sbjct: 230 RPGVYT------STWPYLNWIASKIGSNALQM 255
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 51/147 (34%), Positives = 73/147 (49%), Gaps = 3/147 (2%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVP 343
AL+K++ P + CL P Q C TGWG +K KG S L++ RV
Sbjct: 103 ALIKITPPVPC-GPFIGPGCLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVA 161
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK-DGRWYLAGITSF 402
L ++ +C + + ++C G G C GDSGGPL C + + + + GITS+
Sbjct: 162 LIDLELCNSTRWYNGRIRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSW 221
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA++ P VYT YL WI +I
Sbjct: 222 GVGCARAKRPGVYTSTWPYLNWIASKI 248
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 101 bits (252), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 17/223 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E+ R +WP Q+SLQ + H CG LI +WV+TAAHC+ ++
Sbjct: 1 VVGGTEAQRNSWPSQISLQ--YRSGSSWAHTCGGTLIRQNWVMTAAHCVDREL------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSARDKGVR 142
+ V+G+ + + + +E + V++I VH ++ +DIALL+L++ + V+
Sbjct: 52 TFRVVVGEHNLNQNDGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSY-VQ 110
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
L A N C TGWG + G L L+Q +P + ++C +
Sbjct: 111 LGVLPRAGTILAN-NSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVK 169
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
+C G DG C GDSGGPL C L +G++ + G+TSF S
Sbjct: 170 NSMVCAGG-DGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVS 210
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 4/113 (3%)
Query: 319 CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACI 378
C TGWG + G L L+Q +P + ++C + +C G DG C
Sbjct: 127 CYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGG-DGVRSGCQ 185
Query: 379 GDSGGPLQCSLKDGRWYLAGITSFGS--GCAKSGYPDVYTKLSFYLPWIRKQI 429
GDSGGPL C L +G++ + G+TSF S GC + P V+T++S Y+ WI I
Sbjct: 186 GDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVI 237
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 101 bits (252), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 17/223 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E+ R +WP Q+SLQ + H CG LI +WV+TAAHC+ ++
Sbjct: 1 VVGGTEAQRNSWPSQISLQ--YRSGSSWAHTCGGTLIRQNWVMTAAHCVDREL------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSARDKGVR 142
+ V+G+ + + +E + V++I VH ++ +DIALL+L++ + V+
Sbjct: 52 TFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSY-VQ 110
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
L A N C TGWG + G L L+Q +P + ++C +
Sbjct: 111 LGVLPRAGTILAN-NSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVK 169
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
+C G DG C GDSGGPL C L +G++ + G+TSF S
Sbjct: 170 NSMVCAGG-DGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVS 210
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 4/113 (3%)
Query: 319 CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACI 378
C TGWG + G L L+Q +P + ++C + +C G DG C
Sbjct: 127 CYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGG-DGVRSGCQ 185
Query: 379 GDSGGPLQCSLKDGRWYLAGITSFGS--GCAKSGYPDVYTKLSFYLPWIRKQI 429
GDSGGPL C L +G++ + G+TSF S GC + P V+T++S Y+ WI I
Sbjct: 186 GDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVI 237
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 77/237 (32%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+ G ++ G WPWQVS+ G+ H CG L+ WV++AAHC ++ E
Sbjct: 1 ITGGSSAVAGQWPWQVSITYE----GV--HVCGGSLVSEQWVLSAAHCFPSEHHK----E 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ LG + ++ I H + DIALL+LSRP + + +R +
Sbjct: 51 AYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPIT-FSRYIRPI 109
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRVPLHNISVCRDKYGDSVELH 202
L A N C TGWG V P L++ L+Q+ VPL + C Y +
Sbjct: 110 SLPAAQASFPN-GLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPE 168
Query: 203 GGHL------CGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIR 253
H C G ++G AC GDSGGPL C + +G WYL GI S+G CG R
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYLTGIVSWGDA-CGARNR 223
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 57/154 (37%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRV 342
ALL+LSRP + + +R + L A N C TGWG V P L++ L+Q+ V
Sbjct: 92 ALLQLSRPIT-FSRYIRPISLPAAQASFPN-GLHCTVTGWGHVAPSVSLLTPKPLQQLEV 149
Query: 343 PLHNISVCRDKYGDSVELHGGHL------CGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
PL + C Y + H C G ++G AC GDSGGPL C + +G WYL
Sbjct: 150 PLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYL 208
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
GI S+G C P VYT S Y WI+ ++
Sbjct: 209 TGIVSWGDACGARNRPGVYTLASSYASWIQSKVT 242
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 77/237 (32%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+ G ++ G WPWQVS+ G+ H CG L+ WV++AAHC ++ E
Sbjct: 1 ITGGSSAVAGQWPWQVSITYE----GV--HVCGGSLVSEQWVLSAAHCFPSEHHK----E 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ LG + ++ I H + DIALL+LSRP + + +R +
Sbjct: 51 AYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPIT-FSRYIRPI 109
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRVPLHNISVCRDKYGDSVELH 202
L A N C TGWG V P L++ L+Q+ VPL + C Y +
Sbjct: 110 SLPAAQASFPN-GLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPE 168
Query: 203 GGHL------CGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIR 253
H C G ++G AC GDSGGPL C + +G WYL GI S+G CG R
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYLTGIVSWGDA-CGARNR 223
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 57/154 (37%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRV 342
ALL+LSRP + + +R + L A N C TGWG V P L++ L+Q+ V
Sbjct: 92 ALLQLSRPIT-FSRYIRPISLPAAQASFPN-GLHCTVTGWGHVAPSVSLLTPKPLQQLEV 149
Query: 343 PLHNISVCRDKYGDSVELHGGHL------CGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
PL + C Y + H C G ++G AC GDSGGPL C + +G WYL
Sbjct: 150 PLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYL 208
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
GI S+G C P VYT S Y WI+ ++
Sbjct: 209 TGIVSWGDACGARNRPGVYTLASSYASWIQSKVT 242
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 76/234 (32%), Positives = 108/234 (46%), Gaps = 24/234 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+ G ++ G WPWQVS+ G+ H CG L+ WV++AAHC ++ E
Sbjct: 1 ITGGSSAVAGQWPWQVSIT----YEGV--HVCGGSLVSEQWVLSAAHCFPSEHHK----E 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ LG + ++ I H + DIALL+LSRP + + +R +
Sbjct: 51 AYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPIT-FSRYIRPI 109
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRVPLHNISVCRDKYGDSVELH 202
L A+ N C TGWG V P L++ L+Q+ VPL + C Y +
Sbjct: 110 SLPAANASFPN-GLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPE 168
Query: 203 GGHL------CGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGV 250
H C G ++G AC GDSGGPL C + +G WYL GI S+G CG
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYLTGIVSWGDA-CGA 220
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 57/154 (37%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK--LRQIRV 342
ALL+LSRP + + +R + L A+ N C TGWG V P L++ L+Q+ V
Sbjct: 92 ALLQLSRPIT-FSRYIRPISLPAANASFPN-GLHCTVTGWGHVAPSVSLLTPKPLQQLEV 149
Query: 343 PLHNISVCRDKYGDSVELHGGHL------CGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
PL + C Y + H C G ++G AC GDSGGPL C + +G WYL
Sbjct: 150 PLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPV-EGLWYL 208
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
GI S+G C P VYT S Y WI+ ++
Sbjct: 209 TGIVSWGDACGARNRPGVYTLASSYASWIQSKVT 242
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/233 (31%), Positives = 113/233 (48%), Gaps = 23/233 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+ + G +PWQV L G + +CG +I+ WVVTAAHCI +
Sbjct: 1 IVGGENAKPGQFPWQVLLN------GKIDAFCGGSIINEKWVVTAAHCIEPGV------- 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF----HNYHHDIALLKLSRPTSARDKGVR 142
T V G+++ E E +E R V R H + + Y HDIALL+L P + + V
Sbjct: 48 KITVVAGEYNTEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTL-NSYVT 106
Query: 143 AVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+C+ D + + K +GWGRV +G + L+ ++VPL + + C +
Sbjct: 107 PICIADKEYTNIFLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRS--TKFTI 164
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRY 254
+ C G +G +C GDSGGP + +G +L GI S+G C V +Y
Sbjct: 165 YSNMFCAGFHEGGKDSCQGDSGGP-HVTEVEGTSFLTGIISWGEE-CAVKGKY 215
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 5/149 (3%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVP 343
ALL+L P + + V +C+ D + + K +GWGRV +G + L+ ++VP
Sbjct: 91 ALLELDEPLTL-NSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFNRGRSATILQYLKVP 149
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
L + + C ++ C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 150 LVDRATCLRS--TKFTIYSNMFCAGFHEGGKDSCQGDSGGP-HVTEVEGTSFLTGIISWG 206
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQINIA 432
CA G +YTK+S Y+ WI+++ +
Sbjct: 207 EECAVKGKYGIYTKVSRYVNWIKEKTKLT 235
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 83/248 (33%), Positives = 119/248 (47%), Gaps = 20/248 (8%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG+ +YS Q R+ G + + PWQ ++ H R CG +LI W+++AAH
Sbjct: 2 CGLR-QYSQPQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAH 60
Query: 74 CIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLS 131
C P T +LG R + E + VE+ VH+EF + Y +DIALL+L
Sbjct: 61 CFQERF----PPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLK 116
Query: 132 RPTS---ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHN 187
+S VR VCL AD + + +C +G+G+ + S +L++ V L+
Sbjct: 117 SDSSRCAQESSVVRTVCLPPADLQ-LPDWTECELSGYGKHEALSPFYSERLKEAHVRLYP 175
Query: 188 ISVCRDKYGDSVELHGGHLC------GGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGIT 241
S C ++ + + LC GG AC GDSGGPL C L DGR L GI
Sbjct: 176 SSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVC-LNDGRMTLVGII 234
Query: 242 SFGSGYCG 249
S+G G CG
Sbjct: 235 SWGLG-CG 241
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 56/155 (36%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 285 ALLKLSRPTS---ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQI 340
ALL+L +S VR VCL AD + + +C +G+G+ + S +L++
Sbjct: 111 ALLQLKSDSSRCAQESSVVRTVCLPPADLQ-LPDWTECELSGYGKHEALSPFYSERLKEA 169
Query: 341 RVPLHNISVCRDKYGDSVELHGGHLC------GGQLDGFSGACIGDSGGPLQCSLKDGRW 394
V L+ S C ++ + + LC GG AC GDSGGPL C L DGR
Sbjct: 170 HVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVC-LNDGRM 228
Query: 395 YLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L GI S+G GC + P VYTK++ YL WIR +
Sbjct: 229 TLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM 263
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 17/223 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E+ R +WP Q+SLQ + H CG LI +WV+TAAHC+ ++
Sbjct: 1 VVGGTEAQRNSWPSQISLQ--YRSGSSWAHTCGGTLIRQNWVMTAAHCVDREL------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSARDKGVR 142
+ V+G+ + + +E + V++I VH ++ +DIALL+L++ + + V+
Sbjct: 52 TFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTL-NSYVQ 110
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
L A N C TGWG + G L L+Q +P + ++C +
Sbjct: 111 LGVLPRAGTILRN-NSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVK 169
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
+C G DG C GDSGGPL C L +G++ + G+TSF S
Sbjct: 170 NSMVCAGG-DGVRSGCQGDSGGPLHC-LVNGQYAVHGVTSFVS 210
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 4/113 (3%)
Query: 319 CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACI 378
C TGWG + G L L+Q +P + ++C + +C G DG C
Sbjct: 127 CYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGG-DGVRSGCQ 185
Query: 379 GDSGGPLQCSLKDGRWYLAGITSFGS--GCAKSGYPDVYTKLSFYLPWIRKQI 429
GDSGGPL C L +G++ + G+TSF S GC + P V+T++S Y+ WI I
Sbjct: 186 GDSGGPLHC-LVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVI 237
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 68/221 (30%), Positives = 106/221 (47%), Gaps = 16/221 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ GAWPW V L L CGA L+ W+V+AAHC++ P
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLL------CGASLVSSDWLVSAAHCVYGRNLE---PS 51
Query: 87 LWTAVLG---DWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRA 143
WTA+LG + T + I I H +DIA++ L + D ++
Sbjct: 52 KWTAILGLHMKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDY-IQP 110
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
+ L + + + P + C GWG V +G L++ VPL + C+ + + +
Sbjct: 111 ISLPE-ENQVFPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPE-YNITE 168
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
+C G +G +C GDSGGPL C ++ RW+LAG+TSFG
Sbjct: 169 NMICAGYEEGGIDSCQGDSGGPLMCQ-ENNRWFLAGVTSFG 208
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 2/113 (1%)
Query: 315 PKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 374
P + C GWG V +G L++ VPL + C+ + + + +C G +G
Sbjct: 122 PGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPE-YNITENMICAGYEEGGI 180
Query: 375 GACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
+C GDSGGPL C ++ RW+LAG+TSFG CA P VY ++S + WI+
Sbjct: 181 DSCQGDSGGPLMCQ-ENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQS 232
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 18/222 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G +S GAWPW V+L ++ CGA L+ W+V+AAHC++ P
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQV------CGASLVSRDWLVSAAHCVYGRNME---PS 51
Query: 87 LWTAVLG--DWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVR 142
W AVLG + E R+ +++I ++ ++ ++DIA++ L + D ++
Sbjct: 52 KWKAVLGLHMASNLTSPQIETRL-IDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDY-IQ 109
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
+CL + + + P + C GWG + +G L++ VPL + C+ + + +
Sbjct: 110 PICLPE-ENQVFPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPE-YNIT 167
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
+C G G +C GDSGGPL C ++ RW LAG+TSFG
Sbjct: 168 ENMVCAGYEAGGVDSCQGDSGGPLMCQ-ENNRWLLAGVTSFG 208
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
A++ L + D ++ +CL + + + P + C GWG + +G L++ VPL
Sbjct: 94 AMMHLEMKVNYTDY-IQPICLPE-ENQVFPPGRICSIAGWGALIYQGSTADVLQEADVPL 151
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ C+ + + + +C G G +C GDSGGPL C ++ RW LAG+TSFG
Sbjct: 152 LSNEKCQQQMPE-YNITENMVCAGYEAGGVDSCQGDSGGPLMCQ-ENNRWLLAGVTSFGY 209
Query: 405 GCAKSGYPDVYTKLSFYLPWIRK 427
CA P VY ++ + WI+
Sbjct: 210 QCALPNRPGVYARVPRFTEWIQS 232
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 99.8 bits (247), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G++ G PWQ +L V G +CG +++ +V+TAAHC+H +
Sbjct: 1 IVGGRDCAEGECPWQ-ALLVNEENEG----FCGGTILNEFYVLTAAHCLHQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+T +GD + +EE +E+ VE H F Y DIA+L+L P R + V
Sbjct: 49 RFTVRVGDRNTEQEEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFR-RNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG L S L+ + VP + S C K S +
Sbjct: 108 CLPEKDWAEATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTC--KLSSSFTIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 PNMFCAGYDTQPEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 52/145 (35%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
A+L+L P R + V CL + D + + ++ + +G+GR KG L S L+ + V
Sbjct: 90 AVLRLKTPIRFR-RNVAPACLPEKDWAEATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEV 148
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P + S C K S + C G AC GDSGGP KD +++ GI S+
Sbjct: 149 PYVDRSTC--KLSSSFTITPNMFCAGYDTQPEDACQGDSGGPHVTRFKD-TYFVTGIVSW 205
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRK 427
G GCA+ G VYTK+S +L WI K
Sbjct: 206 GEGCARKGKFGVYTKVSNFLKWIDK 230
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 99.0 bits (245), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 22/224 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ G +PWQV L G + +CG +++ W+VTAAHC+ +
Sbjct: 1 VVGGEDAKPGQFPWQVVLN------GKVDAFCGGSIVNEKWIVTAAHCVETGV------- 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF----HNYHHDIALLKLSRPTSARDKGVR 142
T V G+ + E E +E + V RI H F + Y+HDIALL+L P + V
Sbjct: 48 KITVVAGEHNIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPL-VLNSYVT 106
Query: 143 AVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+C+ D + + K +GWGRV KG L+ +RVPL + + C +
Sbjct: 107 PICIADKEYTNIFLKFGSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRS--TKFTI 164
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 165 TNNMFCAGFHEGGRDSCQGDSGGP-HVTEVEGTSFLTGIISWGE 207
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVP 343
ALL+L P + V +C+ D + + K +GWGRV KG L+ +RVP
Sbjct: 91 ALLELDEPL-VLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRAALVLQYLRVP 149
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
L + + C + C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 150 LVDRATCLRS--TKFTITNNMFCAGFHEGGRDSCQGDSGGP-HVTEVEGTSFLTGIISWG 206
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQINIA 432
CA G +YTK+S Y+ WI+++ +
Sbjct: 207 EECAMKGKYGIYTKVSRYVNWIKEKTKLT 235
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 98.6 bits (244), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 22/223 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+ + +WPWQ+SLQ + H CG LI WV+TAAHC+ +
Sbjct: 1 VVGGRVAQPNSWPWQISLQ--YKSGSSYYHTCGGSLIRQGWVMTAAHCVDS-------AR 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH----HDIALLKLSRPTSARDKGVR 142
W VLG+ + E E + V + +H +++ +DIALL+L+ S + V+
Sbjct: 52 TWRVVLGEHNLNTNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQAS-LNSAVQ 110
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDK--YGDSVE 200
L +++ N C TGWG+ G L L+Q +P + + C +G +V+
Sbjct: 111 LAALPPSNQILPN-NNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWGSTVK 169
Query: 201 LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 243
+C G G + C GDSGGPL C + +G +Y+ G+TSF
Sbjct: 170 TT--MVCAG--GGANSGCNGDSGGPLNCQV-NGSYYVHGVTSF 207
Score = 71.2 bits (173), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 49/146 (33%), Positives = 76/146 (52%), Gaps = 11/146 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
ALL+L+ S + V+ L +++ N C TGWG+ G L L+Q +P
Sbjct: 95 ALLRLNTQAS-LNSAVQLAALPPSNQILPN-NNPCYITGWGKTSTGGPLSDSLKQAWLPS 152
Query: 345 HNISVCRDK--YGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
+ + C +G +V+ +C G G + C GDSGGPL C + +G +Y+ G+TSF
Sbjct: 153 VDHATCSSSGWWGSTVKTT--MVCAG--GGANSGCNGDSGGPLNCQV-NGSYYVHGVTSF 207
Query: 403 --GSGCAKSGYPDVYTKLSFYLPWIR 426
SGC S P V+T++S Y+ W+
Sbjct: 208 VSSSGCNASKKPTVFTRVSAYISWMN 233
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 98.6 bits (244), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 22/224 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ G +PWQV L G + +CG +++ W+VTAAHC+ +
Sbjct: 1 VVGGEDAKPGQFPWQVVLN------GKVDAFCGGSIVNEKWIVTAAHCVETGV------- 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF----HNYHHDIALLKLSRPTSARDKGVR 142
T V G+ + E E +E + V RI H F + Y+HDIALL+L P + V
Sbjct: 48 KITVVAGEHNIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPL-VLNSYVT 106
Query: 143 AVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+C+ D + + K +GWGRV KG L+ +RVPL + + C +
Sbjct: 107 PICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS--TKFTI 164
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 165 TNNMFCAGFHEGGRDSCQGDSGGP-HVTEVEGTSFLTGIISWGE 207
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVP 343
ALL+L P + V +C+ D + + K +GWGRV KG L+ +RVP
Sbjct: 91 ALLELDEPL-VLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVP 149
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
L + + C + C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 150 LVDRATCLRS--TKFTITNNMFCAGFHEGGRDSCQGDSGGP-HVTEVEGTSFLTGIISWG 206
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQINIA 432
CA G +YTK+S Y+ WI+++ +
Sbjct: 207 EECAMKGKYGIYTKVSRYVNWIKEKTKLT 235
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 98.6 bits (244), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ G +PWQV L G + +CG +++ W+VTAAHC+ +
Sbjct: 1 VVGGEDAKPGQFPWQVVLN------GKVDAFCGGSIVNEKWIVTAAHCVETGV------- 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF----HNYHHDIALLKLSRPTSARDKGVR 142
T V G+ + E E +E + V RI H + + Y+HDIALL+L P + V
Sbjct: 48 KITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPL-VLNSYVT 106
Query: 143 AVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+C+ D + + K +GWGRV KG L+ +RVPL + + C +
Sbjct: 107 PICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS--TKFTI 164
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
+ C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 165 YNNMFCAGFHEGGRDSCQGDSGGP-HVTEVEGTSFLTGIISWGE 207
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVP 343
ALL+L P + V +C+ D + + K +GWGRV KG L+ +RVP
Sbjct: 91 ALLELDEPL-VLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVP 149
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
L + + C ++ C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 150 LVDRATCLRS--TKFTIYNNMFCAGFHEGGRDSCQGDSGGP-HVTEVEGTSFLTGIISWG 206
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQINIA 432
CA G +YTK+S Y+ WI+++ +
Sbjct: 207 EECAMKGKYGIYTKVSRYVNWIKEKTKLT 235
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 82/267 (30%), Positives = 122/267 (45%), Gaps = 41/267 (15%)
Query: 1 MINLCD------TVTFARDCGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLM 54
+I++CD +DCG R R++ G+++ G WPWQVSL+
Sbjct: 89 VISVCDCPRGRFLAAICQDCG---RRKLPVDRIVGGRDTSLGRWPWQVSLRYDG------ 139
Query: 55 PHWCGAVLIHPSWVVTAAHCI--HNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERI 112
H CG L+ WV+TAAHC N + S W G + +++ V+ +
Sbjct: 140 AHLCGGSLLSGDWVLTAAHCFPERNRVLS-----RWRVFAG--AVAQASPHGLQLGVQAV 192
Query: 113 RVHEEFHNYH--------HDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATG 164
H + + +DIAL+ LS P + ++ VCL A + V+ K C TG
Sbjct: 193 VYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEY-IQPVCLPAAGQALVDGK-ICTVTG 250
Query: 165 WGRVKPKGDLVSKLRQIRVPLHNISVCR--DKYGDSVELHGGHLCGGQLDGFSGACIGDS 222
WG + G L++ RVP+ + VC D YG+ ++ C G +G AC GDS
Sbjct: 251 WGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPK--MFCAGYPEGGIDACQGDS 308
Query: 223 GGPLQCS---LKDGRWYLAGITSFGSG 246
GGP C + RW L GI S+G+G
Sbjct: 309 GGPFVCEDSISRTPRWRLCGIVSWGTG 335
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 57/151 (37%), Positives = 79/151 (52%), Gaps = 9/151 (5%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+ LS P + ++ VCL A + V+ K C TGWG + G L++ RVP+
Sbjct: 214 ALVHLSSPLPLTEY-IQPVCLPAAGQALVDGKI-CTVTGWGNTQYYGQQAGVLQEARVPI 271
Query: 345 HNISVCR--DKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCS---LKDGRWYLAGI 399
+ VC D YG+ ++ C G +G AC GDSGGP C + RW L GI
Sbjct: 272 ISNDVCNGADFYGNQIKPK--MFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGI 329
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G+GCA + P VYTK+S + WI + I
Sbjct: 330 VSWGTGCALAQKPGVYTKVSDFREWIFQAIK 360
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 82/267 (30%), Positives = 122/267 (45%), Gaps = 41/267 (15%)
Query: 1 MINLCDT------VTFARDCGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLM 54
+I++CD +DCG R R++ G+++ G WPWQVSL+
Sbjct: 89 VISVCDCPRGRFLAAICQDCG---RRKLPVDRIVGGRDTSLGRWPWQVSLRYDG------ 139
Query: 55 PHWCGAVLIHPSWVVTAAHCI--HNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERI 112
H CG L+ WV+TAAHC N + S W G + +++ V+ +
Sbjct: 140 AHLCGGSLLSGDWVLTAAHCFPERNRVLS-----RWRVFAG--AVAQASPHGLQLGVQAV 192
Query: 113 RVHEEFHNYH--------HDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATG 164
H + + +DIAL+ LS P + ++ VCL A + V+ K C TG
Sbjct: 193 VYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEY-IQPVCLPAAGQALVDGK-ICTVTG 250
Query: 165 WGRVKPKGDLVSKLRQIRVPLHNISVCR--DKYGDSVELHGGHLCGGQLDGFSGACIGDS 222
WG + G L++ RVP+ + VC D YG+ ++ C G +G AC GDS
Sbjct: 251 WGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPK--MFCAGYPEGGIDACQGDS 308
Query: 223 GGPLQCS---LKDGRWYLAGITSFGSG 246
GGP C + RW L GI S+G+G
Sbjct: 309 GGPFVCEDSISRTPRWRLCGIVSWGTG 335
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 57/151 (37%), Positives = 79/151 (52%), Gaps = 9/151 (5%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+ LS P + ++ VCL A + V+ K C TGWG + G L++ RVP+
Sbjct: 214 ALVHLSSPLPLTEY-IQPVCLPAAGQALVDGKI-CTVTGWGNTQYYGQQAGVLQEARVPI 271
Query: 345 HNISVCR--DKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCS---LKDGRWYLAGI 399
+ VC D YG+ ++ C G +G AC GDSGGP C + RW L GI
Sbjct: 272 ISNDVCNGADFYGNQIKPK--MFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGI 329
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G+GCA + P VYTK+S + WI + I
Sbjct: 330 VSWGTGCALAQKPGVYTKVSDFREWIFQAIK 360
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 69/231 (29%), Positives = 109/231 (47%), Gaps = 18/231 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHC--IHNDIFSLPI 84
+I G+++ GAWPW VSLQ+ H CG L++ W++TAAHC I +
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTD--- 57
Query: 85 PELWTAVLGDWDRTEEEKSEVRIP-----VERIRVHEEF--HNYHHDIALLKLSRPTSAR 137
W + G + V+ P VE+I +HE++ + +DIAL+K++ P +
Sbjct: 58 ---WRLIFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTC- 113
Query: 138 DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYG 196
+ CL P Q C GWG ++ S L++ RV L ++ +C
Sbjct: 114 GHFIGPGCLPQFRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRW 173
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQCS-LKDGRWYLAGITSFGSG 246
+ + ++C G +G C GDSGGPL C + + + GITS+G G
Sbjct: 174 YNGRIRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVG 224
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 3/147 (2%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVP 343
AL+K++ P + + CL P Q C GWG ++ S L++ RV
Sbjct: 103 ALMKITPPVTC-GHFIGPGCLPQFRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVD 161
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCS-LKDGRWYLAGITSF 402
L ++ +C + + ++C G +G C GDSGGPL C + + + GITS+
Sbjct: 162 LIDLGLCNSTRWYNGRIRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSW 221
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA++ P VYT YL WI +I
Sbjct: 222 GVGCARAKRPGVYTSTWSYLNWIASKI 248
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ G +PWQV L G + +CG +++ W+VTAAHC+ +
Sbjct: 1 VVGGEDAKPGQFPWQVVLN------GKVDAFCGGSIVNEKWIVTAAHCVETGV------- 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF----HNYHHDIALLKLSRPTSARDKGVR 142
T V G+ + E E +E + V RI H + + Y+HDIALL+L P + V
Sbjct: 48 KITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPL-VLNSYVT 106
Query: 143 AVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+C+ D + + K +GWGRV KG L+ +RVPL + + C +
Sbjct: 107 PICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS--TKFTI 164
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
+ C G +G +C GD+GGP + +G +L GI S+G
Sbjct: 165 YNNMFCAGFHEGGRDSCQGDAGGP-HVTEVEGTSFLTGIISWGE 207
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVP 343
ALL+L P + V +C+ D + + K +GWGRV KG L+ +RVP
Sbjct: 91 ALLELDEPL-VLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVP 149
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
L + + C ++ C G +G +C GD+GGP + +G +L GI S+G
Sbjct: 150 LVDRATCLRS--TKFTIYNNMFCAGFHEGGRDSCQGDAGGP-HVTEVEGTSFLTGIISWG 206
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQINIA 432
CA G +YTK+S Y+ WI+++ +
Sbjct: 207 EECAMKGKYGIYTKVSRYVNWIKEKTKLT 235
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 22/224 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ G +PWQV L G + +CG +++ W+VTAAHC+ +
Sbjct: 1 VVGGEDAKPGQFPWQVVLN------GKVDAFCGGSIVNEKWIVTAAHCVETGV------- 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF----HNYHHDIALLKLSRPTSARDKGVR 142
T V G+ + E E +E + V RI H + + Y+HDIALL+L P + V
Sbjct: 48 KITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPL-VLNSYVT 106
Query: 143 AVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+C+ D + + K +GWGRV KG L+ +RVPL + + C +
Sbjct: 107 PICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRS--TKFTI 164
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 165 TNNMFCAGFHEGGRDSCQGDSGGP-HVTEVEGTSFLTGIISWGE 207
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 5/149 (3%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQIRVP 343
ALL+L P + V +C+ D + + K +GWGRV KG L+ +RVP
Sbjct: 91 ALLELDEPL-VLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVP 149
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
L + + C + C G +G +C GDSGGP + +G +L GI S+G
Sbjct: 150 LVDRATCLRS--TKFTITNNMFCAGFHEGGRDSCQGDSGGP-HVTEVEGTSFLTGIISWG 206
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQINIA 432
CA G +YTK+S Y+ WI+++ +
Sbjct: 207 EECAMKGKYGIYTKVSRYVNWIKEKTKLT 235
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 76/232 (32%), Positives = 110/232 (47%), Gaps = 19/232 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ GK+ +G PWQV L V +L CG LI+ WVV+AAHC +
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQL------CGGTLINTIWVVSAAHCFDK----IKNWR 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
AVLG+ D +E + E V ++ + + +HDIALL+L +P D V +
Sbjct: 51 NLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDH-VVPL 109
Query: 145 CLTD--ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRD---KYGDSV 199
CL + +R + + + +GWG++ +G L+ + VP C K GDS
Sbjct: 110 CLPERTFSERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSP 169
Query: 200 ELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVG 251
+ C G DG +C GDSGGP + G WYL GI S+G G VG
Sbjct: 170 NITEYMFCAGYSDGSKDSCKGDSGGPHATHYR-GTWYLTGIVSWGQGCATVG 220
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/148 (35%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTD--ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
ALL+L +P D V +CL + +R + + + +GWG++ +G L+ + V
Sbjct: 92 ALLRLHQPVVLTDH-VVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALVLQVLNV 150
Query: 343 PLHNISVCRD---KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
P C K GDS + C G DG +C GDSGGP + G WYL GI
Sbjct: 151 PRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYR-GTWYLTGI 209
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
S+G GCA G+ VYT++S Y+ W++K
Sbjct: 210 VSWGQGCATVGHFGVYTRVSQYIEWLQK 237
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 76/223 (34%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
PWQ ++ H R CG +LI W+++AAHC P T +LG R
Sbjct: 13 PWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERF----PPHHLTVILGRTYRV 68
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTS---ARDKGVRAVCLTDADKRP 153
+ E + VE+ VH+EF + Y +DIALL+L +S VR VCL AD +
Sbjct: 69 VPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQ- 127
Query: 154 VNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCRDKYGDSVELHGGHLC----- 207
+ +C +G+G+ + S +L++ V L+ S C ++ + + LC
Sbjct: 128 LPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTR 187
Query: 208 -GGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
GG AC GDSGGPL C L DGR L GI S+G G CG
Sbjct: 188 SGGPQANLHDACQGDSGGPLVC-LNDGRMTLVGIISWGLG-CG 228
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 56/155 (36%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 285 ALLKLSRPTS---ARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQI 340
ALL+L +S VR VCL AD + + +C +G+G+ + S +L++
Sbjct: 98 ALLQLKSDSSRCAQESSVVRTVCLPPADLQ-LPDWTECELSGYGKHEALSPFYSERLKEA 156
Query: 341 RVPLHNISVCRDKYGDSVELHGGHLC------GGQLDGFSGACIGDSGGPLQCSLKDGRW 394
V L+ S C ++ + + LC GG AC GDSGGPL C L DGR
Sbjct: 157 HVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVC-LNDGRM 215
Query: 395 YLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L GI S+G GC + P VYTK++ YL WIR +
Sbjct: 216 TLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM 250
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 95.1 bits (235), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 82/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG+ +Y Q G + + PWQ ++ + R CG +LI WV+TAAH
Sbjct: 2 CGLR-KYKEPQLHSTGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAH 60
Query: 74 CIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKL- 130
C +P+ VLG R + + E V++ VH+EF + Y++DIALL+L
Sbjct: 61 CFQESY----LPDQLKVVLGRTYRVKPGEEEQTFKVKKYIVHKEFDDDTYNNDIALLQLK 116
Query: 131 -SRPTSARDK-GVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHN 187
P A++ VRA+CL +A+ + + +C +G+G+ K S +L++ V L+
Sbjct: 117 SDSPQCAQESDSVRAICLPEANLQ-LPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLYP 175
Query: 188 ISVCRDKYGDSVELHGGHLCGGQLDGFSG--------ACIGDSGGPLQCSLKDGRWYLAG 239
S C K+ + + LC G D SG AC GDSGGPL C + D L G
Sbjct: 176 SSRCAPKFLFNKTVTNNMLCAG--DTRSGEIYPNVHDACQGDSGGPLVC-MNDNHMTLLG 232
Query: 240 ITSFGSGYCG 249
I S+G G CG
Sbjct: 233 IISWGVG-CG 241
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 55/155 (35%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 287 LKLSRPTSARDK-GVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPL 344
LK P A++ VRA+CL +A+ + + +C +G+G+ K S +L++ V L
Sbjct: 115 LKSDSPQCAQESDSVRAICLPEANLQ-LPDWTECELSGYGKHKSSSPFYSEQLKEGHVRL 173
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSG--------ACIGDSGGPLQCSLKDGRWYL 396
+ S C K+ + + LC G D SG AC GDSGGPL C + D L
Sbjct: 174 YPSSRCAPKFLFNKTVTNNMLCAG--DTRSGEIYPNVHDACQGDSGGPLVC-MNDNHMTL 230
Query: 397 AGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQINI 431
GI S+G GC + P VYTK++ YL WIR +++
Sbjct: 231 LGIISWGVGCGEKDVPGVYTKVTNYLGWIRDNMHL 265
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 95.1 bits (235), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 76/232 (32%), Positives = 109/232 (46%), Gaps = 19/232 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ GK +G PWQV L V +L CG LI+ WVV+AAHC +
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQL------CGGTLINTIWVVSAAHCFDK----IKNWR 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
AVLG+ D +E + E V ++ + + +HDIALL+L +P D V +
Sbjct: 51 NLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDH-VVPL 109
Query: 145 CLTD--ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRD---KYGDSV 199
CL + +R + + + +GWG++ +G +L + VP C K GDS
Sbjct: 110 CLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSP 169
Query: 200 ELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVG 251
+ C G DG +C GDSGGP + G WYL GI S+G G VG
Sbjct: 170 NITEYMFCAGYSDGSKDSCKGDSGGPHATHYR-GTWYLTGIVSWGQGCATVG 220
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/148 (35%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTD--ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
ALL+L +P D V +CL + +R + + + +GWG++ +G +L + V
Sbjct: 92 ALLRLHQPVVLTDH-VVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNV 150
Query: 343 PLHNISVCRD---KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
P C K GDS + C G DG +C GDSGGP + G WYL GI
Sbjct: 151 PRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYR-GTWYLTGI 209
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
S+G GCA G+ VYT++S Y+ W++K
Sbjct: 210 VSWGQGCATVGHFGVYTRVSQYIEWLQK 237
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 94.7 bits (234), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 74/235 (31%), Positives = 110/235 (46%), Gaps = 32/235 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCI--HNDIFSLPI 84
++ G+++ G WPWQVSL+ H CG L+ WV+TAAHC N + S
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGA------HLCGGSLLSGDWVLTAAHCFPERNRVLS--- 51
Query: 85 PELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--------HDIALLKLSRPTSA 136
W G + +++ V+ + H + + +DIAL+ LS P
Sbjct: 52 --RWRVFAG--AVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPL 107
Query: 137 RDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCR--DK 194
+ ++ VCL A + V+ K C TGWG + G L++ RVP+ + VC D
Sbjct: 108 TEY-IQPVCLPAAGQALVDGK-ICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADF 165
Query: 195 YGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCS---LKDGRWYLAGITSFGSG 246
YG+ ++ C G +G AC GDSGGP C + RW L GI S+G+G
Sbjct: 166 YGNQIKPK--MFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTG 218
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 57/150 (38%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+ LS P + ++ VCL A + V+ K C TGWG + G L++ RVP+
Sbjct: 97 ALVHLSSPLPLTEY-IQPVCLPAAGQALVDGKI-CTVTGWGNTQYYGQQAGVLQEARVPI 154
Query: 345 HNISVCR--DKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCS---LKDGRWYLAGI 399
+ VC D YG+ ++ C G +G AC GDSGGP C + RW L GI
Sbjct: 155 ISNDVCNGADFYGNQIKPK--MFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGI 212
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
S+G+GCA + P VYTK+S + WI + I
Sbjct: 213 VSWGTGCALAQKPGVYTKVSDFREWIFQAI 242
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 30/257 (11%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG+ ++ NG+ + +G PW L L+ + +CG L+ SW+VTAAH
Sbjct: 143 CGLPKFSRKLMAQIFNGRPAQKGTTPWIAMLSHLNGQ-----PFCGGSLLGSSWIVTAAH 197
Query: 74 CIHNDI---------FSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYH 122
C+H + L P + +LG R +++E + V+ +H ++ + +
Sbjct: 198 CLHQSLDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFE 257
Query: 123 HDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQ---CVATGWGRVKPKGDLVSKLR 179
+D+AL++L + + V +CL P P+Q+ + +GWG+ + L
Sbjct: 258 NDVALVELLE-SPVLNAFVMPICL------PEGPQQEGAMVIVSGWGK-QFLQRFPETLM 309
Query: 180 QIRVPLHNISVCRDKYGD-SVELHGGHLCGGQLDGFSGACIGDSGGPL-QCSLKDGRWYL 237
+I +P+ + S C+ Y ++ +C G+ +G AC GDSGGP+ + + G+WYL
Sbjct: 310 EIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYL 369
Query: 238 AGITSFGSGYCGVGIRY 254
G S+G CG RY
Sbjct: 370 VGTVSWGDD-CGKKDRY 385
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 39/133 (29%), Positives = 65/133 (48%), Gaps = 12/133 (9%)
Query: 300 VRAVCLTDADKRPVNPKQQ---CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGD 356
V +CL P P+Q+ + +GWG+ + L +I +P+ + S C+ Y
Sbjct: 275 VMPICL------PEGPQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYAP 327
Query: 357 -SVELHGGHLCGGQLDGFSGACIGDSGGPL-QCSLKDGRWYLAGITSFGSGCAKSGYPDV 414
++ +C G+ +G AC GDSGGP+ + + G+WYL G S+G C K V
Sbjct: 328 LKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGV 387
Query: 415 YTKLSFYLPWIRK 427
Y+ + WI++
Sbjct: 388 YSYIHHNKDWIQR 400
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 76/240 (31%), Positives = 115/240 (47%), Gaps = 19/240 (7%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CGV R R+ R++ GK + G PWQV+++ G+ CG + I W++TAAH
Sbjct: 309 CGVKNRMHIRRKRIVGGKRAQLGDLPWQVAIK---DASGIT---CGGIYIGGCWILTAAH 362
Query: 74 CIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLS 131
C+ ++WT V+ DW + ++ + V+RI HE ++ Y +DIAL+++
Sbjct: 363 CLRAS--KTHRYQIWTTVV-DWIHPDLKRIVIEY-VDRIIFHENYNAGTYQNDIALIEMK 418
Query: 132 RPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNIS 189
+ + +D + P P C+ +GWGR K + V L+ V L IS
Sbjct: 419 KDGNKKDCELPRSIPACVPWSPYLFQPNDTCIVSGWGREK-DNERVFSLQWGEVKL--IS 475
Query: 190 VCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
C YG+ C G DG AC GDSGGPL C + Y+ G+ S+G CG
Sbjct: 476 NCSKFYGNRF-YEKEMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGEN-CG 533
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 44/115 (38%), Positives = 57/115 (49%), Gaps = 4/115 (3%)
Query: 315 PKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 374
P C+ +GWGR K + V L+ V L IS C YG+ C G DG
Sbjct: 445 PNDTCIVSGWGREK-DNERVFSLQWGEVKL--ISNCSKFYGNRF-YEKEMECAGTYDGSI 500
Query: 375 GACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
AC GDSGGPL C + Y+ G+ S+G C K +P VYTK++ Y WI +
Sbjct: 501 DACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWISYHV 555
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 73/230 (31%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIH---NDIFSL 82
R+ NG E + PW L+ + + G CG +I +++TAAHC+H ND++ +
Sbjct: 118 RVSNGYEVKLSSRPWMALLR--YQQFGESRFLCGGAMISERYILTAAHCVHGLQNDLYEI 175
Query: 83 PIPELWTAVLGDWDRTEEEKS----EVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSA 136
+ E + D + +K V + +E+ +HE++ H HDIALLKL+R
Sbjct: 176 RLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIMHDIALLKLNRSVPF 235
Query: 137 RDKGVRAVCL--TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDK 194
+ K ++ +CL TD K TGWG + G L Q VPL S C
Sbjct: 236 Q-KHIKPICLPITDELKEKAEQISTYFVTGWGTTE-NGSSSDVLLQANVPLQPRSACSQA 293
Query: 195 YGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
Y +V L LC G D +C GDSGGPLQ + Y + FG
Sbjct: 294 YRRAVPL--SQLCVGGGD-LQDSCKGDSGGPLQAPAQYLGEYAPKMVEFG 340
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 64/149 (42%), Gaps = 13/149 (8%)
Query: 285 ALLKLSRPTSARDKGVRAVCL--TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
ALLKL+R + K ++ +CL TD K TGWG + G L Q V
Sbjct: 225 ALLKLNRSVPFQ-KHIKPICLPITDELKEKAEQISTYFVTGWGTTE-NGSSSDVLLQANV 282
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
PL S C Y +V L LC G D +C GDSGGPLQ + Y + F
Sbjct: 283 PLQPRSACSQAYRRAVPL--SQLCVGGGD-LQDSCKGDSGGPLQAPAQYLGEYAPKMVEF 339
Query: 403 G------SGCAKSGYPDVYTKLSFYLPWI 425
G C + P +YT + Y+ WI
Sbjct: 340 GIVSQGVVTCGQISLPGLYTNVGEYVQWI 368
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 78/231 (33%), Positives = 113/231 (48%), Gaps = 19/231 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSV 199
VCL D + + + TGWG +K KG S L+ + +P+ VC+D +
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKEKGQ-PSVLQVVNLPIVERPVCKD--STRI 172
Query: 200 ELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
+ C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 173 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 223
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 52/152 (34%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
AL+KL +P + D + VCL D + + + TGWG +K KG S L+ + +
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKEKGQ-PSVLQVVNL 158
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAG 398
P+ VC+D + + C G +G G AC GDSGGP S + RWY G
Sbjct: 159 PIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 216
Query: 399 ITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+G GC + G YT + WI+K I+
Sbjct: 217 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 248
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 68/244 (27%), Positives = 119/244 (48%), Gaps = 30/244 (12%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDI------- 79
+ NG+ + +G PW L L+ + +CG L+ SW+VTAAHC+H +
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQ-----PFCGGSLLGSSWIVTAAHCLHQSLDPKDPTL 55
Query: 80 --FSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTS 135
L P + +LG R +++E + V+ +H ++ + + +D+AL++L +
Sbjct: 56 RDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLE-SP 114
Query: 136 ARDKGVRAVCLTDADKRPVNPKQQ---CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCR 192
+ V +CL P P+Q+ + +GWG+ + L +I +P+ + S C+
Sbjct: 115 VLNAFVMPICL------PEGPQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHSTCQ 167
Query: 193 DKYGD-SVELHGGHLCGGQLDGFSGACIGDSGGPL-QCSLKDGRWYLAGITSFGSGYCGV 250
Y ++ +C G+ +G AC GDSGGP+ + + G+WYL G S+G CG
Sbjct: 168 KAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDD-CGK 226
Query: 251 GIRY 254
RY
Sbjct: 227 KDRY 230
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 39/133 (29%), Positives = 65/133 (48%), Gaps = 12/133 (9%)
Query: 300 VRAVCLTDADKRPVNPKQQ---CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGD 356
V +CL P P+Q+ + +GWG+ + L +I +P+ + S C+ Y
Sbjct: 120 VMPICL------PEGPQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYAP 172
Query: 357 -SVELHGGHLCGGQLDGFSGACIGDSGGPL-QCSLKDGRWYLAGITSFGSGCAKSGYPDV 414
++ +C G+ +G AC GDSGGP+ + + G+WYL G S+G C K V
Sbjct: 173 LKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGV 232
Query: 415 YTKLSFYLPWIRK 427
Y+ + WI++
Sbjct: 233 YSYIHHNKDWIQR 245
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 72/237 (30%), Positives = 111/237 (46%), Gaps = 42/237 (17%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + + + PWQV++ + + CG VLI PSWV+TAAHC N+
Sbjct: 1 IVGGYKCEKNSQPWQVAV--------INEYLCGGVLIDPSWVITAAHCYSNN-------- 44
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF-------------HNYHHDIALLKLSRP 133
+ +LG + ++E R V + H ++ H++ +D+ LL LS P
Sbjct: 45 -YQVLLGRNNLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEP 103
Query: 134 TSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCR 192
GV+ + D + C+A+GWG P +VS L+ + + L + C
Sbjct: 104 ADITG-GVKVI---DLPTKEPKVGSTCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEKCI 159
Query: 193 DKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+ Y D+V LC G+++G C GDSGGPL C DG L GITS G+ C
Sbjct: 160 ETYKDNVT--DVMLCAGEMEGGKDTCAGDSGGPLIC---DG--VLQGITSGGATPCA 209
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 59/178 (33%), Positives = 82/178 (46%), Gaps = 16/178 (8%)
Query: 252 IRYSHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKR 311
+R S R P I + P + + LL LS P GV+ + D +
Sbjct: 66 VRQSFRHPDYIPLIVTNDTEQPVHDHSNDLM---LLHLSEPADITG-GVKVI---DLPTK 118
Query: 312 PVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL 370
C+A+GWG P +VS L+ + + L + C + Y D+V LC G++
Sbjct: 119 EPKVGSTCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEKCIETYKDNVT--DVMLCAGEM 176
Query: 371 DGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWIRK 427
+G C GDSGGPL C DG L GITS G+ CAK P +Y KL + WI+K
Sbjct: 177 EGGKDTCAGDSGGPLIC---DG--VLQGITSGGATPCAKPKTPAIYAKLIKFTSWIKK 229
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 73/236 (30%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 24 QPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLP 83
+PR+I G S+ G+ PW ++ + +C L+H WVV+AAHC + P
Sbjct: 33 RPRIIGGSSSLPGSHPWLAAIYIGD-------SFCAGSLVHTCWVVSAAHCFSHS----P 81
Query: 84 IPELWTAVLGD------WDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRP---T 134
+ + VLG D T+ E IP ++ F+ HD+ L++L +
Sbjct: 82 PRDSVSVVLGQHFFNRTTDVTQTFGIEKYIPYT---LYSVFNPSDHDLVLIRLKKKGDRC 138
Query: 135 SARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPK-GDLVSKLRQIRVPLHNISVCRD 193
+ R + V+ +CL + +C GWG + S LR+ VPL C
Sbjct: 139 ATRSQFVQPICLPEPGST-FPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSS 197
Query: 194 KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
++ LC G D S AC GDSGGPL C K+G YL GI S+G G CG
Sbjct: 198 PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDG-CG 251
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 48/137 (35%), Positives = 66/137 (48%), Gaps = 3/137 (2%)
Query: 294 SARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPK-GDLVSKLRQIRVPLHNISVCRD 352
+ R + V+ +CL + +C GWG + S LR+ VPL C
Sbjct: 139 ATRSQFVQPICLPEPGST-FPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSS 197
Query: 353 KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYP 412
++ LC G D S AC GDSGGPL C K+G YL GI S+G GC + P
Sbjct: 198 PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDGCGRLHKP 256
Query: 413 DVYTKLSFYLPWIRKQI 429
VYT+++ Y+ WI +I
Sbjct: 257 GVYTRVANYVDWINDRI 273
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
R++ G+E G PWQ +L + G +CG ++ +++TAAHC++
Sbjct: 15 RIVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------A 62
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRA 143
+ + +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 63 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAP 121
Query: 144 VCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 122 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFII 179
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 180 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 223
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 102 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 160
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 161 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 217
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 218 VSWGEGCARKGKYGIYTKVTAFLKWIDRSM 247
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 111/231 (48%), Gaps = 18/231 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSV 199
VCL D + + + TGWG +K S L+ + +P+ VC+D +
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKD--STRI 173
Query: 200 ELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
+ C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 174 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 224
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 50/152 (32%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
AL+KL +P + D + VCL D + + + TGWG +K S L+ + +
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWGQPSVLQVVNL 159
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAG 398
P+ VC+D + + C G +G G AC GDSGGP S + RWY G
Sbjct: 160 PIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 217
Query: 399 ITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+G GC + G YT + WI+K I+
Sbjct: 218 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 249
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 77/231 (33%), Positives = 112/231 (48%), Gaps = 19/231 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSV 199
VCL D + + + TGWG +K G S L+ + +P+ VC+D +
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKD--STRI 172
Query: 200 ELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
+ C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 173 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 223
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
AL+KL +P + D + VCL D + + + TGWG +K G S L+ + +
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETGQ-PSVLQVVNL 158
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAG 398
P+ VC+D + + C G +G G AC GDSGGP S + RWY G
Sbjct: 159 PIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 216
Query: 399 ITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+G GC + G YT + WI+K I+
Sbjct: 217 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 248
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 77/231 (33%), Positives = 112/231 (48%), Gaps = 19/231 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSV 199
VCL D + + + TGWG +K G S L+ + +P+ VC+D +
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKD--STRI 172
Query: 200 ELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
+ C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 173 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 223
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
AL+KL +P + D + VCL D + + + TGWG +K G S L+ + +
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETGQ-PSVLQVVNL 158
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAG 398
P+ VC+D + + C G +G G AC GDSGGP S + RWY G
Sbjct: 159 PIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 216
Query: 399 ITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+G GC + G YT + WI+K I+
Sbjct: 217 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 248
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S D V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTS---CASA 113
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 114 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 171
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 172 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 197
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 70/238 (29%), Positives = 104/238 (43%), Gaps = 39/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S D V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTS---C 110
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 111 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 168
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 169 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 221
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG+ ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG+ ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG+ ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG+ ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 29/233 (12%)
Query: 16 VGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCI 75
+G ++ +++ G E + P QVSL + H+CG L++ +WVV+AAHC
Sbjct: 10 IGAAFATEDDKIVGGYECKPYSQPHQVSLNSGY-------HFCGGSLVNENWVVSAAHCY 62
Query: 76 HNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRP 133
+ + LG+ + E SE I R+ H + +Y+ +DI L+KLS+P
Sbjct: 63 KSRV---------EVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKP 113
Query: 134 TSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRD 193
+ + V+ V L + C +GWG +KL+ + +P+ + S C +
Sbjct: 114 AT-LNTYVQPVALPTSCAP---AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNN 169
Query: 194 KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 170 SYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 215
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KLS+P + + V+ V L + C +GWG +KL+ + +P+
Sbjct: 107 LIKLSKPAT-LNTYVQPVALPTSCAPA---GTMCTVSGWGNTMSSTADSNKLQCLNIPIL 162
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ S C + Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 163 SYSDCNNSYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 215
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ G P VY K+ + W+ +
Sbjct: 216 CAEPGNPGVYAKVCIFNDWLTSTM 239
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 75.9 bits (185), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E++ +WP Q +L + ++CG LI P W++TAAHC+ F
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDM------YFCGGSLISPEWILTAAHCMDGAGFV----- 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVRAV 144
VLG + E+E ++V I VHE ++++ +DIA+++L P + + V
Sbjct: 50 --DVVLGAHNIREDEATQVTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLT-AAIATV 106
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHG 203
L D V TGWG +S LRQ+ VP+ + + C YG +
Sbjct: 107 GLPSTD---VGVGTVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGIVTD--- 160
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
G++C G G C GDSGGPL +G Y GITSFG+
Sbjct: 161 GNICIDSTGG-KGTCNGDSGGPLN---YNGLTY--GITSFGA 196
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 55/153 (35%), Positives = 79/153 (51%), Gaps = 30/153 (19%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQI 340
L+AA+ + P++ D GV V V P TGWG +S LRQ+
Sbjct: 99 LTAAIATVGLPST--DVGVGTV---------VTP------TGWGLPSDSALGISDVLRQV 141
Query: 341 RVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGIT 400
VP+ + + C YG + G++C G G C GDSGGPL +G Y GIT
Sbjct: 142 DVPIMSNADCDAVYGIVTD---GNICIDSTGG-KGTCNGDSGGPLN---YNGLTY--GIT 192
Query: 401 SFGS--GCAKSGYPDVYTKLSFYLPWIRKQINI 431
SFG+ GC ++GYPD +T+++++L WI+ Q I
Sbjct: 193 SFGAAAGC-EAGYPDAFTRVTYFLDWIQTQTGI 224
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 74/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG LI P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLISPCWVISATHC----FIDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH----NYHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ +CL P C TG+G+ L +L+ V L + C+ +
Sbjct: 115 RTIQTICLPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 52/147 (35%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 285 ALLKLSRPTSAR----DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQ 339
ALLK+ R R + ++ +CL P C TG+G+ L +L+
Sbjct: 99 ALLKI-RSKEGRCAQPSRTIQTICLPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKM 156
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
V L + C+ + E+ LC + +C GDSGGPL CSL+ GR L GI
Sbjct: 157 TVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGI 215
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIR 426
S+G GCA P VYT++S +LPWIR
Sbjct: 216 VSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GDSGGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 74/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG L+ P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLMSPCWVISATHCF----IDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ +CL P C TG+G+ L +L+ V L + C+ +
Sbjct: 115 RTIQTICLPSMYNDP-QFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + AC GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDACQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 53/147 (36%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 285 ALLKLSRPTSAR----DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQ 339
ALLK+ R R + ++ +CL P C TG+G+ L +L+
Sbjct: 99 ALLKI-RSKEGRCAQPSRTIQTICLPSMYNDP-QFGTSCEITGFGKEASTDYLYPEQLKM 156
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
V L + C+ + E+ LC + AC GDSGGPL CSL+ GR L GI
Sbjct: 157 TVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDACQGDSGGPLVCSLQ-GRMTLTGI 215
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIR 426
S+G GCA P VYT++S +LPWIR
Sbjct: 216 VSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 76/231 (32%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSV 199
VCL D + + + TGWG +K + S L+ + +P+ VC+D +
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKGQP---SVLQVVNLPIVERPVCKD--STRI 170
Query: 200 ELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
+ C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 171 RITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 221
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/152 (32%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
AL+KL +P + D + VCL D + + + TGWG +K + S L+ + +
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKGQP---SVLQVVNL 156
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAG 398
P+ VC+D + + C G +G G AC GDSGGP S + RWY G
Sbjct: 157 PIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 214
Query: 399 ITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+G GC + G YT + WI+K I+
Sbjct: 215 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 246
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 73/248 (29%), Positives = 112/248 (45%), Gaps = 22/248 (8%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
++I G+ + PW ++ H R G + + CG L+ P WV++A HC P
Sbjct: 23 KIIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLMSPCWVISATHCF----IDYPKK 77
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSAR---- 137
E + LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 78 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQP 136
Query: 138 DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYG 196
+ ++ +CL P C TG+G+ L +L+ V L + C+ +
Sbjct: 137 SRTIQTICLPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY 195
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVG 251
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 196 YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVY 254
Query: 252 IRYSHRQP 259
R SH P
Sbjct: 255 TRVSHFLP 262
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 52/147 (35%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 285 ALLKLSRPTSAR----DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQ 339
ALLK+ R R + ++ +CL P C TG+G+ L +L+
Sbjct: 122 ALLKI-RSKEGRCAQPSRTIQTICLPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKM 179
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
V L + C+ + E+ LC + +C GDSGGPL CSL+ GR L GI
Sbjct: 180 TVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGI 238
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIR 426
S+G GCA P VYT++S +LPWIR
Sbjct: 239 VSWGRGCALKDKPGVYTRVSHFLPWIR 265
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 27 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 82
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 83 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 142
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 143 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 200
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 201 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 258
Query: 243 FGSG 246
+G G
Sbjct: 259 WGEG 262
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 133 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 190
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 191 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 248
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 249 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 287
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 25 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 80
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 81 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 140
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 141 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 198
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 199 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 256
Query: 243 FGSG 246
+G G
Sbjct: 257 WGEG 260
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 131 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 188
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 189 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 246
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 247 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 285
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 112/247 (45%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG L+ P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLMSPCWVISATHCF----IDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ +CL P C TG+G+ + L +L+ V L + C+ +
Sbjct: 115 RTIQTICLPSMYNDP-QFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 52/147 (35%), Positives = 73/147 (49%), Gaps = 8/147 (5%)
Query: 285 ALLKLSRPTSAR----DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQ 339
ALLK+ R R + ++ +CL P C TG+G+ + L +L+
Sbjct: 99 ALLKI-RSKEGRCAQPSRTIQTICLPSMYNDP-QFGTSCEITGFGKEQSTDYLYPEQLKM 156
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
V L + C+ + E+ LC + +C GDSGGPL CSL+ GR L GI
Sbjct: 157 TVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGI 215
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIR 426
S+G GCA P VYT++S +LPWIR
Sbjct: 216 VSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 27 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 82
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 83 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 142
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 143 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 200
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 201 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 258
Query: 243 FGSG 246
+G G
Sbjct: 259 WGEG 262
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 133 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 190
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 191 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 248
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 249 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 287
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 25 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 80
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 81 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 140
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 141 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 198
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 199 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 256
Query: 243 FGSG 246
+G G
Sbjct: 257 WGEG 260
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 131 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 188
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 189 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 246
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 247 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 285
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 31 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 86
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 87 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 146
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 147 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 204
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 205 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 262
Query: 243 FGSG 246
+G G
Sbjct: 263 WGEG 266
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 137 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 194
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 195 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 252
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 253 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 291
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 24 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 79
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 80 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 139
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 140 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 197
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 198 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 255
Query: 243 FGSG 246
+G G
Sbjct: 256 WGEG 259
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 130 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 187
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 188 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 245
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 246 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 284
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTAAEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GDSGGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 6/148 (4%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+ + V
Sbjct: 90 AVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEV 148
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P + + C K S + C G AC GDSGGP KD +++ GI S+
Sbjct: 149 PYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSW 205
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
G GCA+ G +YTK++ +L WI + +
Sbjct: 206 GEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 25 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 80
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 81 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 140
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 141 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 198
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 199 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 256
Query: 243 FGSG 246
+G G
Sbjct: 257 WGEG 260
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 131 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 188
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 189 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 246
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 247 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 285
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGQECKDGECPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
CL + D + + ++ + +G+GR KG ++L+ + VP + + C K S +
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSC--KLSSSFIIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G AC GD+GGP KD +++ GI S+G G
Sbjct: 166 QNMFCAGYDTKQEDACQGDAGGPHVTRFKD-TYFVTGIVSWGEG 208
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 282 LSAALLKLSRPTSARDKGVRAVCLTDAD--KRPVNPKQQCVATGWGRVKPKGDLVSKLRQ 339
A+L+L P + R V CL + D + + ++ + +G+GR KG ++L+
Sbjct: 87 FDIAVLRLKTPITFR-MNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKM 145
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
+ VP + + C K S + C G AC GD+GGP KD +++ GI
Sbjct: 146 LEVPYVDRNSC--KLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKD-TYFVTGI 202
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S+G GCA+ G +YTK++ +L WI + +
Sbjct: 203 VSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 31 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 86
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 87 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 146
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 147 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 204
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 205 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 262
Query: 243 FGSG 246
+G G
Sbjct: 263 WGEG 266
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 137 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 194
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 195 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 252
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 253 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 291
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG L+ P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLMSPCWVISATHCF----IDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ +CL P C TG+G+ L +L+ V L + C+ +
Sbjct: 115 RTIQTICLPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 52/149 (34%), Positives = 72/149 (48%), Gaps = 8/149 (5%)
Query: 285 ALLKLSRPTSAR----DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQ 339
ALLK+ R R + ++ +CL P C TG+G+ L +L+
Sbjct: 99 ALLKI-RSKEGRCAQPSRTIQTICLPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKM 156
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
V L + C+ + E+ LC + +C GDSGGPL CSL+ GR L GI
Sbjct: 157 TVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGI 215
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
S+G GCA P VYT++S +LPWIR
Sbjct: 216 VSWGRGCALKDKPGVYTRVSHFLPWIRSH 244
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+++ G + P+QVSL H+CG LI+ WVV+AAHC + I
Sbjct: 8 KIVGGYTCAANSIPYQVSLNS-------GSHFCGGSLINSQWVVSAAHCYKSRI------ 54
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRA 143
LG+ + E +E I +I H F + +DI L+KLS P + +
Sbjct: 55 ---QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR---- 107
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
V + +C+ +GWG K G L Q ++ P+ + S C+ Y ++
Sbjct: 108 VATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG--QIT 165
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
G +C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 166 GNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYG 204
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 39/233 (16%)
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLI 262
G H CGG SL + +W ++ + S + +R ++
Sbjct: 29 GSHFCGG-------------------SLINSQWVVSAAHCYKSR---IQVRLGEHNIDVL 66
Query: 263 NGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQ 317
G E A P N T L+KLS P + + V +
Sbjct: 67 EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR----VATVSLPRSCAAAGT 122
Query: 318 QCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGA 376
+C+ +GWG K G L Q ++ P+ + S C+ Y ++ G +C G L+G +
Sbjct: 123 ECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG--QITGNMICVGFLEGGKDS 180
Query: 377 CIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
C GDSGGP+ C+ + L GI S+G GCA+ P VYTK+ Y+ WI++ I
Sbjct: 181 CQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTI 228
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG L+ P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLMSPCWVISATHCF----IDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ +CL P C TG+G+ L +L+ V L + C+ +
Sbjct: 115 RTIQTICLPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 52/147 (35%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 285 ALLKLSRPTSAR----DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQ 339
ALLK+ R R + ++ +CL P C TG+G+ L +L+
Sbjct: 99 ALLKI-RSKEGRCAQPSRTIQTICLPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKM 156
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
V L + C+ + E+ LC + +C GDSGGPL CSL+ GR L GI
Sbjct: 157 TVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGI 215
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIR 426
S+G GCA P VYT++S +LPWIR
Sbjct: 216 VSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 160 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 215
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 216 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 275
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 276 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 333
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 334 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 391
Query: 243 FGSG 246
+G G
Sbjct: 392 WGEG 395
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 266 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 323
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 324 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 381
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 382 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 420
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG L+ P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLMSPCWVISATHCF----IDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ +CL P C TG+G+ L +L+ V L + C+ +
Sbjct: 115 RTIQTICLPSMYNDP-QFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 52/147 (35%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 285 ALLKLSRPTSAR----DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQ 339
ALLK+ R R + ++ +CL P C TG+G+ L +L+
Sbjct: 99 ALLKI-RSKEGRCAQPSRTIQTICLPSMYNDP-QFGTSCEITGFGKEASTDYLYPEQLKM 156
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
V L + C+ + E+ LC + +C GDSGGPL CSL+ GR L GI
Sbjct: 157 TVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGI 215
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIR 426
S+G GCA P VYT++S +LPWIR
Sbjct: 216 VSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG L+ P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLMSPCWVISATHCF----IDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ +CL P C TG+G+ L +L+ V L + C+ +
Sbjct: 115 RTIQTICLPSMYNDP-QFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 52/149 (34%), Positives = 72/149 (48%), Gaps = 8/149 (5%)
Query: 285 ALLKLSRPTSAR----DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQ 339
ALLK+ R R + ++ +CL P C TG+G+ L +L+
Sbjct: 99 ALLKI-RSKEGRCAQPSRTIQTICLPSMYNDP-QFGTSCEITGFGKEASTDYLYPEQLKM 156
Query: 340 IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI 399
V L + C+ + E+ LC + +C GDSGGPL CSL+ GR L GI
Sbjct: 157 TVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGI 215
Query: 400 TSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
S+G GCA P VYT++S +LPWIR
Sbjct: 216 VSWGRGCALKDKPGVYTRVSHFLPWIRSH 244
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 44 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 99
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 100 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 159
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 160 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 217
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GD+GGP S + RWY GI S
Sbjct: 218 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVS 275
Query: 243 FGSG 246
+G G
Sbjct: 276 WGEG 279
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 150 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 207
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GD+GGP S +
Sbjct: 208 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFN 265
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 266 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 304
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 115/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 25 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 80
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E + +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 81 DKNFTENDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 140
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 141 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 198
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GDSGGP S + RWY GI S
Sbjct: 199 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVS 256
Query: 243 FGSG 246
+G G
Sbjct: 257 WGEG 260
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 131 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 188
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 189 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 246
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 247 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 285
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCAANSIPYQVSLNS-------GSHFCGGSLINSQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H F + +DI L+KLS P + + V
Sbjct: 47 --QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR----V 100
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHG 203
+ +C+ +GWG K G L Q ++ P+ + S C+ Y ++ G
Sbjct: 101 ATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG--QITG 158
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 159 NMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYG 196
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 12/145 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPL 344
L+KLS P + + V + +C+ +GWG K G L Q ++ P+
Sbjct: 87 LIKLSSPATLNSR----VATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPV 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ S C+ Y ++ G +C G L+G +C GDSGGP+ C+ + L GI S+G
Sbjct: 143 LSDSSCKSSYPG--QITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGY 195
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA+ P VYTK+ Y+ WI++ I
Sbjct: 196 GCAQKNKPGVYTKVCNYVNWIQQTI 220
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 27/254 (10%)
Query: 13 DCGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAA 72
DCG Y +++NG +++ +PW + + CG LI+ ++VTAA
Sbjct: 13 DCG----YQVEADKILNGDDTVPEEFPWTAMIGYKNSS-NFEQFACGGSLINNRYIVTAA 67
Query: 73 HCIHNDIFSLPIPELWTAVLGDWDRTEEEK-----------SEVRIPVERIRVHEEF--- 118
HC+ + + + L LG+W+ + + + +E H ++
Sbjct: 68 HCVAGRVLRV-VGALNKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDG 126
Query: 119 -HNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK 177
+ +HDIAL++L+R + +R VCL ++ V Q+ GWGR + G +
Sbjct: 127 SKDRYHDIALIRLNRQVEFTNY-IRPVCLPQPNEE-VQVGQRLTVVGWGRTE-TGQYSTI 183
Query: 178 LRQIRVPLHNISVCRDKYGDS-VELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 236
+++ VP+ + C +G + V + LC G + +C GDSGGPL + +++
Sbjct: 184 KQKLAVPVVHAEQCAKTFGAAGVRVRSSQLCAGG-EKAKDSCGGDSGGPLLAERANQQFF 242
Query: 237 LAGITSFGSGYCGV 250
L G+ SFG+ CG
Sbjct: 243 LEGLVSFGA-TCGT 255
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 5/146 (3%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL++L+R + +R VCL ++ V Q+ GWGR + G + +++ VP+
Sbjct: 135 ALIRLNRQVEFTNY-IRPVCLPQPNEE-VQVGQRLTVVGWGRTE-TGQYSTIKQKLAVPV 191
Query: 345 HNISVCRDKYGDS-VELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ C +G + V + LC G + +C GDSGGPL + +++L G+ SFG
Sbjct: 192 VHAEQCAKTFGAAGVRVRSSQLCAGG-EKAKDSCGGDSGGPLLAERANQQFFLEGLVSFG 250
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQI 429
+ C G+P +YTK+ Y WI I
Sbjct: 251 ATCGTEGWPGIYTKVGKYRDWIEGNI 276
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 86.7 bits (213), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 78/239 (32%), Positives = 114/239 (47%), Gaps = 26/239 (10%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFT 56
Query: 86 ELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKG 140
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D
Sbjct: 57 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY- 115
Query: 141 VRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVC 191
+ VCL D + + + TGWG +K KG S L+ + +P+ VC
Sbjct: 116 IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVC 174
Query: 192 RDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
+D + + C G +G G AC GD+GGP S + RWY GI S+G G
Sbjct: 175 KD--STRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEG 231
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 102 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 159
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GD+GGP S +
Sbjct: 160 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFN 217
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 218 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 256
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCAANSVPYQVSLNS-------GSHFCGGSLINSQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H F + +DI L+KLS P + + V
Sbjct: 47 --QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR----V 100
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHG 203
+ +C+ +GWG K G L Q ++ P+ + S C+ Y ++ G
Sbjct: 101 ATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAYPG--QITG 158
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 159 NMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYG 196
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 12/145 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPL 344
L+KLS P + + V + +C+ +GWG K G L Q ++ P+
Sbjct: 87 LIKLSSPATLNSR----VATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPV 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ S C+ Y ++ G +C G L+G +C GDSGGP+ C+ + L GI S+G
Sbjct: 143 LSDSSCKSAYPG--QITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGY 195
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA+ P VYTK+ Y+ WI++ I
Sbjct: 196 GCAQKNKPGVYTKVCNYVNWIQQTI 220
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 79/244 (32%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ R++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 26 SYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 81
Query: 81 SLPIPELWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTS 135
E V +G RT E++ +I + E+I +H ++ N DIAL+KL +P +
Sbjct: 82 DKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 141
Query: 136 ARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLH 186
D + VCL D + + + TGWG +K KG S L+ + +P+
Sbjct: 142 FSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIV 199
Query: 187 NISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITS 242
VC+D + + C G +G G AC GD+GGP S + RWY GI S
Sbjct: 200 ERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVS 257
Query: 243 FGSG 246
+G G
Sbjct: 258 WGEG 261
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 132 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 189
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GD+GGP S +
Sbjct: 190 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFN 247
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 248 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 286
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+++ G P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 20 KIVGGYTCGANTVPYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI------ 66
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRA 143
LG+ + E +E I + VH +++ ++DI L+KL S + V +
Sbjct: 67 ---QVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VAS 122
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELH 202
+ L + + QC+ +GWG K G L+ ++ P+ + S C+ Y ++
Sbjct: 123 ISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QIT 177
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ CS K L GI S+GSG
Sbjct: 178 SNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSG 216
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 25/241 (10%)
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQC--SLKDGRWYLAGITSFGSGYCGVGIRY 254
D ++ GG+ CG + + + G C SL + +W ++ + SG + +R
Sbjct: 17 DDDKIVGGYTCGANTVPYQ---VSLNSGYHFCGGSLINSQWVVSAAHCYKSG---IQVRL 70
Query: 255 SHRQPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDAD 309
++ G E A P N T L+KL S + V ++ L +
Sbjct: 71 GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS- 128
Query: 310 KRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGG 368
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G
Sbjct: 129 --CASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAG 184
Query: 369 QLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
L+G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++
Sbjct: 185 YLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQT 239
Query: 429 I 429
I
Sbjct: 240 I 240
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 16 VGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCI 75
+G ++ +++ G E + QVSL + H+CG L++ +WVV+AAHC
Sbjct: 5 IGAAFATEDDKIVGGYECKAYSQAHQVSLNSGY-------HFCGGSLVNENWVVSAAHCY 57
Query: 76 HNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRP 133
+ + LG+ + E SE I R+ H + +Y+ +DI L+KLS+P
Sbjct: 58 KSRV---------EVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKP 108
Query: 134 TSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRD 193
+ + V+ V L + C +GWG +KL+ + +P+ + S C +
Sbjct: 109 AT-LNTYVQPVALPTSCAP---AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNN 164
Query: 194 KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 165 SYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 210
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KLS+P + + V+ V L + C +GWG +KL+ + +P+
Sbjct: 102 LIKLSKPAT-LNTYVQPVALPTSCAPA---GTMCTVSGWGNTMSSTADSNKLQCLNIPIL 157
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ S C + Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 158 SYSDCNNSYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 210
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ G P VY K+ + W+ +
Sbjct: 211 CAEPGNPGVYAKVCIFNDWLTSTM 234
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCAANSIPYQVSLNS-------GSHFCGGSLINSQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H F + +DI L+KLS P + + V
Sbjct: 47 --QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSR----V 100
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHG 203
+ +C+ +GWG K G L Q ++ P+ + S C+ Y ++ G
Sbjct: 101 ATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG--QITG 158
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 159 NMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYG 196
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 12/145 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPL 344
L+KLS P + + V + +C+ +GWG K G L Q ++ P+
Sbjct: 87 LIKLSSPATLXSR----VATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPV 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ S C+ Y ++ G +C G L+G +C GDSGGP+ C+ + L GI S+G
Sbjct: 143 LSDSSCKSSYPG--QITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGY 195
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA+ P VYTK+ Y+ WI++ I
Sbjct: 196 GCAQKNKPGVYTKVCNYVNWIQQTI 220
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 71/246 (28%), Positives = 109/246 (44%), Gaps = 18/246 (7%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
++I G+ + PW ++ H R G + + CG LI P WV++A HC P
Sbjct: 15 KIIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLISPCWVISATHC----FIDYPKK 69
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH----NYHHDIALLKLSRPTSARDKGV 141
E + LG + E++ VE + +H+++ +H+DIALLK+ +
Sbjct: 70 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPS 129
Query: 142 RAVCLTDADKRPVNPK--QQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDS 198
R + +P+ C TG+G+ L +L+ V L + C+ +
Sbjct: 130 RTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYG 189
Query: 199 VELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGIR 253
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV R
Sbjct: 190 SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTR 248
Query: 254 YSHRQP 259
SH P
Sbjct: 249 VSHFLP 254
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 43/109 (39%), Positives = 58/109 (53%), Gaps = 2/109 (1%)
Query: 319 CVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C TG+G+ L +L+ V L + C+ + E+ LC + +C
Sbjct: 150 CEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSC 209
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
GDSGGPL CSL+ GR L GI S+G GCA P VYT++S +LPWIR
Sbjct: 210 QGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR 257
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+++ G P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 6 KIVGGYTCGANTVPYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI------ 52
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRA 143
LG+ + E +E I + VH +++ ++DI L+KL S + V +
Sbjct: 53 ---QVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VAS 108
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELH 202
+ L + + QC+ +GWG K G L+ ++ P+ + S C+ Y ++
Sbjct: 109 ISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QIT 163
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ CS K L GI S+GSG
Sbjct: 164 SNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSG 202
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 25/241 (10%)
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQC--SLKDGRWYLAGITSFGSGYCGVGIRY 254
D ++ GG+ CG + + + G C SL + +W ++ + SG + +R
Sbjct: 3 DDDKIVGGYTCGANTVPYQ---VSLNSGYHFCGGSLINSQWVVSAAHCYKSG---IQVRL 56
Query: 255 SHRQPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDAD 309
++ G E A P N T L+KL S + V ++ L +
Sbjct: 57 GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS- 114
Query: 310 KRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGG 368
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G
Sbjct: 115 --CASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAG 170
Query: 369 QLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
L+G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++
Sbjct: 171 YLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQT 225
Query: 429 I 429
I
Sbjct: 226 I 226
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+++ G P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 14 KIVGGYTCGANTVPYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI------ 60
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRA 143
LG+ + E +E I + VH +++ ++DI L+KL S + V +
Sbjct: 61 ---QVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VAS 116
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELH 202
+ L + + QC+ +GWG K G L+ ++ P+ + S C+ Y ++
Sbjct: 117 ISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QIT 171
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ CS K L GI S+GSG
Sbjct: 172 SNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSG 210
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 30 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 67
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 68 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 123
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 124 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 181
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 182 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 234
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCAANSIPYQVSLNS-------GSHFCGGSLINSQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H F + +DI L+KLS P + + V
Sbjct: 47 --QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR----V 100
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHG 203
+ +C+ +GWG K G L Q ++ P+ + S C+ Y ++ G
Sbjct: 101 ATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSYPG--QITG 158
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 159 NMICVGFLQGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYG 196
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 48/145 (33%), Positives = 73/145 (50%), Gaps = 12/145 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPL 344
L+KLS P + + V + +C+ +GWG K G L Q ++ P+
Sbjct: 87 LIKLSSPATLNSR----VATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPV 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ S C+ Y ++ G +C G L G +C GDSGGP+ C+ + L GI S+G
Sbjct: 143 LSNSSCKSSYPG--QITGNMICVGFLQGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGY 195
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA+ P VYTK+ Y+ WI++ I
Sbjct: 196 GCAQKNKPGVYTKVCNYVNWIQQTI 220
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 71/233 (30%), Positives = 103/233 (44%), Gaps = 27/233 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G S+ G+ PW ++ + +C L+H WVV+AAHC + P +
Sbjct: 1 IIGGSSSLPGSHPWLAAIYI-------GDSFCAGSLVHTCWVVSAAHCFSHS----PPRD 49
Query: 87 LWTAVLGD------WDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRP---TSAR 137
+ VLG D T+ E IP ++ F+ HD+ L++L + + R
Sbjct: 50 SVSVVLGQHFFNRTTDVTQTFGIEKYIPYT---LYSVFNPSDHDLVLIRLKKKGDRCATR 106
Query: 138 DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPK-GDLVSKLRQIRVPLHNISVCRDKYG 196
+ V+ +CL + +C GWG + S LR+ VPL C
Sbjct: 107 SQFVQPICLPEPGST-FPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEV 165
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
++ LC G D S AC GDSGGPL C K+G YL GI S+G G CG
Sbjct: 166 YGADISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDG-CG 216
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 48/137 (35%), Positives = 66/137 (48%), Gaps = 3/137 (2%)
Query: 294 SARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPK-GDLVSKLRQIRVPLHNISVCRD 352
+ R + V+ +CL + +C GWG + S LR+ VPL C
Sbjct: 104 ATRSQFVQPICLPEPGST-FPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSS 162
Query: 353 KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYP 412
++ LC G D S AC GDSGGPL C K+G YL GI S+G GC + P
Sbjct: 163 PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDGCGRLHKP 221
Query: 413 DVYTKLSFYLPWIRKQI 429
VYT+++ Y+ WI +I
Sbjct: 222 GVYTRVANYVDWINDRI 238
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 71/233 (30%), Positives = 103/233 (44%), Gaps = 27/233 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G S+ G+ PW ++ + +C L+H WVV+AAHC + P +
Sbjct: 1 IIGGSSSLPGSHPWLAAIYI-------GDSFCAGSLVHTCWVVSAAHCFSHS----PPRD 49
Query: 87 LWTAVLGD------WDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRP---TSAR 137
+ VLG D T+ E IP ++ F+ HD+ L++L + + R
Sbjct: 50 SVSVVLGQHFFNRTTDVTQTFGIEKYIPYT---LYSVFNPSDHDLVLIRLKKKGDRCATR 106
Query: 138 DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPK-GDLVSKLRQIRVPLHNISVCRDKYG 196
+ V+ +CL + +C GWG + S LR+ VPL C
Sbjct: 107 SQFVQPICLPEPGST-FPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEV 165
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
++ LC G D S AC GDSGGPL C K+G YL GI S+G G CG
Sbjct: 166 YGADISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDG-CG 216
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 48/137 (35%), Positives = 66/137 (48%), Gaps = 3/137 (2%)
Query: 294 SARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPK-GDLVSKLRQIRVPLHNISVCRD 352
+ R + V+ +CL + +C GWG + S LR+ VPL C
Sbjct: 104 ATRSQFVQPICLPEPGST-FPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSS 162
Query: 353 KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYP 412
++ LC G D S AC GDSGGPL C K+G YL GI S+G GC + P
Sbjct: 163 PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDGCGRLHKP 221
Query: 413 DVYTKLSFYLPWIRKQI 429
VYT+++ Y+ WI +I
Sbjct: 222 GVYTRVANYVDWINDRI 238
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 106/238 (44%), Gaps = 39/238 (16%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + + PWQ +L CG +L+H WV+TAAHCI ++ +
Sbjct: 1 IVGGWECEQHSQPWQAAL------YHFSTFQCGGILVHRQWVLTAAHCISDNY------Q 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH-------------NYHHDIALLKLSRP 133
LW LG + ++E + + V H F+ +Y HD+ LL+L+ P
Sbjct: 49 LW---LGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEP 105
Query: 134 TSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCR 192
V+ V L + C+A+GWG ++P+ L+ + + + C+
Sbjct: 106 ADTITDAVKVVELPTEEPEV---GSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECK 162
Query: 193 DKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGV 250
+ V LC G L+G C+GDSGGPL C DG L G+TS+G CG
Sbjct: 163 KAHVQKVT--DFMLCVGHLEGGKDTCVGDSGGPLMC---DG--VLQGVTSWGYVPCGT 213
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 66/146 (45%), Gaps = 12/146 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPL 344
LL+L+ P V+ V L + C+A+GWG ++P+ L+ + + +
Sbjct: 99 LLRLTEPADTITDAVKVVELPTEEPEV---GSTCLASGWGSIEPENFSFPDDLQCVDLKI 155
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
C+ + V LC G L+G C+GDSGGPL C DG L G+TS+G
Sbjct: 156 LPNDECKKAHVQKVT--DFMLCVGHLEGGKDTCVGDSGGPLMC---DG--VLQGVTSWGY 208
Query: 405 -GCAKSGYPDVYTKLSFYLPWIRKQI 429
C P V ++ Y+ WI I
Sbjct: 209 VPCGTPNKPSVAVRVLSYVKWIEDTI 234
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCXKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGXLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 225 PLQCSLKDGRWYLAG--ITS---FGSGYC---GVGIRYSHRQPRLINGKESIRGAW---- 272
P Q SL G + G I S + +C G+ +R ++ G E A
Sbjct: 13 PYQVSLNSGYHFCGGSLINSQWVVSAAHCXKSGIQVRLGEDNINVVEGNEQFISASKSIV 72
Query: 273 -PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG 331
P N T L+KL S + V ++ L + + QC+ +GWG K G
Sbjct: 73 HPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSG 128
Query: 332 DLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 390
L+ ++ P+ + S C+ Y ++ C G L+G +C GDSGGP+ CS K
Sbjct: 129 TSXPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGXLEGGKDSCQGDSGGPVVCSGK 186
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 187 -----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+++ G P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 5 KIVGGYTCGANTVPYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI------ 51
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRA 143
LG+ + E +E I + VH +++ ++DI L+KL S + V +
Sbjct: 52 ---QVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VAS 107
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELH 202
+ L + + QC+ +GWG K G L+ ++ P+ + S C+ Y ++
Sbjct: 108 ISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QIT 162
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ CS K L GI S+GSG
Sbjct: 163 SNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSG 201
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 21 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 58
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 59 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 114
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 115 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 172
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 173 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 225
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 28 INGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPEL 87
+ G + P+QVSL H+CG LI+ WVV+AAHC + I
Sbjct: 2 VGGYTCAANSIPYQVSLNS-------GSHFCGGSLINSQWVVSAAHCYKSRI-------- 46
Query: 88 WTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAVC 145
LG+ + E +E I +I H F + +DI L+KLS P + + V
Sbjct: 47 -QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR----VA 101
Query: 146 LTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGG 204
+ +C+ +GWG K G L Q ++ P+ + S C+ Y ++ G
Sbjct: 102 TVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG--QITGN 159
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 160 MICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYG 196
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 12/145 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQ-IRVPL 344
L+KLS P + + V + +C+ +GWG K G L Q ++ P+
Sbjct: 87 LIKLSSPATLNSR----VATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPV 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ S C+ Y ++ G +C G L+G +C GDSGGP+ C+ + L GI S+G
Sbjct: 143 LSDSSCKSSYPG--QITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGY 195
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA+ P VYTK+ Y+ WI++ I
Sbjct: 196 GCAQKNKPGVYTKVCNYVNWIQQTI 220
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E + P+ + L ++G +CG L+ +V+TAAHC +
Sbjct: 1 IIGGNEISPHSRPYMAYYEFL--KVGGKKMFCGGFLVRDKFVLTAAHCKGRSM------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
T LG + +E+++ IPV + H +++ + +DI LLKL R + R + VR +
Sbjct: 52 --TVTLGAHNIKAKEETQQIIPVAKAIPHPDYNPDDRSNDIMLLKLVR-NAKRTRAVRPL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + V P +C GWG+V P G+ L ++++ + VC ++ S
Sbjct: 109 NLPRRNAH-VKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYN-RAN 166
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
+C G + GDSGGPL C + AGI S+G
Sbjct: 167 EICVGDSKIKGASFRGDSGGPLVC-----KRAAAGIVSYG 201
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
LLKL R + R + VR + L + V P +C GWG+V P G+ L ++++ +
Sbjct: 92 LLKLVR-NAKRTRAVRPLNLPRRNAH-VKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQ 149
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
VC ++ S +C G + GDSGGPL C + AGI S+G
Sbjct: 150 KDQVCESQFQSSYN-RANEICVGDSKIKGASFRGDSGGPLVC-----KRAAAGIVSYGQ- 202
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
P V+T++ ++ WI+K +
Sbjct: 203 -TDGSAPQVFTRVLSFVSWIKKTM 225
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 53/159 (33%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GCA+ G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCARKGKYGFYTHVFRLKKWIQKVID 255
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLIDSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH + + ++DI L+KL + ++ D V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYDSNTLNNDIMLIKL-KSAASLDSRVASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL D +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLIDSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P + T L+KL + ++ D V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYDSNTLNNDIMLIKL-KSAASLDSRVASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCRDDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 111/238 (46%), Gaps = 22/238 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L H R CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTE 60
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 61 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 119
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 120 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 178
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 179 D--STRIRITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 234
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 105 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 162
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C +G G AC GDSGGP S +
Sbjct: 163 VLQVVNLPIVERPVCKD--STRIRITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFN 220
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 221 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 259
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKG 230
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGKGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKFGFYTHVFRLKKWIQKVID 255
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG LI P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLISPCWVISATHC----FIDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH----NYHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ + L P C TG+G+ + L +L+ V L + C+ +
Sbjct: 115 RTIQTIALPSMYNDP-QFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 43/109 (39%), Positives = 59/109 (54%), Gaps = 2/109 (1%)
Query: 319 CVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C TG+G+ + L +L+ V L + C+ + E+ LC + +C
Sbjct: 135 CEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSC 194
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
GDSGGPL CSL+ GR L GI S+G GCA P VYT++S +LPWIR
Sbjct: 195 QGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKIGFYTHVFRLKKWIQKVID 255
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 85.1 bits (209), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG LI P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLISPCWVISATHC----FIDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH----NYHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ + L P C TG+G+ + L +L+ V L + C+ +
Sbjct: 115 RTIQTIALPSMYNDP-QFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 43/109 (39%), Positives = 59/109 (54%), Gaps = 2/109 (1%)
Query: 319 CVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C TG+G+ + L +L+ V L + C+ + E+ LC + +C
Sbjct: 135 CEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSC 194
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
GDSGGPL CSL+ GR L GI S+G GCA P VYT++S +LPWIR
Sbjct: 195 QGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 53/159 (33%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G P YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKPGFYTHVFRLKKWIQKVID 255
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+++ G P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 20 KIVGGYTCGANTVPYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI------ 66
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRA 143
LG+ + E +E I + VH +++ ++DI L+KL S + V +
Sbjct: 67 ---QVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VAS 122
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELH 202
+ L + + QC+ +GWG K G L+ ++ P+ + S C+ Y ++
Sbjct: 123 ISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QIT 177
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GD+GGP+ CS K L GI S+GSG
Sbjct: 178 SNMFCAGYLEGGKDSCQGDAGGPVVCSGK-----LQGIVSWGSG 216
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 68/241 (28%), Positives = 109/241 (45%), Gaps = 25/241 (10%)
Query: 197 DSVELHGGHLCGGQLDGFSGACIGDSGGPLQC--SLKDGRWYLAGITSFGSGYCGVGIRY 254
D ++ GG+ CG + + + G C SL + +W ++ + SG + +R
Sbjct: 17 DDDKIVGGYTCGANTVPYQ---VSLNSGYHFCGGSLINSQWVVSAAHCYKSG---IQVRL 70
Query: 255 SHRQPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDAD 309
++ G E A P N T L+KL S + V ++ L +
Sbjct: 71 GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS- 128
Query: 310 KRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGG 368
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G
Sbjct: 129 --CASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAG 184
Query: 369 QLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
L+G +C GD+GGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++
Sbjct: 185 YLEGGKDSCQGDAGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQT 239
Query: 429 I 429
I
Sbjct: 240 I 240
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 71/245 (28%), Positives = 108/245 (44%), Gaps = 18/245 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG LI P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLISPCWVISATHC----FIDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH----NYHHDIALLKLSRPTSARDKGVR 142
+ LG + E++ VE + +H+++ +H+DIALLK+ + R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSR 115
Query: 143 AVCLTDADKRPVNPK--QQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSV 199
+ +P+ C TG+G+ L +L+ V L + C+ +
Sbjct: 116 TIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS 175
Query: 200 ELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGIRY 254
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV R
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 255 SHRQP 259
SH P
Sbjct: 235 SHFLP 239
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 43/109 (39%), Positives = 58/109 (53%), Gaps = 2/109 (1%)
Query: 319 CVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C TG+G+ L +L+ V L + C+ + E+ LC + +C
Sbjct: 135 CEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSC 194
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
GDSGGPL CSL+ GR L GI S+G GCA P VYT++S +LPWIR
Sbjct: 195 QGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH ++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V +V L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASVSLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ C+ K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCAGK-----LQGIVSWGSG 196
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V +V L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASVSLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ C+ K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCAGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S G+G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAG 230
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S G+GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S G+G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAG 230
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S G+GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 71/245 (28%), Positives = 108/245 (44%), Gaps = 18/245 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG LI P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLISPCWVISATHC----FIDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH----NYHHDIALLKLSRPTSARDKGVR 142
+ LG + E++ VE + +H+++ +H+DIALLK+ + R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSR 115
Query: 143 AVCLTDADKRPVNPK--QQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSV 199
+ +P+ C TG+G+ L +L+ V L + C+ +
Sbjct: 116 TIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS 175
Query: 200 ELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGIRY 254
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV R
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 255 SHRQP 259
SH P
Sbjct: 235 SHFLP 239
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 43/109 (39%), Positives = 58/109 (53%), Gaps = 2/109 (1%)
Query: 319 CVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C TG+G+ L +L+ V L + C+ + E+ LC + +C
Sbjct: 135 CEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSC 194
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
GDSGGPL CSL+ GR L GI S+G GCA P VYT++S +LPWIR
Sbjct: 195 QGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E I + PWQ +L RL CG VL+ WV+TAAHC +
Sbjct: 1 ILEGRECIPHSQPWQAAL-FQGERL-----ICGGVLVGDRWVLTAAHCKK---------Q 45
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN-----YHHDIALLKLSRPTSARDKGV 141
++ LGD ++ E I V + H ++N + HDI L++L + DK V
Sbjct: 46 KYSVRLGDHSLQSRDQPEQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDK-V 104
Query: 142 RAVCLTDADKRPVNPK--QQCVATGWGRV-KPKGDLVSKLRQIRVPLHNISVCRDKYGDS 198
+ V L + + PK Q+C+ +GWG V P+ + + L V +++ + C Y
Sbjct: 105 KPVQLAN-----LCPKVGQKCIISGWGTVTSPQENFPNTLNCAEVKIYSQNKCERAYPGK 159
Query: 199 VELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+ G +C G +G + C GDSGGPL C DG L GITS+GS CG
Sbjct: 160 IT--EGMVCAGSSNG-ADTCQGDSGGPLVC---DG--MLQGITSWGSDPCG 202
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 53/149 (35%), Positives = 78/149 (52%), Gaps = 18/149 (12%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPK--QQCVATGWGRV-KPKGDLVSKLRQIRV 342
L++L + DK V+ V L + + PK Q+C+ +GWG V P+ + + L V
Sbjct: 91 LIRLQNSANLGDK-VKPVQLAN-----LCPKVGQKCIISGWGTVTSPQENFPNTLNCAEV 144
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
+++ + C Y + G +C G +G + C GDSGGPL C DG L GITS+
Sbjct: 145 KIYSQNKCERAYPGKIT--EGMVCAGSSNG-ADTCQGDSGGPLVC---DG--MLQGITSW 196
Query: 403 GSG-CAKSGYPDVYTKLSFYLPWIRKQIN 430
GS C K P VYTK+ Y WI+K ++
Sbjct: 197 GSDPCGKPEKPGVYTKICRYTTWIKKTMD 225
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 79/247 (31%), Positives = 113/247 (45%), Gaps = 44/247 (17%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHC----------IH 76
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC I
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFIE 56
Query: 77 NDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSR 132
ND+ +G RT E++ +I + E+I +H ++ N DIAL+KL +
Sbjct: 57 NDLL---------VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKK 107
Query: 133 PTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRV 183
P + D + VCL D + + + TGWG +K KG S L+ + +
Sbjct: 108 PVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNL 165
Query: 184 PLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAG 239
P+ VC+D + + C G +G G AC GDSGGP S + RWY G
Sbjct: 166 PIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 223
Query: 240 ITSFGSG 246
I S+G G
Sbjct: 224 IVSWGEG 230
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 110/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG LI P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLISPCWVISATHC----FIDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH----NYHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ + L P C TG+G+ L +L+ V L + C+ +
Sbjct: 115 RTIQTIALPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 43/109 (39%), Positives = 58/109 (53%), Gaps = 2/109 (1%)
Query: 319 CVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C TG+G+ L +L+ V L + C+ + E+ LC + +C
Sbjct: 135 CEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSC 194
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
GDSGGPL CSL+ GR L GI S+G GCA P VYT++S +LPWIR
Sbjct: 195 QGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + P QVSL + H+CG L++ +WVV+AAHC + +
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGY-------HFCGGSLVNENWVVSAAHCYKSRV------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
LG+ + E SE I R+ H + +Y+ +DI L+KLS+P + + V+ V
Sbjct: 47 --EVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPAT-LNTYVQPV 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + C +GWG +KL+ + +P+ + S C + Y +
Sbjct: 104 ALPSSCAP---AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMIT--NA 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 159 MFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KLS+P + V+ V L + C +GWG +KL+ + +P+
Sbjct: 87 LIKLSKPATLNTY-VQPVALPSSCAPA---GTMCTVSGWGNTMSSTADKNKLQCLNIPIL 142
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ S C + Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 143 SYSDCNNSYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ G P VY K+ + W+ +
Sbjct: 196 CAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 29/222 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + P QVSL + H+CG L++ +WVV+AAHC + +
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGY-------HFCGGSLVNENWVVSAAHCYKSRV------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
LG+ + E SE I R+ H + +Y+ +DI L+KLS+P + V+ V
Sbjct: 47 --EVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTY-VQPV 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + C +GWG +KL+ + +P+ + S C + Y +
Sbjct: 104 ALPTSCAP---AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMIT--NA 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 159 MFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KLS+P + V+ V L + C +GWG +KL+ + +P+
Sbjct: 87 LIKLSKPATLNTY-VQPVALPTSCAPA---GTMCTVSGWGNTMSSTADSNKLQCLNIPIL 142
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ S C + Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 143 SYSDCNNSYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ G P VY K+ + W+ +
Sbjct: 196 CAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + P QVSL + H+CG L++ +WVV+AAHC +
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGY-------HFCGGSLVNENWVVSAAHCYKTRV------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
LG+ + E SE I R+ H + +Y+ +DI L+KLS+P + V+ V
Sbjct: 47 --EVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTY-VQPV 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + C +GWG +KL+ + +P+ + S C + Y +
Sbjct: 104 ALPSSCAP---AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMIT--NA 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 159 MFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KLS+P + V+ V L + C +GWG +KL+ + +P+
Sbjct: 87 LIKLSKPATLNTY-VQPVALPSSCAPA---GTMCTVSGWGNTMSSTADKNKLQCLNIPIL 142
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ S C + Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 143 SYSDCNNSYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ G P VY K+ + W+ +
Sbjct: 196 CAEPGNPGVYAKVCIFNNWLTSTM 219
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 29/222 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + P QVSL + H+CG L++ +WVV+AAHC + +
Sbjct: 1 IVGGYECKPYSQPHQVSLNSGY-------HFCGGSLVNENWVVSAAHCYKSRV------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
LG+ + E SE I R+ H + +Y+ +DI L+KLS+P + V+ V
Sbjct: 47 --EVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTY-VQPV 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + C +GWG +KL+ + +P+ + S C + Y +
Sbjct: 104 ALPTSCAP---AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGMIT--NA 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 159 MFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KLS+P + V+ V L + C +GWG +KL+ + +P+
Sbjct: 87 LIKLSKPATLNTY-VQPVALPTSCAPA---GTMCTVSGWGNTMSSTADSNKLQCLNIPIL 142
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ S C + Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 143 SYSDCNNSYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ G P VY K+ + W+ +
Sbjct: 196 CAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + + + PW V++ L CG VL+ P+WV+TAAHC ++ +
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYL------CGGVLLDPNWVLTAAHCYDDNY------K 48
Query: 87 LW---TAVLGDWDRTEEEKSEVRIP-----VERIRVHEEF--HNYHHDIALLKLSRPTSA 136
+W + D + IP + +R H F ++Y +D+ LL+LS+P
Sbjct: 49 VWLGKNNLFKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADI 108
Query: 137 RDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKP-KGDLVSKLRQIRVPLHNISVCRDKY 195
D V+ + L + + C+A+GWG + P K L + + L C +
Sbjct: 109 TDT-VKPITLPTEEPKL---GSTCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAKAH 164
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+ V LC G++DG C GDSGGPL C DG L GITS+G CG
Sbjct: 165 IEKVT--DAMLCAGEMDGGKDTCKGDSGGPLIC---DG--VLQGITSWGHTPCG 211
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 50/146 (34%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKP-KGDLVSKLRQIRVPL 344
LL+LS+P D V+ + L + + C+A+GWG + P K L + + L
Sbjct: 99 LLRLSKPADITDT-VKPITLPTEEPKL---GSTCLASGWGSITPTKFQFTDDLYCVNLKL 154
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG- 403
C + + V LC G++DG C GDSGGPL C DG L GITS+G
Sbjct: 155 LPNEDCAKAHIEKVT--DAMLCAGEMDGGKDTCKGDSGGPLIC---DG--VLQGITSWGH 207
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQI 429
+ C + P VYTKL+ + WI+ +
Sbjct: 208 TPCGEPDMPGVYTKLNKFTSWIKDTM 233
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 79/249 (31%), Positives = 115/249 (46%), Gaps = 36/249 (14%)
Query: 21 SHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF 80
S+ + R++ G+++ G PWQV L P+ L CGA LI WV+TAAHC+ +
Sbjct: 44 SYIEGRIVEGQDAEVGLSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPW 99
Query: 81 --SLPIPELWTAVLGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPT 134
+ + +L + G RT E+ +I + ++I +H ++ N DIALLKL RP
Sbjct: 100 DKNFTVDDLLVRI-GKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPI 158
Query: 135 SARDKGVRAVCLTDADK--RPVNPKQQCVATGWG-----------RVKPKGDLVSKLRQI 181
D + VCL D + ++ + TGWG V+P S L+ +
Sbjct: 159 ELSDY-IHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQP-----SVLQVV 212
Query: 182 RVPLHNISVCRDKYGDSVELHGGHLCGGQLDGF---SGACIGDSGGPL-QCSLKDGRWYL 237
+PL VC K + + C G G AC GDSGGP S + RWY
Sbjct: 213 NLPLVERPVC--KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQ 270
Query: 238 AGITSFGSG 246
GI S+G G
Sbjct: 271 MGIVSWGEG 279
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/163 (32%), Positives = 70/163 (42%), Gaps = 25/163 (15%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADK--RPVNPKQQCVATGWG-----------RVKPKG 331
ALLKL RP D + VCL D + ++ + TGWG V+P
Sbjct: 150 ALLKLKRPIELSDY-IHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQP-- 206
Query: 332 DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS---GACIGDSGGPL-QC 387
S L+ + +PL VC K + + C G G AC GDSGGP
Sbjct: 207 ---SVLQVVNLPLVERPVC--KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMK 261
Query: 388 SLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S + RWY GI S+G GC + G YT + WI+K I+
Sbjct: 262 SPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 304
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GD+GGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GD+GGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E + +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E + +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 78/238 (32%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G D G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 52/159 (32%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G D G AC GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKKWIQKVID 255
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 72/247 (29%), Positives = 111/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG LI P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLISPCWVISATHC----FIDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH----NYHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ + L P C TG+G+ + L +L+ V L + C+ +
Sbjct: 115 RTIQTIALPSMYNDP-QFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GD+GGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 42/109 (38%), Positives = 59/109 (54%), Gaps = 2/109 (1%)
Query: 319 CVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C TG+G+ + L +L+ V L + C+ + E+ LC + +C
Sbjct: 135 CEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSC 194
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
GD+GGPL CSL+ GR L GI S+G GCA P VYT++S +LPWIR
Sbjct: 195 QGDAGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR 242
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + P QVSL + H+CG L++ +WVV+AAHC + +
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGY-------HFCGGSLVNENWVVSAAHCYKSRV------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
LG+ + E SE I R+ H + +Y+ +DI L+KLS+P + V+ V
Sbjct: 47 --AVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPATLNTY-VQPV 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + C +GWG KL+ + +P+ + S C + Y +
Sbjct: 104 ALPSSCAP---AGTMCTVSGWGNTMSSTADGDKLQCLNIPILSYSDCNNSYPGMIT--NA 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 159 MFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KLS+P + V+ V L + C +GWG KL+ + +P+
Sbjct: 87 LIKLSKPATLNTY-VQPVALPSSCAPA---GTMCTVSGWGNTMSSTADGDKLQCLNIPIL 142
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ S C + Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 143 SYSDCNNSYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ G P VY K+ + W+ +
Sbjct: 196 CAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GD GGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDXGGPVVCSGK-----LQGIVSWGSG 196
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GD GGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDXGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 34 IRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLG 93
I G + + Q L H+CG L++ +WVV+AAHC + + LG
Sbjct: 1 IVGGYECKAYSQAHQVSLNSGYHFCGGSLVNENWVVSAAHCYKSRV---------EVRLG 51
Query: 94 DWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAVCLTDADK 151
+ + E SE I R+ H + +Y+ +DI L+KLS+P + + V+ V L +
Sbjct: 52 EHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSKPAT-LNTYVQPVALPTSCA 110
Query: 152 RPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL 211
C +GWG KL+ + +P+ + S C D Y + C G L
Sbjct: 111 P---AGTMCTVSGWGNTMSSTADSDKLQCLNIPILSYSDCNDSYPGMIT--NAMFCAGYL 165
Query: 212 DGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 166 EGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KLS+P + V+ V L + C +GWG KL+ + +P+
Sbjct: 87 LIKLSKPATLNTY-VQPVALPTSCAPA---GTMCTVSGWGNTMSSTADSDKLQCLNIPIL 142
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ S C D Y + C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 143 SYSDCNDSYPGMIT--NAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ G P VY K+ + W+ +
Sbjct: 196 CAEPGNPGVYAKVCIFSDWLTSTM 219
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 24/237 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDL------VSKLRQIRVPLHNISVCRD 193
VCL D + + + TGWG ++ S L+ + +P+ VC+D
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKD 175
Query: 194 KYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
+ + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 176 --STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLV------SK 336
AL+KL +P + D + VCL D + + + TGWG ++ S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSV 159
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDG 392
L+ + +P+ VC+D + + C G +G G AC GDSGGP S +
Sbjct: 160 LQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN 217
Query: 393 RWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 218 RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 113/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N +IAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 52/161 (32%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 283 SAALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDL 333
+ AL+KL +P + D + VCL D + + + TGWG +K KG
Sbjct: 99 NIALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ- 156
Query: 334 VSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSL 389
S L+ + +P+ VC+D + + C G +G G AC GDSGGP S
Sbjct: 157 PSVLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSP 214
Query: 390 KDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
+ RWY GI S+G GC + G YT + WI+K I+
Sbjct: 215 FNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 72/247 (29%), Positives = 110/247 (44%), Gaps = 22/247 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ + PW ++ H R G + + CG L+ P WV++A HC P E
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRH-RGGSVTYVCGGSLMSPCWVISATHCF----IDYPKKE 55
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN----YHHDIALLKLSRPTSAR----D 138
+ LG + E++ VE + +H+++ +H+DIALLK+ R R
Sbjct: 56 DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKI-RSKEGRCAQPS 114
Query: 139 KGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGD 197
+ ++ + L P C TG+G+ L +L+ V L + C+ +
Sbjct: 115 RTIQTIALPSMYNDP-QFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYY 173
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC-----GVGI 252
E+ LC + +C GDSGGPL CSL+ GR L GI S+G G GV
Sbjct: 174 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYT 232
Query: 253 RYSHRQP 259
R SH P
Sbjct: 233 RVSHFLP 239
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 43/111 (38%), Positives = 58/111 (52%), Gaps = 2/111 (1%)
Query: 319 CVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C TG+G+ L +L+ V L + C+ + E+ LC + +C
Sbjct: 135 CEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSC 194
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQ 428
GDSGGPL CSL+ GR L GI S+G GCA P VYT++S +LPWIR
Sbjct: 195 QGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSH 244
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC DSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC DSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E+ + P+ SLQ+ R H+CG LIHPS+V+TAAHC+ + IP+
Sbjct: 1 IVGGHEAQPHSRPYMASLQM---RGNPGSHFCGGTLIHPSFVLTAAHCLRD------IPQ 51
Query: 87 -LWTAVLGDWDRTEEEKSEVRIPVERIRVHE-EFHNYHHDIALLKLSRPTSARDKGVRAV 144
L VLG + +E ++ V ++ ++ + N +DI L++LS P + V V
Sbjct: 52 RLVNVVLGAHNVRTQEPTQQHFSVAQVFLNNYDAENKLNDILLIQLSSPANL-SASVATV 110
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L D+ PV QC+A GWGRV L+++ V + CR
Sbjct: 111 QLPQQDQ-PVPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVVTF-FCRPH---------- 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 243
++C +G C GDSGGPL C DG + GI SF
Sbjct: 159 NICTFVPRRKAGICFGDSGGPLIC---DG--IIQGIDSF 192
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/145 (33%), Positives = 69/145 (47%), Gaps = 19/145 (13%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L++LS P + V V L D+ PV QC+A GWGRV L+++ V +
Sbjct: 94 LIQLSSPANL-SASVATVQLPQQDQ-PVPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVV 151
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS- 404
CR ++C +G C GDSGGPL C DG + GI SF
Sbjct: 152 TF-FCRPH----------NICTFVPRRKAGICFGDSGGPLIC---DG--IIQGIDSFVIW 195
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA +PD +T+++ Y+ WIR +
Sbjct: 196 GCATRLFPDFFTRVALYVDWIRSTL 220
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + + +Q SLQ + H+CG LI +WVV+AAHC + I
Sbjct: 1 IVGGYECRKNSASYQASLQSGY-------HFCGGSLISSTWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I ++ +H ++ N +DI L+KLS+P S V V
Sbjct: 47 --QVRLGEHNIAVNEGTEQFIDSVKVIMHPSYNSRNLDNDIMLIKLSKPASLNSY-VSTV 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVK-PKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
L + + +C+ +GWG + + LR + +P+ + S C Y ++
Sbjct: 104 ALPSS---CASSGTRCLVSGWGNLSGSSSNYPDTLRCLDLPILSSSSCNSAYPG--QITS 158
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G ++G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 159 NMFCAGFMEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWGYG 196
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 12/146 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVK-PKGDLVSKLRQIRVPL 344
L+KLS+P S V V L + + +C+ +GWG + + LR + +P+
Sbjct: 87 LIKLSKPASLNSY-VSTVALPSS---CASSGTRCLVSGWGNLSGSSSNYPDTLRCLDLPI 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ S C Y ++ C G ++G +C GDSGGP+ C+ + L G+ S+G
Sbjct: 143 LSSSSCNSAYPG--QITSNMFCAGFMEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWGY 195
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQIN 430
GCA+ P VYTK+ Y WI ++
Sbjct: 196 GCAQRNKPGVYTKVCNYRSWISSTMS 221
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E + P+ + L ++G +CG L+ +V+TAAHC +
Sbjct: 1 IIGGNEISPHSRPYMAYYEFL--KVGGKKMFCGGFLVRDKFVLTAAHCKGRSM------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
T LG + +E+++ IPV + H +++ + +DI LLKL R + R + VR +
Sbjct: 52 --TVTLGAHNIKAKEETQQIIPVAKAIPHPDYNPDDRSNDIMLLKLVR-NAKRTRAVRPL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + V P +C GWG+V P G+ L ++++ + VC ++ S
Sbjct: 109 NLPRRNAH-VKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYN-RAN 166
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
+C G + DSGGPL C + AGI S+G
Sbjct: 167 EICVGDSKIKGASFEEDSGGPLVC-----KRAAAGIVSYG 201
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 10/144 (6%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
LLKL R + R + VR + L + V P +C GWG+V P G+ L ++++ +
Sbjct: 92 LLKLVR-NAKRTRAVRPLNLPRRNAH-VKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQ 149
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
VC ++ S +C G + DSGGPL C + AGI S+G
Sbjct: 150 KDQVCESQFQSSYN-RANEICVGDSKIKGASFEEDSGGPLVC-----KRAAAGIVSYGQ- 202
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
P V+T++ ++ WI+K +
Sbjct: 203 -TDGSAPQVFTRVLSFVSWIKKTM 225
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G AC DSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G AC DSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVSKLRQIRVPLHNISVCR 192
VCL D + + + TGWG +K KG S L+ + +P+ VC+
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCK 174
Query: 193 DKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
D + + C G +G G A GDSGGP S + RWY GI S+G G
Sbjct: 175 D--STRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKP-------KGDLVS 335
AL+KL +P + D + VCL D + + + TGWG +K KG S
Sbjct: 101 ALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQ-PS 158
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKD 391
L+ + +P+ VC+D + + C G +G G A GDSGGP S +
Sbjct: 159 VLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFN 216
Query: 392 GRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G G + G YT + WI+K I+
Sbjct: 217 NRWYQMGIVSWGEGADRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 78/237 (32%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF------ 80
++ G E + + PWQV + + CG VL+HP WV+TAAHCI N
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAV------CGGVLVHPQWVLTAAHCIRNKSVILLGRH 54
Query: 81 SLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKG 140
SL PE V ++ + + R + HD+ LL+LS P D
Sbjct: 55 SLFHPEDTGQVFQVSHSFPHPLYDMSL--LKNRFLRPGDDSSHDLMLLRLSEPAELTD-- 110
Query: 141 VRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNIS--VCRDKYGDS 198
AV + D + C A+GWG ++P+ L K Q V LH IS VC +
Sbjct: 111 --AVKVMDLPTQEPALGTTCYASGWGSIEPEEFLTPKKLQC-VDLHVISNDVCAQVHPQK 167
Query: 199 VELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYS 255
V LC G+ G C GDSGGPL C+ L GITS+GS C + R S
Sbjct: 168 VTKF--MLCAGRWTGGKSTCSGDSGGPLVCN-----GVLQGITSWGSEPCALPERPS 217
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 56/147 (38%), Positives = 70/147 (47%), Gaps = 15/147 (10%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
LL+LS P D AV + D + C A+GWG ++P+ L K Q V LH
Sbjct: 99 LLRLSEPAELTD----AVKVMDLPTQEPALGTTCYASGWGSIEPEEFLTPKKLQC-VDLH 153
Query: 346 NIS--VCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
IS VC + V LC G+ G C GDSGGPL C+ L GITS+G
Sbjct: 154 VISNDVCAQVHPQKVTKF--MLCAGRWTGGKSTCSGDSGGPLVCN-----GVLQGITSWG 206
Query: 404 SG-CAKSGYPDVYTKLSFYLPWIRKQI 429
S CA P +YTK+ Y WI+ I
Sbjct: 207 SEPCALPERPSLYTKVVHYRKWIKDTI 233
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 69/236 (29%), Positives = 109/236 (46%), Gaps = 22/236 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E+ +PWQVS++ R H+CG +I+ WVV AAHC+ + P
Sbjct: 1 IVGGIEARPYEFPWQVSVR----RKSSDSHFCGGSIINDRWVVCAAHCMQGE-----APA 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
L + V+G+ D + V+ I V+E + +D++++K + + D V +
Sbjct: 52 LVSLVVGEHDSSAASTVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAIT-FDINVGPI 110
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYGDSVELHG 203
C D V K QC +GWG + G + LR + + + + C Y S ++
Sbjct: 111 CAPDPANDYVYRKSQC--SGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVY-TSDTIYD 167
Query: 204 GHLCGGQLDGFS--GACIGDSGGPLQCSLKDGRWYLAGITSFG----SGYCGVGIR 253
+C G + +C GDSGGPL G + L GI S+G SGY GV R
Sbjct: 168 DMICATDNTGMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCASGYPGVYSR 223
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 46/136 (33%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 297 DKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV-SKLRQIRVPLHNISVCRDKYG 355
D V +C D V K QC +GWG + G + LR + + + + C Y
Sbjct: 104 DINVGPICAPDPANDYVYRKSQC--SGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVY- 160
Query: 356 DSVELHGGHLCGGQLDGFSG--ACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPD 413
S ++ +C G + +C GDSGGPL G + L GI S+G GCA SGYP
Sbjct: 161 TSDTIYDDMICATDNTGMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCA-SGYPG 219
Query: 414 VYTKLSFYLPWIRKQI 429
VY+++ F+ WI I
Sbjct: 220 VYSRVGFHAGWITDTI 235
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + P QVSL + H+CG L++ +WVV+AAHC + +
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGY-------HFCGGSLVNENWVVSAAHCYKSRV------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
LG+ + E SE I R+ H + +Y+ +DI L+KLS+ ++ + V+ V
Sbjct: 47 --EVRLGEHNIKVTEGSEQFISSSRVIRHPNYSSYNIDNDIMLIKLSK-SATLNTYVQPV 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + C +GWG +KL+ + +P+ + S C + Y +
Sbjct: 104 ALPSSCAP---AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMIT--NA 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 159 MFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYG 195
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 318 QCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C +GWG +KL+ + +P+ + S C + Y + C G L+G +C
Sbjct: 115 MCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGMIT--NAMFCAGYLEGGKDSC 172
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GDSGGP+ C+ + L G+ S+G GCA+ G P VY K+ + W+ +
Sbjct: 173 QGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTM 219
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAYGLEGKG 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAYGLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGC P VYTK+ Y+ WI++ I
Sbjct: 168 GKGDSCQGDSGGPVVCSGK-----LQGIVSWGSGCQAKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 75/238 (31%), Positives = 109/238 (45%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF--SLPI 84
++ G+++ G PWQV L P+ L CGA LI WV+TAAHC+ + + +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTV 56
Query: 85 PELWTAVLGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKG 140
+L + G RT E+ +I + ++I +H ++ N DIALLKL RP D
Sbjct: 57 DDLLVRI-GKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDY- 114
Query: 141 VRAVCLTDADK--RPVNPKQQCVATGWGRVKPKGDLV------SKLRQIRVPLHNISVCR 192
+ VCL D + ++ + TGWG + S L+ + +PL VC
Sbjct: 115 IHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVC- 173
Query: 193 DKYGDSVELHGGHLCGGQLDGF---SGACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
K + + C G G AC GDSGGP S + RWY GI S+G G
Sbjct: 174 -KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEG 230
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADK--RPVNPKQQCVATGWGRVKPKGDLV------SK 336
ALLKL RP D + VCL D + ++ + TGWG + S
Sbjct: 101 ALLKLKRPIELSDY-IHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSV 159
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS---GACIGDSGGPL-QCSLKDG 392
L+ + +PL VC K + + C G G AC GDSGGP S +
Sbjct: 160 LQVVNLPLVERPVC--KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNN 217
Query: 393 RWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 218 RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 75/238 (31%), Positives = 109/238 (45%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF--SLPI 84
++ G+++ G PWQV L P+ L CGA LI WV+TAAHC+ + + +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTV 56
Query: 85 PELWTAVLGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKG 140
+L + G RT E+ +I + ++I +H ++ N DIALLKL RP D
Sbjct: 57 DDLLVRI-GKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDY- 114
Query: 141 VRAVCLTDADK--RPVNPKQQCVATGWGRVKPKGDLV------SKLRQIRVPLHNISVCR 192
+ VCL D + ++ + TGWG + S L+ + +PL VC
Sbjct: 115 IHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVC- 173
Query: 193 DKYGDSVELHGGHLCGGQLDGF---SGACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
K + + C G G AC GDSGGP S + RWY GI S+G G
Sbjct: 174 -KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEG 230
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADK--RPVNPKQQCVATGWGRVKPKGDLV------SK 336
ALLKL RP D + VCL D + ++ + TGWG + S
Sbjct: 101 ALLKLKRPIELSDY-IHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSV 159
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS---GACIGDSGGPL-QCSLKDG 392
L+ + +PL VC K + + C G G AC GDSGGP S +
Sbjct: 160 LQVVNLPLVERPVC--KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNN 217
Query: 393 RWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 218 RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 78/237 (32%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ +G PWQV L P+ L CGA LI WV+TAAHCI + E
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCILYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I VH ++ N DIALLKL +P D +
Sbjct: 57 NDLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDL------VSKLRQIRVPLHNISVCRD 193
VCL D + + TGWG ++ S L+ + +P+ VC
Sbjct: 116 HPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVC-- 173
Query: 194 KYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
K + + C G D G AC GDSGGP S + RWY GI S+G G
Sbjct: 174 KASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/158 (31%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLV------SK 336
ALLKL +P D + VCL D + + TGWG ++ S
Sbjct: 101 ALLKLKKPVPFSDY-IHPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSV 159
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDG 392
L+ + +P+ VC K + + C G D G AC GDSGGP S +
Sbjct: 160 LQVVNLPIVERPVC--KASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNN 217
Query: 393 RWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 218 RWYQMGIVSWGEGCDRKGKYGFYTHVFRLKAWIQKVID 255
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 78/237 (32%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ +G PWQV L P+ L CGA LI WV+TAAHCI + E
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCILYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I VH ++ N DIALLKL +P D +
Sbjct: 57 NDLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDL------VSKLRQIRVPLHNISVCRD 193
VCL D + + TGWG ++ S L+ + +P+ VC
Sbjct: 116 HPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVC-- 173
Query: 194 KYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
K + + C G D G AC GDSGGP S + RWY GI S G+G
Sbjct: 174 KASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAG 230
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 50/158 (31%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLV------SK 336
ALLKL +P D + VCL D + + TGWG ++ S
Sbjct: 101 ALLKLKKPVPFSDY-IHPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSV 159
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDG 392
L+ + +P+ VC K + + C G D G AC GDSGGP S +
Sbjct: 160 LQVVNLPIVERPVC--KASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNN 217
Query: 393 RWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S G+GC + G YT + WI+K I+
Sbjct: 218 RWYQMGIVSAGAGCDRKGKYGFYTHVFRLKRWIQKVID 255
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GSGCA+ P YTKL Y+ WI++ I
Sbjct: 194 GSGCAQKNKPGFYTKLCNYVSWIKQTI 220
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 101/238 (42%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ +S K S + C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G AC GDSGGP+ CS K L GI S+GSGCA+ P YTK+ Y+ WI++ I
Sbjct: 168 GGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GSGCA+ P +YTK+ Y+ WI++ I
Sbjct: 194 GSGCAQKNKPGIYTKVCNYVSWIKQTI 220
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 70/238 (29%), Positives = 102/238 (42%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ +S K S + C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G AC GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 77/237 (32%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ +G PWQV L P+ L CGA LI WV+TAAHCI + E
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCILYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I VH ++ N DIALLKL +P D +
Sbjct: 57 NDLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDL------VSKLRQIRVPLHNISVCRD 193
VCL D + + TGWG ++ S L+ + +P+ VC
Sbjct: 116 HPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVC-- 173
Query: 194 KYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDGRWYLAGITSFGSG 246
K + + C G D G AC GD+GGP S + RWY GI S+G G
Sbjct: 174 KASTRIRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEG 230
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/158 (31%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVATGWGRVKPKGDLV------SK 336
ALLKL +P D + VCL D + + TGWG ++ S
Sbjct: 101 ALLKLKKPVPFSDY-IHPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSV 159
Query: 337 LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLKDG 392
L+ + +P+ VC K + + C G D G AC GD+GGP S +
Sbjct: 160 LQVVNLPIVERPVC--KASTRIRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNN 217
Query: 393 RWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
RWY GI S+G GC + G YT + WI+K I+
Sbjct: 218 RWYQMGIVSWGEGCDRKGKYGFYTHVFRLKRWIQKVID 255
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 80.1 bits (196), Expect = 2e-15, Method: Composition-based stats.
Identities = 50/145 (34%), Positives = 78/145 (53%), Gaps = 17/145 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++NG+++I G+WPWQVSLQ + G H+CG LI WVVTAAHC +
Sbjct: 1 IVNGEDAIPGSWPWQVSLQ---DKTGF--HFCGGSLISEDWVVTAAHC--------GVKT 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVRAV 144
V G++D+ +E++ + + ++ + +F+ + +DI LLKL+ P + V AV
Sbjct: 48 SDVVVAGEFDQGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSET-VSAV 106
Query: 145 CLTDADKRPVNPKQQCVATGWGRVK 169
L + D P C TGWG+ K
Sbjct: 107 SLPNVDD-DFPPGTVCATTGWGKTK 130
Score = 29.6 bits (65), Expect = 3.2, Method: Composition-based stats.
Identities = 20/56 (35%), Positives = 25/56 (44%), Gaps = 2/56 (3%)
Query: 273 PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVK 328
P N+ T LLKL+ P + V AV L + D P C TGWG+ K
Sbjct: 77 PKFNMFTVRNDITLLKLATPAQFSET-VSAVSLPNVDD-DFPPGTVCATTGWGKTK 130
Score = 29.6 bits (65), Expect = 3.3, Method: Composition-based stats.
Identities = 8/15 (53%), Positives = 14/15 (93%)
Query: 261 LINGKESIRGAWPWQ 275
++NG+++I G+WPWQ
Sbjct: 1 IVNGEDAIPGSWPWQ 15
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 71/238 (29%), Positives = 111/238 (46%), Gaps = 44/238 (18%)
Query: 28 INGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPEL 87
+ + + PW V++ + + CG VL+ +WV+TAAHC +ND + ++
Sbjct: 5 VQSQVDCENSQPWHVAVYRFNK------YQCGGVLLDRNWVLTAAHC-YNDKY-----QV 52
Query: 88 WTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH-------------NYHHDIALLKLSRPT 134
W LG + E+E S+ V + H +F+ +Y +D+ LL+LS+P
Sbjct: 53 W---LGKNNFLEDEPSDQHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPA 109
Query: 135 SARDKGVRAVCLTDADKRPVNPK--QQCVATGWGRVKP-KGDLVSKLRQIRVPLHNISVC 191
D V+ + L + PK C+A+GWG P K L+ + + L C
Sbjct: 110 DITDV-VKPITLPTEE-----PKLGSTCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDC 163
Query: 192 RDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+ +++ LC G++DG S C DSGGPL C DG L GITS+G CG
Sbjct: 164 DKAH--EMKVTDAMLCAGEMDGGSYTCEHDSGGPLIC---DG--ILQGITSWGPEPCG 214
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/148 (35%), Positives = 73/148 (49%), Gaps = 17/148 (11%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPK--QQCVATGWGRVKP-KGDLVSKLRQIRV 342
LL+LS+P D V+ + L + PK C+A+GWG P K L+ + +
Sbjct: 102 LLRLSKPADITDV-VKPITLPTEE-----PKLGSTCLASGWGSTTPIKFKYPDDLQCVNL 155
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
L C + +++ LC G++DG S C DSGGPL C DG L GITS+
Sbjct: 156 KLLPNEDCDKAH--EMKVTDAMLCAGEMDGGSYTCEHDSGGPLIC---DG--ILQGITSW 208
Query: 403 G-SGCAKSGYPDVYTKLSFYLPWIRKQI 429
G C + P VYTKL + WIR+ +
Sbjct: 209 GPEPCGEPTEPSVYTKLIKFSSWIRETM 236
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E+ + P+ LQ++ G CG LI +V+TAAHC + I
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSG--SKKCGGFLIREDFVLTAAHCSGSKI------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAV 144
LG + E+EK + IPV +I H +++ +DI LLKL + + R V+ +
Sbjct: 52 --QVTLGAHNIKEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKL-KSKAKRSSAVKPL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + + V P C GWG++ P G L+++ + + C + Y +
Sbjct: 109 NLPRRNVK-VKPGDVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKC-ESYLKNYFDKAN 166
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
+C G + GDSGGPL C + AGI S+G
Sbjct: 167 EICAGDPKIKRASFRGDSGGPLVC-----KKVAAGIVSYG 201
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 10/157 (6%)
Query: 273 PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGD 332
P N T LLKL + + R V+ + L + + V P C GWG++ P G
Sbjct: 79 PAYNSKTISNDIMLLKL-KSKAKRSSAVKPLNLPRRNVK-VKPGDVCYVAGWGKLGPMGK 136
Query: 333 LVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDG 392
L+++ + + C + Y + +C G + GDSGGPL C
Sbjct: 137 YSDTLQEVELTVQEDQKC-ESYLKNYFDKANEICAGDPKIKRASFRGDSGGPLVC----- 190
Query: 393 RWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+ AGI S+G + P +TK+S +L WI+K +
Sbjct: 191 KKVAAGIVSYGQNDGST--PRAFTKVSTFLSWIKKTM 225
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 101/238 (42%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ +S K S + C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P YTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG L++ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLLNSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLLNSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GSGCA+ P +YTK+ Y+ WI++ I
Sbjct: 194 GSGCAQKNKPGIYTKVCNYVSWIKQTI 220
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GD+GGP+ CS K L GI S+GSG
Sbjct: 171 DACQGDAGGPVVCSGK-----LQGIVSWGSG 196
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GD+GGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 194 GSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GD+GGP+ CS K L GI S+GSG
Sbjct: 171 DACQGDAGGPVVCSGK-----LQGIVSWGSG 196
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GD+GGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GSGCA+ P YTK+ Y+ WI++ I
Sbjct: 194 GSGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 79.3 bits (194), Expect = 4e-15, Method: Composition-based stats.
Identities = 50/142 (35%), Positives = 76/142 (53%), Gaps = 17/142 (11%)
Query: 30 GKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWT 89
G+++I G+WPWQVSLQ + G H+CG LI WVVTAAHC +
Sbjct: 1 GEDAIPGSWPWQVSLQ---DKTGF--HFCGGSLISEDWVVTAAHC--------GVKTSDV 47
Query: 90 AVLGDWDRTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVRAVCLT 147
V G++D+ +E++ + + ++ + +F+ + +DI LLKL+ P + V AVCL
Sbjct: 48 VVAGEFDQGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSET-VSAVCLP 106
Query: 148 DADKRPVNPKQQCVATGWGRVK 169
+ D P C TGWG+ K
Sbjct: 107 NVDD-DFPPGTVCATTGWGKTK 127
Score = 33.5 bits (75), Expect = 0.27, Method: Composition-based stats.
Identities = 21/56 (37%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 273 PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVK 328
P N+ T LLKL+ P + V AVCL + D P C TGWG+ K
Sbjct: 74 PKFNMFTVRNDITLLKLATPAQFSET-VSAVCLPNVDD-DFPPGTVCATTGWGKTK 127
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 75/231 (32%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 27 LINGKESIRGAWPWQVSL---QVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLP 83
+I+G RG+ PWQV+L LH CG VL++ WV+TAAHC N+
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLH---------CGGVLVNERWVLTAAHCKMNE----- 46
Query: 84 IPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHH--DIALLKLSRPT--SARDK 139
+T LG T ++ RI + H + H D+ L+KL+ S+ K
Sbjct: 47 ----YTVHLG--SDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVK 100
Query: 140 GVRAVCLTDADKRPVNPKQQCVATGWG-RVKPKGDLVSKLRQIRVPLHNISVCRDKYGDS 198
VR R P C +GWG P S L + V L + C Y D
Sbjct: 101 KVR------LPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDL 154
Query: 199 VELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+E LC G D AC GDSGGPL C R L G+ S+G+ CG
Sbjct: 155 LE--NSMLCAGIPDSKKNACNGDSGGPLVC-----RGTLQGLVSWGTFPCG 198
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 40/117 (34%), Positives = 52/117 (44%), Gaps = 9/117 (7%)
Query: 315 PKQQCVATGWGRV-KPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGF 373
P C +GWG P S L + V L + C Y D +E LC G D
Sbjct: 111 PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLE--NSMLCAGIPDSK 168
Query: 374 SGACIGDSGGPLQCSLKDGRWYLAGITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQI 429
AC GDSGGPL C R L G+ S+G+ C + P VYT++ + WI +
Sbjct: 169 KNACNGDSGGPLVC-----RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTM 220
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 75/231 (32%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 27 LINGKESIRGAWPWQVSL---QVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLP 83
+I+G RG+ PWQV+L LH CG VL++ WV+TAAHC N+
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLH---------CGGVLVNERWVLTAAHCKMNE----- 46
Query: 84 IPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHH--DIALLKLSRPT--SARDK 139
+T LG T ++ RI + H + H D+ L+KL+ S+ K
Sbjct: 47 ----YTVHLG--SDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVK 100
Query: 140 GVRAVCLTDADKRPVNPKQQCVATGWG-RVKPKGDLVSKLRQIRVPLHNISVCRDKYGDS 198
VR R P C +GWG P S L + V L + C Y D
Sbjct: 101 KVR------LPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDL 154
Query: 199 VELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+E LC G D AC GDSGGPL C R L G+ S+G+ CG
Sbjct: 155 LE--NSMLCAGIPDSKKNACNGDSGGPLVC-----RGTLQGLVSWGTFPCG 198
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 40/117 (34%), Positives = 52/117 (44%), Gaps = 9/117 (7%)
Query: 315 PKQQCVATGWGRV-KPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGF 373
P C +GWG P S L + V L + C Y D +E LC G D
Sbjct: 111 PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLE--NSMLCAGIPDSK 168
Query: 374 SGACIGDSGGPLQCSLKDGRWYLAGITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQI 429
AC GDSGGPL C R L G+ S+G+ C + P VYT++ + WI +
Sbjct: 169 KNACNGDSGGPLVC-----RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTM 220
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+G G
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGEG 196
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA+ P VYTK+ Y+ WI++ I
Sbjct: 194 GEGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+G G
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGEG 196
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA+ P +YTK+ Y+ WI++ I
Sbjct: 194 GEGCAQKNKPGIYTKVCNYVSWIKQTI 220
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 78.6 bits (192), Expect = 7e-15, Method: Composition-based stats.
Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 21/144 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHC--IHNDIFSLPI 84
++NG+E++ G+WPWQVSLQ + G H+CG LI+ +WVVTAAHC +D+
Sbjct: 1 IVNGEEAVPGSWPWQVSLQ---DKTGF--HFCGGSLINENWVVTAAHCGVTTSDV----- 50
Query: 85 PELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVR 142
V G++D+ + ++ + ++ + ++++ ++DI LLKLS S + V
Sbjct: 51 -----VVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASF-SQTVS 104
Query: 143 AVCLTDADKRPVNPKQQCVATGWG 166
AVCL A CV TGWG
Sbjct: 105 AVCLPSASD-DFAAGTTCVTTGWG 127
Score = 30.4 bits (67), Expect = 1.9, Method: Composition-based stats.
Identities = 8/15 (53%), Positives = 14/15 (93%)
Query: 261 LINGKESIRGAWPWQ 275
++NG+E++ G+WPWQ
Sbjct: 1 IVNGEEAVPGSWPWQ 15
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G G S
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGLEGGDS 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 --CQGDSGGPVVCSGK-----LQGIVSWGSG 194
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 70/238 (29%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ + S C+ Y ++ C G
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG--QITSNMFCAGLEG 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G S C GDSGGP+ CS K L GI S+GSGCAK+ P VYTK+ Y+ WI++ I
Sbjct: 168 GDS--CQGDSGGPVVCSGK-----LQGIVSWGSGCAKN-KPGVYTKVCNYVSWIKQTI 217
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GD+GGP+ CS K L GI S+G G
Sbjct: 171 DACQGDAGGPVVCSGK-----LQGIVSWGEG 196
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GD+GGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA+ P YTK+ Y+ WI++ I
Sbjct: 194 GEGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GD+GGP+ CS K L GI S+G G
Sbjct: 171 DACQGDAGGPVVCSGK-----LQGIVSWGEG 196
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GD+GGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDACQGDAGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA+ P VYTK+ Y+ WI++ I
Sbjct: 194 GEGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 27/193 (13%)
Query: 58 CGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEE 117
CG LI +V+TAAHC + I LG + E+E ++ IPV+R H
Sbjct: 29 CGGFLIQDDFVLTAAHCWGSSI---------NVTLGAHNIKEQEPTQQFIPVKRPIPHPA 79
Query: 118 FH--NYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV 175
++ N+ +DI LL+L R + R + V+ + L ++K V P Q C GWG+ P G
Sbjct: 80 YNPKNFSNDIMLLQLER-KAKRTRAVQPLRLP-SNKAQVKPGQTCSVAGWGQTAPLGKHS 137
Query: 176 SKLRQIRVPLHNISVC----RDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 231
L+++++ + C R Y ++E LC G + + GDSGGPL C+
Sbjct: 138 HTLQEVKMTVQEDRKCESDLRHYYDSTIE-----LCVGDPEIKKTSFKGDSGGPLVCNK- 191
Query: 232 DGRWYLAGITSFG 244
GI S+G
Sbjct: 192 ----VAQGIVSYG 200
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
LL+L R + R + V+ + L ++K V P Q C GWG+ P G L+++++ +
Sbjct: 91 LLQLER-KAKRTRAVQPLRLP-SNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQ 148
Query: 346 NISVC----RDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
C R Y ++E LC G + + GDSGGPL C+ GI S
Sbjct: 149 EDRKCESDLRHYYDSTIE-----LCVGDPEIKKTSFKGDSGGPLVCNK-----VAQGIVS 198
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G P TK+S ++ WI+K +
Sbjct: 199 YGRNNGMP--PRACTKVSSFVHWIKKTM 224
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCVGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+G G
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGEG 196
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCVGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA+ P YTK+ Y+ WI++ I
Sbjct: 194 GEGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 27/193 (13%)
Query: 58 CGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEE 117
CG LI +V+TAAHC + I LG + E+E ++ IPV+R H
Sbjct: 29 CGGFLIRDDFVLTAAHCWGSSI---------NVTLGAHNIKEQEPTQQFIPVKRPIPHPA 79
Query: 118 FH--NYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV 175
++ N+ +DI LL+L R + R + V+ + L ++K V P Q C GWG+ P G
Sbjct: 80 YNPKNFSNDIMLLQLER-KAKRTRAVQPLRLP-SNKAQVKPGQTCSVAGWGQTAPLGKHS 137
Query: 176 SKLRQIRVPLHNISVC----RDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 231
L+++++ + C R Y ++E LC G + + GDSGGPL C+
Sbjct: 138 HTLQEVKMTVQEDRKCESDLRHYYDSTIE-----LCVGDPEIKKTSFKGDSGGPLVCNK- 191
Query: 232 DGRWYLAGITSFG 244
GI S+G
Sbjct: 192 ----VAQGIVSYG 200
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
LL+L R + R + V+ + L ++K V P Q C GWG+ P G L+++++ +
Sbjct: 91 LLQLER-KAKRTRAVQPLRLP-SNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQ 148
Query: 346 NISVC----RDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
C R Y ++E LC G + + GDSGGPL C+ GI S
Sbjct: 149 EDRKCESDLRHYYDSTIE-----LCVGDPEIKKTSFKGDSGGPLVCNK-----VAQGIVS 198
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G P TK+S ++ WI+K +
Sbjct: 199 YGRNNGMP--PRACTKVSSFVHWIKKTM 224
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G ESI + P+ L ++ + GL CG LI +V+TAAHC +I
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEK-GLRV-ICGGFLISRQFVLTAAHCKGREI------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYH--HDIALLKLSRPTSARDKGVRAV 144
T +LG D + E ++ +I VE+ +HE +++ HDI LLKL + V V
Sbjct: 52 --TVILGAHDVRKRESTQQKIKVEKQIIHESYNSVPNLHDIMLLKLEKKVEL-TPAVNVV 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRD-KYGDSVELHG 203
L ++P C A GWG+ + LR++ + + + C D +Y + +
Sbjct: 109 PLPSPSDF-IHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKACVDYRYYE----YK 163
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCS 229
+C G A +GDSGGPL C+
Sbjct: 164 FQVCVGSPTTLRAAFMGDSGGPLLCA 189
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 12/119 (10%)
Query: 313 VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRD-KYGDSVELHGGHLCGGQLD 371
++P C A GWG+ + LR++ + + + C D +Y + + +C G
Sbjct: 117 IHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKACVDYRYYE----YKFQVCVGSPT 172
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
A +GDSGGPL C+ GI S+G AK P ++T++S Y+PWI IN
Sbjct: 173 TLRAAFMGDSGGPLLCA-----GVAHGIVSYGHPDAKP--PAIFTRVSTYVPWINAVIN 224
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+E I + P+ SLQ R G H CG VL+HP WV+TAAHC+ + L +
Sbjct: 1 IIGGREVIPHSRPYMASLQ----RNG--SHLCGGVLVHPKWVLTAAHCLAQRMAQLRL-V 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
L L T K+ ++ P ++ +D+ALL+L + +R + L
Sbjct: 54 LGLHTLDSPGLTFHIKAAIQHP-----RYKPVPALENDLALLQLDGKVKP-SRTIRPLAL 107
Query: 147 TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHL 206
+ ++ V +C GWG G L LR++ + + + +C + + L +
Sbjct: 108 -PSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMV 166
Query: 207 CGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC 248
C C GDSGGPL C GR LAG+ SF S C
Sbjct: 167 CLAADSKDQAPCKGDSGGPLVCG--KGR-VLAGVLSFSSRVC 205
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 61/239 (25%), Positives = 96/239 (40%), Gaps = 32/239 (13%)
Query: 195 YGDSVELHGGHLCGGQLDG-----FSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y S++ +G HLCGG L + C+ L+ L G+ + S
Sbjct: 14 YMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVL--------GLHTLDSPGLT 65
Query: 250 VGIRYSHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDAD 309
I+ + + PR ++ + ALL+L + +R + L +
Sbjct: 66 FHIKAAIQHPR-------------YKPVPALENDLALLQLDGKVKP-SRTIRPLAL-PSK 110
Query: 310 KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQ 369
++ V +C GWG G L LR++ + + + +C + + L +C
Sbjct: 111 RQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAA 170
Query: 370 LDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWIRK 427
C GDSGGPL C GR LAG+ SF S C P V T ++ Y+ WIRK
Sbjct: 171 DSKDQAPCKGDSGGPLVCG--KGR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRK 226
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G G PWQ +L + G +CG ++ +++TAAHC++ +
Sbjct: 1 IVGGYNCKDGEVPWQ-ALLINEENEG----FCGGTILSEFYILTAAHCLYQ-------AK 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ +GD + +EE E VE + H F Y DIA+L+L P + R V
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFR-MNVAPA 107
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
L A P +C+ +GWG G D +L+ + P+ + + C Y + +
Sbjct: 108 SLPTA---PPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSN- 163
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 164 -MFCVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWGDG 200
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 12/146 (8%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVP 343
A+L+L P + R V L A P +C+ +GWG G D +L+ + P
Sbjct: 90 AVLRLKTPITFR-MNVAPASLPTA---PPATGTKCLISGWGNTASSGADYPDELQCLDAP 145
Query: 344 LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ + + C Y + + C G L+G +C GDSGGP+ C+ + L G+ S+G
Sbjct: 146 VLSQAKCEASYPGKITSN--MFCVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWG 198
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA+ P VYTK+ Y+ WI+ I
Sbjct: 199 DGCAQKNKPGVYTKVYNYVKWIKNTI 224
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ Y++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLXSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCVGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
AC GDSGGP+ CS K L GI S+G G
Sbjct: 171 DACQGDSGGPVVCSGK-----LQGIVSWGEG 196
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLXSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G AC GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCVGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA+ P YTK+ Y+ WI++ I
Sbjct: 194 GEGCAQKNKPGFYTKVCNYVSWIKQTI 220
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 69/237 (29%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + + PWQV++ H CG VL+ +WV+TAAHC + E
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKE------HICGGVLLDRNWVLTAAHCYVDQY------E 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH-------------NYHHDIALLKLSRP 133
+W LG +EE S V + H F+ ++ D+ LL+LS+P
Sbjct: 49 VW---LGKNKLFQEEPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKP 105
Query: 134 TSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKP-KGDLVSKLRQIRVPLHNISVCR 192
D V+ + L + + P +C+A+GWG + P + L+ + + L C
Sbjct: 106 ADITDV-VKPIALPTKEPK---PGSKCLASGWGSITPTRWQKPDDLQCVFITLLPNENCA 161
Query: 193 DKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y V LC G++ G C DSGGPL C DG L G TS+G CG
Sbjct: 162 KVYLQKVT--DVMLCAGEMGGGKDTCRDDSGGPLIC---DG--ILQGTTSYGPVPCG 211
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 69/146 (47%), Gaps = 13/146 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKP-KGDLVSKLRQIRVPL 344
LL+LS+P D V+ + L + +P +C+A+GWG + P + L+ + + L
Sbjct: 99 LLRLSKPADITDV-VKPIALPTKEPKP---GSKCLASGWGSITPTRWQKPDDLQCVFITL 154
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
C Y V LC G++ G C DSGGPL C DG L G TS+G
Sbjct: 155 LPNENCAKVYLQKVT--DVMLCAGEMGGGKDTCRDDSGGPLIC---DG--ILQGTTSYGP 207
Query: 405 -GCAKSGYPDVYTKLSFYLPWIRKQI 429
C K G P +YT L + WI+ +
Sbjct: 208 VPCGKPGVPAIYTNLIKFNSWIKDTM 233
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSAIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 102/238 (42%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ +S K S + C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSAIITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSYIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 102/238 (42%), Gaps = 40/238 (16%)
Query: 199 VELHGG-HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
V L+ G H CGG SL + +W ++ + SG + +R
Sbjct: 16 VSLNSGYHFCGG-------------------SLINSQWVVSAAHCYKSG---IQVRLGED 53
Query: 258 QPRLINGKESIRGAW-----PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRP 312
++ G E A P N T L+KL S + V ++ L +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---C 109
Query: 313 VNPKQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLD 371
+ QC+ +GWG K G L+ ++ P+ +S K S + C G L+
Sbjct: 110 ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSYIITSNMFCAGYLE 167
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G +C GDSGGP+ CS K L GI S+GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 168 GGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F Y++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y ++
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KIT 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y ++ +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPG--KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 69/224 (30%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F Y++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C + S +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADC--EASSSFIIT 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G AC GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDACQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRETYNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C + S + +C G L+G AC GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADC--EASSSFIITDNMVCVGFLEGGKDACQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+E I + P+ SLQ R G H CG VL+HP WV+TAAHC+ + L +
Sbjct: 1 IIGGREVIPHSRPYMASLQ----RNG--SHLCGGVLVHPKWVLTAAHCLAQRMAQLRL-V 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
L L T K+ ++ P ++ +++ALL+L + +R + L
Sbjct: 54 LGLHTLDSPGLTFHIKAAIQHP-----RYKPVPALENNLALLQLDGKVKP-SRTIRPLAL 107
Query: 147 TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHL 206
+ ++ V +C GWG G L LR++ + + + +C + + L +
Sbjct: 108 -PSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMV 166
Query: 207 CGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC 248
C C GDSGGPL C GR LAG+ SF S C
Sbjct: 167 CLAADSKDQAPCKGDSGGPLVCG--KGR-VLAGVLSFSSRVC 205
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 61/239 (25%), Positives = 97/239 (40%), Gaps = 32/239 (13%)
Query: 195 YGDSVELHGGHLCGGQLDG-----FSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y S++ +G HLCGG L + C+ L+ L G+ + S
Sbjct: 14 YMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVL--------GLHTLDSPGLT 65
Query: 250 VGIRYSHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDAD 309
I+ + + PR ++ + + ALL+L + +R + L +
Sbjct: 66 FHIKAAIQHPR-------------YKPVPALENNLALLQLDGKVKP-SRTIRPLAL-PSK 110
Query: 310 KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQ 369
++ V +C GWG G L LR++ + + + +C + + L +C
Sbjct: 111 RQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAA 170
Query: 370 LDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWIRK 427
C GDSGGPL C GR LAG+ SF S C P V T ++ Y+ WIRK
Sbjct: 171 DSKDQAPCKGDSGGPLVCG--KGR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRK 226
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 52/149 (34%), Positives = 73/149 (48%), Gaps = 15/149 (10%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGD---LVSKLRQIRV 342
LL+L P D AV + + + C A+GWG ++P D +++ +++
Sbjct: 12 LLRLQSPAKITD----AVKVLELPTQEPELGSTCEASGWGSIEPGPDDFEFPDEIQCVQL 67
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
L + C D + D V LC G L G C+GDSGGPL C +G W GITS+
Sbjct: 68 TLLQNTFCADAHPDKVT--ESMLCAGYLPGGKDTCMGDSGGPLIC---NGMW--QGITSW 120
Query: 403 G-SGCAKSGYPDVYTKLSFYLPWIRKQIN 430
G + C + P +YTKL FYL WI I
Sbjct: 121 GHTPCGSANKPSIYTKLIFYLDWIDDTIT 149
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 46/139 (33%), Positives = 67/139 (48%), Gaps = 14/139 (10%)
Query: 120 NYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGD---LVS 176
+Y HD+ LL+L P D AV + + + C A+GWG ++P D
Sbjct: 5 DYSHDLMLLRLQSPAKITD----AVKVLELPTQEPELGSTCEASGWGSIEPGPDDFEFPD 60
Query: 177 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 236
+++ +++ L + C D + D V LC G L G C+GDSGGPL C +G W
Sbjct: 61 EIQCVQLTLLQNTFCADAHPDKVT--ESMLCAGYLPGGKDTCMGDSGGPLIC---NGMW- 114
Query: 237 LAGITSFGSGYCGVGIRYS 255
GITS+G CG + S
Sbjct: 115 -QGITSWGHTPCGSANKPS 132
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 20/191 (10%)
Query: 56 HWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVH 115
H CG L+ +V+TAAHC+ + I LG + E E+++ IPV R H
Sbjct: 27 HICGGFLVREDFVLTAAHCLGSSI---------NVTLGAHNIMERERTQQVIPVRRPIPH 77
Query: 116 EEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGD 173
++++ +DI LLKL+R DK V + L + V P C GWGR+
Sbjct: 78 PDYNDETLANDIMLLKLTRKADITDK-VSPINLPRSLAE-VKPGMMCSVAGWGRLGVNMP 135
Query: 174 LVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDG 233
KL+++ + + + C ++ + + +C G + GDSGGPL C+
Sbjct: 136 STDKLQEVDLEVQSEEKCIARFKNYIPF--TQICAGDPSKRKNSFSGDSGGPLVCN---- 189
Query: 234 RWYLAGITSFG 244
GI S+G
Sbjct: 190 -GVAQGIVSYG 199
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
LLKL+R DK V + L + V P C GWGR+ KL+++ + +
Sbjct: 91 LLKLTRKADITDK-VSPINLPRSLAE-VKPGMMCSVAGWGRLGVNMPSTDKLQEVDLEVQ 148
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ C ++ + + +C G + GDSGGPL C+ GI S+G
Sbjct: 149 SEEKCIARFKNYIPF--TQICAGDPSKRKNSFSGDSGGPLVCN-----GVAQGIVSYGRN 201
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
+ PDVYT++S +L WI +
Sbjct: 202 DGTT--PDVYTRISSFLSWIHSTM 223
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSRIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G +C GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSRIITSNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 194 GSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSFIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+G G
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGEG 196
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G +C GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSFIITSNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
G GCA+ P VYTK+ Y+ WI++ I
Sbjct: 194 GEGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 13 PYQVSLNSGY-------HFCGGSLINSQWVVSAAHCYKSGI---------QVRLGEDNIN 56
Query: 99 EEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E I + VH +++ ++DI L+KL S + V ++ L + +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSR-VASISLPTS---CASA 112
Query: 157 KQQCVATGWGRVKPKGDLVSK-LRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS 215
QC+ +GWG K G L+ ++ P+ +S K S + C G L+G
Sbjct: 113 GTQCLISGWGNTKSSGTSYPDVLKCLKAPI--LSDSSCKSASSWIITSNMFCAGYLEGGK 170
Query: 216 GACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ CS K L GI S+GSG
Sbjct: 171 DSCQGDSGGPVVCSGK-----LQGIVSWGSG 196
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + SG + +R ++ G E A P N T
Sbjct: 28 SLINSQWVVSAAHCYKSG---IQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSK-LRQIRV 342
L+KL S + V ++ L + + QC+ +GWG K G L+ ++
Sbjct: 85 IMLIKLKSAASLNSR-VASISLPTS---CASAGTQCLISGWGNTKSSGTSYPDVLKCLKA 140
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ +S K S + C G L+G +C GDSGGP+ CS K L GI S+
Sbjct: 141 PI--LSDSSCKSASSWIITSNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSW 193
Query: 403 GSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GSGCA+ P VYTK+ Y+ WI++ I
Sbjct: 194 GSGCAQKNKPGVYTKVCNYVSWIKQTI 220
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y ++
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KIT 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G G+C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKGSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G G+C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKGSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA PDVYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPDVYTKVCNYVDWIQDTI 220
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 71/231 (30%), Positives = 110/231 (47%), Gaps = 33/231 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+ING++ + PWQ +L V+ L +C VL+HP WV++AAHC N
Sbjct: 1 IINGEDCSPHSQPWQAAL-VMENEL-----FCSGVLVHPQWVLSAAHCFQNS-------- 46
Query: 87 LWTAVLG--DWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVR 142
+T LG + +E S++ +R H E++ +D+ L+KL S D +R
Sbjct: 47 -YTIGLGLHSLEADQEPGSQMVEASLSVR-HPEYNRPLLANDLMLIKLDESVSESDT-IR 103
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
++ + A + P C+ +GWG + G + + L+ + V + + VC Y D + H
Sbjct: 104 SISI--ASQCPT-AGNSCLVSGWGLLA-NGRMPTVLQCVNVSVVSEEVCSKLY-DPL-YH 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG-VGI 252
C G +C GDSGGPL C YL G+ SFG CG VG+
Sbjct: 158 PSMFCAGGGQDQKDSCNGDSGGPLIC-----NGYLQGLVSFGKAPCGQVGV 203
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 234 RWYLAGITSFGSGYC-GVGIRY--SHRQP--RLINGKESIRGAWPWQNLITSFLSAALLK 288
+W L+ F + Y G+G+ + ++P +++ S+R + L+ + L L+K
Sbjct: 34 QWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDL--MLIK 91
Query: 289 LSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNIS 348
L S D +R++ + A + P C+ +GWG + G + + L+ + V + +
Sbjct: 92 LDESVSESDT-IRSISI--ASQCPT-AGNSCLVSGWGLLA-NGRMPTVLQCVNVSVVSEE 146
Query: 349 VCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CA 407
VC Y D + H C G +C GDSGGPL C YL G+ SFG C
Sbjct: 147 VCSKLY-DPL-YHPSMFCAGGGQDQKDSCNGDSGGPLIC-----NGYLQGLVSFGKAPCG 199
Query: 408 KSGYPDVYTKLSFYLPWIRKQI 429
+ G P VYT L + WI K +
Sbjct: 200 QVGVPGVYTNLCKFTEWIEKTV 221
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 33 SIRGAWPWQVSLQVLHPRLGLMPHWC-GAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAV 91
S + P+QVSL H+C G LI+ WVV+AAHC + + + E V
Sbjct: 8 SAANSIPYQVSLNS-------GSHFCSGGSLINSQWVVSAAHCSYKSRIQVRLGEHNIDV 60
Query: 92 LGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAVCLTDA 149
L E +E I +I H F+ +DI L+KLS P + + V
Sbjct: 61 L--------EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR----VATVSL 108
Query: 150 DKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQ--IRVPLHNISVCRDKYGDSVELHGGHL 206
+ +C + +GWG K G L Q ++ P+ + S C+ Y ++ G +
Sbjct: 109 PRSCAAAGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSYPG--QITGNMI 166
Query: 207 CGGQLDGFSGACI-GDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ CS +G+ L GI S+G G
Sbjct: 167 CVGFLEGGKDSCSQGDSGGPVVCS--NGQ--LQGIVSWGYG 203
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 15/149 (10%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQ--IRV 342
L+KLS P + + V + +C + +GWG K G L Q ++
Sbjct: 90 LIKLSSPATLNSR----VATVSLPRSCAAAGTECSLISGWGNTKSSGSSYPSLLQCSLKA 145
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACI-GDSGGPLQCSLKDGRWYLAGITS 401
P+ + S C+ Y ++ G +C G L+G +C GDSGGP+ CS +G+ L GI S
Sbjct: 146 PVLSDSSCKSSYPG--QITGNMICVGFLEGGKDSCSQGDSGGPVVCS--NGQ--LQGIVS 199
Query: 402 FGSGC-AKSGYPDVYTKLSFYLPWIRKQI 429
+G GC A+ P VYTK+ Y+ WI++ I
Sbjct: 200 WGYGCSAQKNKPGVYTKVCNYVNWIQQTI 228
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 67/225 (29%), Positives = 98/225 (43%), Gaps = 32/225 (14%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 22 KIVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------ 68
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRA 143
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 69 ---QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNA 120
Query: 144 VCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVEL 201
T A P QC+ +GWG G L Q + PL + C Y +
Sbjct: 121 HVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKIT- 179
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 180 -DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 218
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 50 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 106
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 107 IMLIKLSSPVK-----LNAHVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 161
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 162 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 214
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 215 WGYGCALPDNPGVYTKVCNYVDWIQDTI 242
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + G +P+ VS+ R G WCG L++ + V+TAAHC+ S
Sbjct: 1 IVGGTSASAGDFPFIVSIS----RNG--GPWCGGSLLNANTVLTAAHCVSGYAQS----- 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPT-SARDKGVRAVC 145
+ G RT + + +RVH + ++D+A+LKLS S + G +
Sbjct: 50 GFQIRAGSLSRTS---GGITSSLSSVRVHPSYSGNNNDLAILKLSTSIPSGGNIGYARLA 106
Query: 146 LTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCRDKYGDSVELHGG 204
+ +D PV VA GWG G L ++ VP+ + + CR +YG S +
Sbjct: 107 ASGSD--PVAGSSATVA-GWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS-AITNQ 162
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G G +C GDSGGP + D L G S+G+G
Sbjct: 163 MFCAGVSSGGKDSCQGDSGGP----IVDSSNTLIGAVSWGNG 200
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 285 ALLKLSRPT-SARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRV 342
A+LKLS S + G + + +D PV VA GWG G L ++ V
Sbjct: 86 AILKLSTSIPSGGNIGYARLAASGSD--PVAGSSATVA-GWGATSEGGSSTPVNLLKVTV 142
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ + + CR +YG S + C G G +C GDSGGP + D L G S+
Sbjct: 143 PIVSRATCRAQYGTS-AITNQMFCAGVSSGGKDSCQGDSGGP----IVDSSNTLIGAVSW 197
Query: 403 GSGCAKSGYPDVYTKLSFYLPWI 425
G+GCA+ Y VY + +I
Sbjct: 198 GNGCARPNYSGVYASVGALRSFI 220
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E+ + P+ +Q L + CG +L+ +V+TAAHC + I
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEK---SRKRCGGILVRKDFVLTAAHCQGSSI------- 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
LG + E+E+++ IPV+R H ++ N+ +DI LL+L R + VR +
Sbjct: 51 --NVTLGAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLER-KAKWTTAVRPL 107
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + K V P Q C GWG V L + L+++ + + C + +
Sbjct: 108 RL-PSSKAQVKPGQLCSVAGWGYVS-MSTLATTLQEVLLTVQKDCQCERLFHGNYS-RAT 164
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGY---CGVGIRYSHRQP 259
+C G GDSGGPL C KD GI S+G+ GV I+ SH P
Sbjct: 165 EICVGDPKKTQTGFKGDSGGPLVC--KD---VAQGILSYGNKKGTPPGVYIKVSHFLP 217
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 15/181 (8%)
Query: 251 GIRYSHRQPRLINGKESI-RGAWPWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDAD 309
I+ R + I K I A+ +N + L + ++ T+A VR + L +
Sbjct: 58 NIKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTA----VRPLRL-PSS 112
Query: 310 KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQ 369
K V P Q C GWG V L + L+++ + + C + + +C G
Sbjct: 113 KAQVKPGQLCSVAGWGYVS-MSTLATTLQEVLLTVQKDCQCERLFHGNYS-RATEICVGD 170
Query: 370 LDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GDSGGPL C KD GI S+G+ K P VY K+S +LPWI++ +
Sbjct: 171 PKKTQTGFKGDSGGPLVC--KD---VAQGILSYGN--KKGTPPGVYIKVSHFLPWIKRTM 223
Query: 430 N 430
Sbjct: 224 K 224
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y ++
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KIT 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKSSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y ++ +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPG--KITDNMVCVGFLEGGKSSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+A HC + I
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGY-------HFCGGSLINEQWVVSAGHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H ++ ++DI L+KLS + V +
Sbjct: 47 --QVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAR-VSTI 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
L A P +C+ +GWG G D +L+ + P+ + + C Y + +
Sbjct: 104 SLPTA---PPATGTKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCEASYPGKITSN- 159
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C+ + L G+ S+G G
Sbjct: 160 -MFCVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWGDG 196
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 225 PLQCSLKDGRWYLAG-------ITSFGSGYCG-VGIRYSHRQPRLINGKESIRGAW---- 272
P Q SL G + G + S G Y + +R ++ G E A
Sbjct: 13 PYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIR 72
Query: 273 -PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG 331
P + T L+KLS + V + L A P +C+ +GWG G
Sbjct: 73 HPQYDRKTLNNDIMLIKLSSRAVINAR-VSTISLPTA---PPATGTKCLISGWGNTASSG 128
Query: 332 -DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 390
D +L+ + P+ + + C Y + + C G L+G +C GDSGGP+ C+ +
Sbjct: 129 ADXPDELQCLDAPVLSQAKCEASYPGKITSN--MFCVGFLEGGKDSCQGDSGGPVVCNGQ 186
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L G+ S+G GCA+ P VYTK+ Y+ WI+ I
Sbjct: 187 -----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTI 220
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y ++
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KIT 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+ + AWP+ VSLQ+ R G H+CGA LI P++V++AAHC+ +
Sbjct: 1 IVGGRRARPHAWPFMVSLQL---RGG---HFCGATLIAPNFVMSAAHCV-----ANVNVR 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH---NYHHDIALLKLSRPTSARDKGVRA 143
VLG + + E + V+RI E+ + N +DI +L+L+ SA
Sbjct: 50 AVRVVLGAHNLSRREPTRQVFAVQRI--FEDGYDPVNLLNDIVILQLN--GSATINANVQ 105
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
V A R + QC+A GWG + + S L+++ V + S+CR
Sbjct: 106 VAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS--------- 155
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGI 252
++C +G C GDSG PL C+ + GI SF G C G+
Sbjct: 156 -NVCTLVRGRQAGVCFGDSGSPLVCN-----GLIHGIASFVRGGCASGL 198
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 17/123 (13%)
Query: 308 ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCG 367
A R + QC+A GWG + + S L+++ V + S+CR ++C
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS----------NVCT 159
Query: 368 GQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF-GSGCAKSGYPDVYTKLSFYLPWIR 426
+G C GDSG PL C+ + GI SF GCA YPD + ++ ++ WI
Sbjct: 160 LVRGRQAGVCFGDSGSPLVCN-----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWID 214
Query: 427 KQI 429
I
Sbjct: 215 SII 217
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 10 KIVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------ 56
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRA 143
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 57 ---QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNA 108
Query: 144 VCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVEL 201
T A P QC+ +GWG G L Q + PL + C Y ++
Sbjct: 109 RVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KI 166
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GD+GGP+ C+ + L GI S+G G
Sbjct: 167 TDNMVCVGFLEGGKDSCQGDAGGPVVCNGE-----LQGIVSWGYG 206
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 38 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 94
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 95 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 149
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y ++ +C G L+G +C GD+GGP+ C+ + L GI S
Sbjct: 150 APLLPQADCEASYPG--KITDNMVCVGFLEGGKDSCQGDAGGPVVCNGE-----LQGIVS 202
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 203 WGYGCALPDNPGVYTKVCNYVDWIQDTI 230
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 11 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 56
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 57 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 109
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y ++
Sbjct: 110 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KIT 167
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 168 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 206
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 38 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 94
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 95 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 149
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y ++ +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 150 APLLPQADCEASYPG--KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 202
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 203 WGYGCALPDNPGVYTKVCNYVDWIQDTI 230
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 42/238 (17%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHW-CGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+I G E + + PWQV+ V H H+ CG VL+HP WV+TAAHC+ +D
Sbjct: 1 IIGGWECEKHSKPWQVA--VYH-----QGHFQCGGVLVHPQWVLTAAHCMSDDY------ 47
Query: 86 ELWTAVLGDWDRTEEEKS-------------EVRIPVERIRVHEEFHNYHHDIALLKLSR 132
++W LG + +++E + + + + + + + + HD+ LL+L++
Sbjct: 48 QIW---LGRHNLSKDEDTAQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQ 104
Query: 133 PTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVC 191
P D AV + D + C +GWG + + S L+ + + L + C
Sbjct: 105 PARITD----AVKILDLPTQEPKLGSTCYTSGWGLISTFTNRGSGTLQCVELRLQSNEKC 160
Query: 192 RDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y + ++ LC D C+GDSGG L C DG GITS+G C
Sbjct: 161 ARAYPE--KMTEFVLCATHRDDSGSICLGDSGGALIC---DG--VFQGITSWGYSECA 211
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 13/147 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPL 344
LL+L++P D AV + D + C +GWG + + S L+ + + L
Sbjct: 99 LLRLAQPARITD----AVKILDLPTQEPKLGSTCYTSGWGLISTFTNRGSGTLQCVELRL 154
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG- 403
+ C Y + ++ LC D C+GDSGG L C DG GITS+G
Sbjct: 155 QSNEKCARAYPE--KMTEFVLCATHRDDSGSICLGDSGGALIC---DG--VFQGITSWGY 207
Query: 404 SGCAKSGYPDVYTKLSFYLPWIRKQIN 430
S CA V+TK+ + WI++ I
Sbjct: 208 SECADFNDNFVFTKVMPHKKWIKETIE 234
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 30/227 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+ + AWP+ VSLQ+ R G H+CGA LI P++V++AAHC+ N
Sbjct: 1 IVGGRRARPHAWPFMVSLQL---RGG---HFCGATLIAPNFVMSAAHCVANV-----NVR 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVH-EEFHNYHHDIALLKLSRPTSARDKGVRAVC 145
VLG + + E + V+RI + + N +DI +L+L+ SA V
Sbjct: 50 AVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLN--GSATINANVQVA 107
Query: 146 LTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGH 205
A R + QC+A GWG + + S L+++ V + S+CR +
Sbjct: 108 QLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS----------N 156
Query: 206 LCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGI 252
+C +G C GDSG PL C+ + GI SF G C G+
Sbjct: 157 VCTLVRGRQAGVCFGDSGSPLVCN-----GLIHGIASFVRGGCASGL 198
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 17/123 (13%)
Query: 308 ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCG 367
A R + QC+A GWG + + S L+++ V + S+CR ++C
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS----------NVCT 159
Query: 368 GQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF-GSGCAKSGYPDVYTKLSFYLPWIR 426
+G C GDSG PL C+ + GI SF GCA YPD + ++ ++ WI
Sbjct: 160 LVRGRQAGVCFGDSGSPLVCN-----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWID 214
Query: 427 KQI 429
I
Sbjct: 215 SII 217
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 28 INGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPEL 87
+ G + G +P+ VS+ R G WCG L++ + V+TAAHC+ S
Sbjct: 2 VGGTSASAGDFPFIVSIS----RNG--GPWCGGSLLNANTVLTAAHCVSGYAQS-----G 50
Query: 88 WTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPT-SARDKGVRAVCL 146
+ G RT + + +RVH + ++D+A+LKLS S + G +
Sbjct: 51 FQIRAGSLSRTS---GGITSSLSSVRVHPSYSGNNNDLAILKLSTSIPSGGNIGYARLAA 107
Query: 147 TDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCRDKYGDSVELHGGH 205
+ +D PV VA GWG G L ++ VP+ + + CR +YG S +
Sbjct: 108 SGSD--PVAGSSATVA-GWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS-AITNQM 163
Query: 206 LCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G G +C GDSGGP + D L G S+G+G
Sbjct: 164 FCAGVSSGGKDSCQGDSGGP----IVDSSNTLIGAVSWGNG 200
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 285 ALLKLSRPT-SARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRV 342
A+LKLS S + G + + +D PV VA GWG G L ++ V
Sbjct: 86 AILKLSTSIPSGGNIGYARLAASGSD--PVAGSSATVA-GWGATSEGGSSTPVNLLKVTV 142
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ + + CR +YG S + C G G +C GDSGGP + D L G S+
Sbjct: 143 PIVSRATCRAQYGTS-AITNQMFCAGVSSGGKDSCQGDSGGP----IVDSSNTLIGAVSW 197
Query: 403 GSGCAKSGYPDVYTKLSFYLPWI 425
G+GCA+ Y VY + +I
Sbjct: 198 GNGCARPNYSGVYASVGALRSFI 220
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKIT-- 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDHKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G + G +PWQ+S Q + G H CGA L+ + ++A+HC+ +P
Sbjct: 1 VIGGTNASPGEFPWQLSQQ---RQSGSWSHSCGASLLSSTSALSASHCVDG-----VLPN 52
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF----HNYHHDIALLKLSRPTSARDKGVR 142
+ G W +++ ++ V+ +HE + +Y +DIA+L L+ TS G
Sbjct: 53 NIRVIAGLWQQSDTSGTQTA-NVDSYTMHENYGAGTASYSNDIAILHLA--TSISLGGNI 109
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGD--SVE 200
+ A+ CV +GWGR +L L++ +P+ + C
Sbjct: 110 QAAVLPANNNNDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGGAN 169
Query: 201 LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 243
+ H+C G +GAC GDSGGPL C DG + G+TS+
Sbjct: 170 IWDNHICVQDPAGNTGACNGDSGGPLNC--PDGGTRVVGVTSW 210
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 48/153 (31%), Positives = 67/153 (43%), Gaps = 8/153 (5%)
Query: 279 TSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLR 338
T+ S + L TS G + A+ CV +GWGR +L L+
Sbjct: 87 TASYSNDIAILHLATSISLGGNIQAAVLPANNNNDYAGTTCVISGWGRTDGTNNLPDILQ 146
Query: 339 QIRVPLHNISVCRDKYGD--SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYL 396
+ +P+ + C + H+C G +GAC GDSGGPL C DG +
Sbjct: 147 KSSIPVITTAQCTAAMVGVGGANIWDNHICVQDPAGNTGACNGDSGGPLNC--PDGGTRV 204
Query: 397 AGITSF----GSGCAKSGYPDVYTKLSFYLPWI 425
G+TS+ G G YP VYT++S YL WI
Sbjct: 205 VGVTSWVVSSGLGACLPDYPSVYTRVSAYLGWI 237
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G E + + QVSL + H+CG L+ WVV+AAHC
Sbjct: 1 IVGGYECTKHSQAHQVSLNSGY-------HFCGGSLVSKDWVVSAAHCY---------KS 44
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
+ LG+ E +E I + H + +N ++DI L+KL++P + ++ V AV
Sbjct: 45 VLRVRLGEHHIRVNEGTEQYISSSSVIRHPNYSSYNINNDIMLIKLTKPAT-LNQYVHAV 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L C +GWG KL+ + +P+ + + C + Y +
Sbjct: 104 ALP---TECAADATMCTVSGWGNTMSSVADGDKLQCLSLPILSHADCANSYPGMITQ--S 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GDSGGP+ C L G+ S+G G
Sbjct: 159 MFCAGYLEGGKDSCQGDSGGPVVC-----NGVLQGVVSWGYG 195
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
L+KL++P + ++ V AV L C +GWG KL+ + +P+
Sbjct: 87 LIKLTKPAT-LNQYVHAVALP---TECAADATMCTVSGWGNTMSSVADGDKLQCLSLPIL 142
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 405
+ + C + Y + C G L+G +C GDSGGP+ C+ L G+ S+G G
Sbjct: 143 SHADCANSYPGMITQ--SMFCAGYLEGGKDSCQGDSGGPVVCN-----GVLQGVVSWGYG 195
Query: 406 CAKSGYPDVYTKLSFYLPWIRKQI 429
CA+ +P VY K+ W+R +
Sbjct: 196 CAERDHPGVYAKVCVLSGWVRDTM 219
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 30/227 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+ + AWP+ VSLQ+ R G H+CGA LI P++V++AAHC+ N
Sbjct: 1 IVGGRRARPHAWPFMVSLQL---RGG---HFCGATLIAPNFVMSAAHCVANV-----NVR 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVH-EEFHNYHHDIALLKLSRPTSARDKGVRAVC 145
VLG + + E + V+RI + + N +DI +L+L+ SA V
Sbjct: 50 AVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLN--GSATINANVQVA 107
Query: 146 LTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGH 205
A R + QC+A GWG + + S L+++ V + S+CR +
Sbjct: 108 QLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS----------N 156
Query: 206 LCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGI 252
+C +G C GDSG PL C+ + GI SF G C G+
Sbjct: 157 VCTLVRGRQAGVCFGDSGSPLVCN-----GLIHGIASFVRGGCASGL 198
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 17/123 (13%)
Query: 308 ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCG 367
A R + QC+A GWG + + S L+++ V + S+CR ++C
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS----------NVCT 159
Query: 368 GQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF-GSGCAKSGYPDVYTKLSFYLPWIR 426
+G C GDSG PL C+ + GI SF GCA YPD + ++ ++ WI
Sbjct: 160 LVRGRQAGVCFGDSGSPLVCN-----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWID 214
Query: 427 KQI 429
I
Sbjct: 215 SII 217
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 71/247 (28%), Positives = 112/247 (45%), Gaps = 36/247 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+ + AWP+ VSLQ+ H+CGA LI P++V++AAHC+ +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGG------HFCGATLIAPNFVMSAAHCV-----ANVNVR 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH---NYHHDIALLKLSRPTSARDKGVRA 143
VLG + + E + V+RI E+ + N +DI +L+L+ SA
Sbjct: 50 AVRVVLGAHNLSRREPTRQVFAVQRI--FEDGYDPVNLLNDIVILQLN--GSATINANVQ 105
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
V A R + QC+A GWG + + S L+++ V + S+CR
Sbjct: 106 VAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS--------- 155
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHRQP--RL 261
++C +G C GDSG PL C+ + GI SF G C G+ P +
Sbjct: 156 -NVCTLVRGRQAGVCFGDSGSPLVCN-----GLIHGIASFVRGGCASGLYPDAFAPVAQF 209
Query: 262 INGKESI 268
+N +SI
Sbjct: 210 VNWIDSI 216
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 17/123 (13%)
Query: 308 ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCG 367
A R + QC+A GWG + + S L+++ V + S+CR ++C
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS----------NVCT 159
Query: 368 GQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF-GSGCAKSGYPDVYTKLSFYLPWIR 426
+G C GDSG PL C+ + GI SF GCA YPD + ++ ++ WI
Sbjct: 160 LVRGRQAGVCFGDSGSPLVCN-----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWID 214
Query: 427 KQI 429
I
Sbjct: 215 SII 217
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 71.6 bits (174), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+ING E+ G +P+Q L + + WCG LI W++TAAHC+H+ + +
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRV--WCGGSLIDNKWILTAAHCVHDAVSV--VVY 56
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
L +AV + + E + ERI H F+ Y +D+AL+K+ P ++ +
Sbjct: 57 LGSAV--------QYEGEAVVNSERIISHSMFNPDTYLNDVALIKI--PHVEYTDNIQPI 106
Query: 145 CLTDADKRPVNPKQQCV---ATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
L ++ +N K + + +GWG + D V + + N C +Y + +
Sbjct: 107 RLPSGEE--LNNKFENIWATVSGWG--QSNTDTVILQYTYNLVIDN-DRCAQEYPPGIIV 161
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+CG DG S C GDSGGP S K+ L G+ SF SG
Sbjct: 162 E-STICGDTSDGKS-PCFGDSGGPFVLSDKN---LLIGVVSFVSG 201
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/69 (40%), Positives = 41/69 (59%), Gaps = 7/69 (10%)
Query: 365 LCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF--GSGCAKSGYPDVYTKLSFYL 422
+CG DG S C GDSGGP S K+ L G+ SF G+GC +SG P +++++ Y+
Sbjct: 165 ICGDTSDGKS-PCFGDSGGPFVLSDKN---LLIGVVSFVSGAGC-ESGKPVGFSRVTSYM 219
Query: 423 PWIRKQINI 431
WI++ I
Sbjct: 220 DWIQQNTGI 228
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 71.2 bits (173), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI WVV+AAHC I
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGY-------HFCGGSLISEQWVVSAAHCYKTRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H +++ +DI L+KLS P + V +
Sbjct: 47 --QVRLGEHNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINAR-VSTI 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
L A P +C+ +GWG G D +L+ + P+ + C+ Y +
Sbjct: 104 SLPTA---PPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKIT--N 158
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C D+GGP+ C+ + L G+ S+G G
Sbjct: 159 SMFCVGFLEGGKDSCQRDAGGPVVCNGQ-----LQGVVSWGHG 196
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 225 PLQCSLKDGRWYLAG-------ITSFGSGY-CGVGIRYSHRQPRLINGKESIRGAW---- 272
P Q SL G + G + S Y + +R +++ G E A
Sbjct: 13 PYQVSLNSGYHFCGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKVLEGNEQFINAAKIIR 72
Query: 273 -PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG 331
P N T L+KLS P + V + L A P +C+ +GWG G
Sbjct: 73 HPKYNRDTLDNDIMLIKLSSPAVINAR-VSTISLPTA---PPAAGTECLISGWGNTLSFG 128
Query: 332 -DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 390
D +L+ + P+ + C+ Y + C G L+G +C D+GGP+ C+ +
Sbjct: 129 ADYPDELKCLDAPVLTQAECKASYPGKIT--NSMFCVGFLEGGKDSCQRDAGGPVVCNGQ 186
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L G+ S+G GCA P VYTK+ Y+ WI+ I
Sbjct: 187 -----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTI 220
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 106/238 (44%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E+ + P+ +Q L + CG +L+ +V+TAAHC + I
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEK---SRKRCGGILVRKDFVLTAAHCQGSSI------- 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
LG + E+E+++ IPV+R H ++ N+ ++I LL+L R + VR +
Sbjct: 51 --NVTLGAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLER-KAKWTTAVRPL 107
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L + K V P Q C GWG V L + L+++ + + C + +
Sbjct: 108 RL-PSSKAQVKPGQLCSVAGWGYVS-MSTLATTLQEVLLTVQKDCQCERLFHGNYS-RAT 164
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGY---CGVGIRYSHRQP 259
+C G GDSGGPL C KD GI S+G+ GV I+ SH P
Sbjct: 165 EICVGDPKKTQTGFKGDSGGPLVC--KD---VAQGILSYGNKKGTPPGVYIKVSHFLP 217
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 15/181 (8%)
Query: 251 GIRYSHRQPRLINGKESI-RGAWPWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDAD 309
I+ R + I K I A+ +N + + L + ++ T+A VR + L +
Sbjct: 58 NIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTA----VRPLRL-PSS 112
Query: 310 KRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQ 369
K V P Q C GWG V L + L+++ + + C + + +C G
Sbjct: 113 KAQVKPGQLCSVAGWGYVS-MSTLATTLQEVLLTVQKDCQCERLFHGNYS-RATEICVGD 170
Query: 370 LDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GDSGGPL C KD GI S+G+ K P VY K+S +LPWI++ +
Sbjct: 171 PKKTQTGFKGDSGGPLVC--KD---VAQGILSYGN--KKGTPPGVYIKVSHFLPWIKRTM 223
Query: 430 N 430
Sbjct: 224 K 224
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+A HC + I
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGY-------HFCGGSLINEQWVVSAGHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H ++ ++DI L+KLS + + V +
Sbjct: 47 --QVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSS-RAVINAHVSTI 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
L A P +C+ +GWG G D +L+ + P+ + + C Y + +
Sbjct: 104 SLPTA---PPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSN- 159
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C GD+GGP+ C+ + L G+ S+G G
Sbjct: 160 -MFCVGFLEGGKDSCQGDAGGPVVCNGQ-----LQGVVSWGDG 196
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 225 PLQCSLKDGRWYLAG-------ITSFGSGYCG-VGIRYSHRQPRLINGKESIRGAW---- 272
P Q SL G + G + S G Y + +R ++ G E A
Sbjct: 13 PYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIR 72
Query: 273 -PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG 331
P + T L+KLS + + V + L A P +C+ +GWG G
Sbjct: 73 HPQYDRKTLNNDIMLIKLSS-RAVINAHVSTISLPTA---PPATGTKCLISGWGNTASSG 128
Query: 332 -DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 390
D +L+ + P+ + + C Y + + C G L+G +C GD+GGP+ C+ +
Sbjct: 129 ADYPDELQCLDAPVLSQAKCEASYPGKITSN--MFCVGFLEGGKDSCQGDAGGPVVCNGQ 186
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L G+ S+G GCA+ P VYTK+ Y+ WI+ I
Sbjct: 187 -----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTI 220
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y +
Sbjct: 100 VATIALPSSCAPAGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGKIT-- 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATIALPSSCAPAGTQCLISGWGHTLSSGVNHPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPGKIT-- 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGHTLSSGVNHPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y ++
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KIT 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GD+GGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDAGGPVVCNGE-----LQGIVSWGYG 196
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GD+GGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDAGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + G +P+ VS+ R G WCG L++ + V+TAAHC+ S
Sbjct: 1 IVGGTSASAGDFPFIVSIS----RNG--GPWCGGSLLNANTVLTAAHCVSGYAQS----- 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPT-SARDKGVRAVC 145
+ G RT + + +RVH + ++D+A+LKLS S + G +
Sbjct: 50 GFQIRAGSLSRTS---GGITSSLSSVRVHPSYSGNNNDLAILKLSTSIPSGGNIGYARLA 106
Query: 146 LTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCRDKYGDSVELHGG 204
+ +D PV VA GWG G L ++ VP+ + + CR +YG S +
Sbjct: 107 ASGSD--PVAGSSATVA-GWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS-AITNQ 162
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G G +C GD GGP + D L G S+G+G
Sbjct: 163 MFCAGVSSGGKDSCQGDXGGP----IVDSSNTLIGAVSWGNG 200
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 45/143 (31%), Positives = 64/143 (44%), Gaps = 10/143 (6%)
Query: 285 ALLKLSRPT-SARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRV 342
A+LKLS S + G + + +D PV VA GWG G L ++ V
Sbjct: 86 AILKLSTSIPSGGNIGYARLAASGSD--PVAGSSATVA-GWGATSEGGSSTPVNLLKVTV 142
Query: 343 PLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF 402
P+ + + CR +YG S + C G G +C GD GGP+ D L G S+
Sbjct: 143 PIVSRATCRAQYGTS-AITNQMFCAGVSSGGKDSCQGDXGGPI----VDSSNTLIGAVSW 197
Query: 403 GSGCAKSGYPDVYTKLSFYLPWI 425
G+GCA+ Y VY + +I
Sbjct: 198 GNGCARPNYSGVYASVGALRSFI 220
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 21 PYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI---------QVRLGEHNIN 64
Query: 99 EEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E + +I H F ++DI L+KLS P + A T A P
Sbjct: 65 VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNARVATVALPSSCAP 119
Query: 157 K-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGF 214
QC+ +GWG G L Q + PL + C Y ++ +C G L+G
Sbjct: 120 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KITDNMVCVGFLEGG 177
Query: 215 SGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ C+ + L GI S+G G
Sbjct: 178 KDSCQGDSGGPVVCNGE-----LQGIVSWGYG 204
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 36 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 92
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 93 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 147
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y ++ +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 148 APLLPQADCEASYPG--KITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 200
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 201 WGYGCALPDNPGVYTKVCNYVDWIQDTI 228
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL H+CG LI WVV+AAHC I
Sbjct: 1 IVGGYTCEENSLPYQVSLNS-------GSHFCGGSLISEQWVVSAAHCYKTRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H +++ +DI L+KLS P + V +
Sbjct: 47 --QVRLGEHNIKVLEGNEQFINAVKIIRHPKYNRDTLDNDIMLIKLSSPAVINAR-VSTI 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
L A P +C+ +GWG G D +L+ + P+ + C+ Y +
Sbjct: 104 SLPTA---PPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKIT--N 158
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C DSGGP+ C+ + L G+ S+G G
Sbjct: 159 SMFCVGFLEGGKDSCQRDSGGPVVCNGQ-----LQGVVSWGHG 196
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 225 PLQCSLKDGRWYLAG-------ITSFGSGY-CGVGIRYSHRQPRLINGKESIRGAW---- 272
P Q SL G + G + S Y + +R +++ G E A
Sbjct: 13 PYQVSLNSGSHFCGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKVLEGNEQFINAVKIIR 72
Query: 273 -PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG 331
P N T L+KLS P + V + L A P +C+ +GWG G
Sbjct: 73 HPKYNRDTLDNDIMLIKLSSPAVINAR-VSTISLPTA---PPAAGTECLISGWGNTLSFG 128
Query: 332 -DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 390
D +L+ + P+ + C+ Y + C G L+G +C DSGGP+ C+ +
Sbjct: 129 ADYPDELKCLDAPVLTQAECKASYPGKIT--NSMFCVGFLEGGKDSCQRDSGGPVVCNGQ 186
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L G+ S+G GCA P VYTK+ Y+ WI+ I
Sbjct: 187 -----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTI 220
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 21 PYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI---------QVRLGEHNIN 64
Query: 99 EEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E + +I H F ++DI L+KLS P + A T A P
Sbjct: 65 VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNARVATVALPSSCAP 119
Query: 157 K-QQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGF 214
QC+ +GWG G + L+ + PL + C Y ++ +C G L+G
Sbjct: 120 AGTQCLISGWGNTLSSGVNEPDLLKCLDAPLLPQADCEASYPG--KITDNMVCVGFLEGG 177
Query: 215 SGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C GDSGGP+ C+ + L GI S+G G
Sbjct: 178 KDSCQGDSGGPVVCNGE-----LQGIVSWGYG 204
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 36 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 92
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKG-DLVSKLRQIR 341
L+KLS P + A T A P QC+ +GWG G + L+ +
Sbjct: 93 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLKCLD 147
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 148 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 200
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 201 WGYGCALPDNPGVYTKVCNYVDWIQDTI 228
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 70/253 (27%), Positives = 115/253 (45%), Gaps = 31/253 (12%)
Query: 17 GIRYSHRQPRLINGK--ESIRGAWPWQVSLQVLH--PRLGLMPHWCGAVLIHPSWVVTAA 72
GIR I G+ E+ G +PW V++ + P G CG LI PS V+T A
Sbjct: 119 GIRNERGLDFKITGQTNEAEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTGA 178
Query: 73 HCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIP-----VERIRVHEEFH--NYHHDI 125
HC+++ +L ++ G+WD E++ R+P + ++ +H F+ +D+
Sbjct: 179 HCVNSYQSNLDAIKIRA---GEWDTLTEKE---RLPYQERKIRQVIIHSNFNPKTVVNDV 232
Query: 126 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVK--PKGDLVSKLRQIRV 183
ALL L RP D + +CL + + +C A+GWG+ + + + L++I++
Sbjct: 233 ALLLLDRPLVQADN-IGTICLPQQSQ--IFDSTECFASGWGKKEFGSRHRYSNILKKIQL 289
Query: 184 PLHNISVCR-----DKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQC--SLKDGRWY 236
P + C+ + G L +C G G C GD G PL C R+
Sbjct: 290 PTVDRDKCQADLRNTRLGLKFVLDQTFVCAGGEQG-KDTCTGDGGSPLFCPDPRNPSRYM 348
Query: 237 LAGITSFGSGYCG 249
GI ++G G CG
Sbjct: 349 QMGIVAWGIG-CG 360
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 13/163 (7%)
Query: 276 NLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVK--PKGDL 333
N T ALL L RP D + +CL + + +C A+GWG+ + +
Sbjct: 224 NPKTVVNDVALLLLDRPLVQADN-IGTICLPQQSQ--IFDSTECFASGWGKKEFGSRHRY 280
Query: 334 VSKLRQIRVPLHNISVCR-----DKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCS 388
+ L++I++P + C+ + G L +C G G C GD G PL C
Sbjct: 281 SNILKKIQLPTVDRDKCQADLRNTRLGLKFVLDQTFVCAGGEQG-KDTCTGDGGSPLFCP 339
Query: 389 --LKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
R+ GI ++G GC P VY ++ + WI +++
Sbjct: 340 DPRNPSRYMQMGIVAWGIGCGDENVPGVYANVAHFRNWIDQEM 382
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 48 HPRLGLM---PHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSE 104
HP L + ++CG LI+ WVVTAAHC + F + + VL + ++T K +
Sbjct: 12 HPFLAFLYSHGYFCGLTLINQEWVVTAAHCDSTN-FQMQLGVHSKKVLNEDEQTRNPKEK 70
Query: 105 VRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQ---CV 161
P + + DI L+KL +P S K + + L P NP C
Sbjct: 71 FICPNKNMS-----EVLDKDIMLIKLDKPIS-NSKHIAPLSL------PSNPPSVGSVCR 118
Query: 162 ATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIG 220
GWG + + + + L + VC+ Y LC G L+G C+G
Sbjct: 119 IMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLPA--KTTLCAGVLEGGKDTCVG 176
Query: 221 DSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIR 253
DSGGPL C+ + GI S+G+ CG G +
Sbjct: 177 DSGGPLICNGQ-----FQGIVSYGAHSCGQGPK 204
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 19/149 (12%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQ---CVATGWGRVKPKGDLVSKLRQ-IR 341
L+KL +P S K + + L P NP C GWG + + +
Sbjct: 88 LIKLDKPIS-NSKHIAPLSL------PSNPPSVGSVCRIMGWGSITIPNETYPDVPYCAN 140
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
+ L + VC+ Y LC G L+G C+GDSGGPL C+ + GI S
Sbjct: 141 INLVDYEVCQGAYNGLPA--KTTLCAGVLEGGKDTCVGDSGGPLICNGQ-----FQGIVS 193
Query: 402 FGS-GCAKSGYPDVYTKLSFYLPWIRKQI 429
+G+ C + P +YT + Y WI++ I
Sbjct: 194 YGAHSCGQGPKPGIYTNVFDYTDWIQRNI 222
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL H+CG LI WVV+AAHC I
Sbjct: 1 IVGGYTCEENSLPYQVSLNS-------GSHFCGGSLISEQWVVSAAHCYKTRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H +++ +DI L+KLS P + V +
Sbjct: 47 --QVRLGEHNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINAR-VSTI 103
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
L A P +C+ +GWG G D +L+ + P+ + C+ Y +
Sbjct: 104 SLPTA---PPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKIT--N 158
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G L+G +C D+GGP+ C+ + L G+ S+G G
Sbjct: 159 SMFCVGFLEGGKDSCQRDAGGPVVCNGQ-----LQGVVSWGHG 196
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 225 PLQCSLKDGRWYLAG-------ITSFGSGY-CGVGIRYSHRQPRLINGKESIRGAW---- 272
P Q SL G + G + S Y + +R +++ G E A
Sbjct: 13 PYQVSLNSGSHFCGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKVLEGNEQFINAAKIIR 72
Query: 273 -PWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKG 331
P N T L+KLS P + V + L A P +C+ +GWG G
Sbjct: 73 HPKYNRDTLDNDIMLIKLSSPAVINAR-VSTISLPTA---PPAAGTECLISGWGNTLSFG 128
Query: 332 -DLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 390
D +L+ + P+ + C+ Y + C G L+G +C D+GGP+ C+ +
Sbjct: 129 ADYPDELKCLDAPVLTQAECKASYPGKIT--NSMFCVGFLEGGKDSCQRDAGGPVVCNGQ 186
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L G+ S+G GCA P VYTK+ Y+ WI+ I
Sbjct: 187 -----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTI 220
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F +++I L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKIT-- 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T +
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNN 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKIT-- 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI +G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVEWGYG 196
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVE 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKIT-- 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI +G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVKWGYG 196
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVK 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E + +I H F ++DI L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPGKIT-- 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GD GGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDCGGPVVCNGE-----LQGIVSWGYG 196
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GD GGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDCGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/241 (29%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E + P+ L+++ +CG LI ++V+TAAHC I
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGP--SKFCGGFLIRRNFVLTAAHCAGRSI------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
T LG + TEEE + ++ V + H +++ HHDI LLKL S
Sbjct: 52 --TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASL--TLAVGT 107
Query: 145 CLTDADKRPVNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+ K V P + C GWGR +KP D L+++++ L + C + D
Sbjct: 108 LPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD-- 161
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC---GVGIRYSHRQ 258
H LC G A GDSGGPL C+ GI S+G V R SH Q
Sbjct: 162 HNLQLCVGNPRKTKSAFKGDSGGPLLCA-----GAAQGIVSYGRSDAKPPAVFTRISHYQ 216
Query: 259 P 259
P
Sbjct: 217 P 217
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 42/123 (34%), Positives = 58/123 (47%), Gaps = 16/123 (13%)
Query: 308 ADKRPVNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGH 364
+ K V P + C GWGR +KP D L+++++ L + C + D H
Sbjct: 112 SQKNFVPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD--HNLQ 165
Query: 365 LCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPW 424
LC G A GDSGGPL C+ GI S+G AK P V+T++S Y PW
Sbjct: 166 LCVGNPRKTKSAFKGDSGGPLLCA-----GAAQGIVSYGRSDAKP--PAVFTRISHYQPW 218
Query: 425 IRK 427
I +
Sbjct: 219 INQ 221
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL + H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E E + +I H F +++I L+KLS P + A
Sbjct: 47 --QVRLGEHNINVLEGDEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVK-----LNAR 99
Query: 145 CLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELH 202
T A P QC+ +GWG G L Q + PL + C Y ++
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KIT 157
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G L+G +C GDSGGP+ C+ + L GI S+G G
Sbjct: 158 DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T +
Sbjct: 28 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGDEQFVNAAKIIKHPNFDRKTLNNN 84
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 85 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 139
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C GDSGGP+ C+ + L GI S
Sbjct: 140 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVS 192
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 193 WGYGCALPDNPGVYTKVCNYVDWIQDTI 220
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+ + AWP+ VSLQ+ R G H+CGA LI P++V++AAHC+ N
Sbjct: 1 IVGGRRARPHAWPFMVSLQL---RGG---HFCGATLIAPNFVMSAAHCVANVNVRAV--- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVH-EEFHNYHHDIALLKLSRPTSARDKGVRAVC 145
VLG + + E + V+RI + + N +DI +L+L+ SA V
Sbjct: 52 --RVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLN--GSATINANVQVA 107
Query: 146 LTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGH 205
A R + QC+A GWG + + S L+++ V + S+CR +
Sbjct: 108 QLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS----------N 156
Query: 206 LCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGI 252
+C +G C GD G PL C+ + GI SF G C G+
Sbjct: 157 VCTLVRGRQAGVCFGDXGSPLVCN-----GLIHGIASFVRGGCASGL 198
Score = 48.1 bits (113), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 36/123 (29%), Positives = 55/123 (44%), Gaps = 17/123 (13%)
Query: 308 ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCG 367
A R + QC+A GWG + + S L+++ V + S+CR ++C
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRS----------NVCT 159
Query: 368 GQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF-GSGCAKSGYPDVYTKLSFYLPWIR 426
+G C GD G PL C+ + GI SF GCA YPD + ++ ++ WI
Sbjct: 160 LVRGRQAGVCFGDXGSPLVCN-----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWID 214
Query: 427 KQI 429
I
Sbjct: 215 SII 217
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
L++G + + P+Q +L L CG VLIHP WV+TAAHC ++
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLL------CGGVLIHPLWVLTAAHCKKPNL------- 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHH--DIALLKLSRPTSARDKGVRAV 144
LG + + E S+ + V R +H ++ H DI LL+L+RP +
Sbjct: 48 --QVFLGKHNLRQRESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLP 105
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
D + C GWG+ GD ++ + L + C Y + +
Sbjct: 106 LERDCSANTTS----CHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHAYPGQITQN-- 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
LC G +C GDSGGPL C +L G+ S+G+ CG
Sbjct: 159 MLCAGDEKYGKDSCQGDSGGPLVCGD-----HLRGLVSWGNIPCG 198
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 319 CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACI 378
C GWG+ GD ++ + L + C Y + + LC G +C
Sbjct: 117 CHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHAYPGQITQN--MLCAGDEKYGKDSCQ 173
Query: 379 GDSGGPLQCSLKDGRWYLAGITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQIN 430
GDSGGPL C +L G+ S+G+ C P VYT + Y WI+K I
Sbjct: 174 GDSGGPLVCGD-----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
P+QVSL + H+CG LI+ WVV+AAHC + I LG+ +
Sbjct: 21 PYQVSLNSGY-------HFCGGSLINDQWVVSAAHCYKSRI---------QVRLGEHNIN 64
Query: 99 EEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNP 156
E +E + +I H F ++DI L+KLS P + A T A P
Sbjct: 65 VLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVK-----LNARVATVALPSSCAP 119
Query: 157 K-QQCVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGF 214
QC+ +GWG G L Q + PL + C Y ++ +C G L+G
Sbjct: 120 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG--KITDNMVCVGFLEGG 177
Query: 215 SGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G+SGGP+ C+ + L GI S+G G
Sbjct: 178 KDSCQGNSGGPVVCNGE-----LQGIVSWGYG 204
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 229 SLKDGRWYLAGITSFGSGYCGVGIRYSHRQPRLINGKESIRGAW-----PWQNLITSFLS 283
SL + +W ++ + S + +R ++ G E A P + T
Sbjct: 36 SLINDQWVVSAAHCYKSR---IQVRLGEHNINVLEGNEQFVNAAKIIKHPNFDRKTLNND 92
Query: 284 AALLKLSRPTSARDKGVRAVCLTDADKRPVNPK-QQCVATGWGRVKPKGDLVSKLRQ-IR 341
L+KLS P + A T A P QC+ +GWG G L Q +
Sbjct: 93 IMLIKLSSPVK-----LNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLD 147
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
PL + C Y + +C G L+G +C G+SGGP+ C+ + L GI S
Sbjct: 148 APLLPQADCEASYPGKIT--DNMVCVGFLEGGKDSCQGNSGGPVVCNGE-----LQGIVS 200
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+G GCA P VYTK+ Y+ WI+ I
Sbjct: 201 WGYGCALPDNPGVYTKVCNYVDWIQDTI 228
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 21/198 (10%)
Query: 57 WCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHE 116
+CG LI+P WVVTAAHC D F + + VL E + R P E+
Sbjct: 25 FCGGTLINPEWVVTAAHCDSTD-FQMQLGVHSKKVL-------NEDEQTRNPKEKFICPN 76
Query: 117 EFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL 174
+ +N DI L+KL +P S + + P + C GWG + P +
Sbjct: 77 KNNNEVLDKDIMLIKLDKPISNS----KHIAPLSLPSSPPSVGSVCRIMGWGSITPVKET 132
Query: 175 VSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDG 233
+ + L + +VC+ Y + + + LC G + G C GDSGGPL C+ +
Sbjct: 133 FPDVPYCANINLLDHAVCQAGYPELLAEY-RTLCAGIVQGGKDTCGGDSGGPLICNGQ-- 189
Query: 234 RWYLAGITSFGSGYCGVG 251
GI S+G+ CG G
Sbjct: 190 ---FQGIVSYGAHPCGQG 204
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 8/113 (7%)
Query: 319 CVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C GWG + P + + + L + +VC+ Y + + + LC G + G C
Sbjct: 118 CRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYR-TLCAGIVQGGKDTC 176
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQI 429
GDSGGPL C+ + GI S+G+ C + P +YT + Y WI++ I
Sbjct: 177 GGDSGGPLICNGQ-----FQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNI 224
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIH--NDIFSLPI 84
++ GK++ G +P+QVSL++ H CGA ++ + V+TAAHC+ +++ L +
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGS------HRCGASILDNNNVLTAAHCVDGLSNLNRLKV 54
Query: 85 PELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNY--HHDIALLKLSRPTSARDKGVR 142
+ T L E +V VE V++ + ++ +D+AL+ L+ P D
Sbjct: 55 -HVGTNYL-------SESGDV-YDVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQP 105
Query: 143 AVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVC-RDKYGDSVEL 201
T+ + NP C TGWG + G+ + L++I + +H C RD++ +
Sbjct: 106 IKLSTNDEDLESNP---CTLTGWGSTRLGGNTPNALQEIELIVHPQKQCERDQW----RV 158
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
H+C G GAC GDSGGPL + +G GI SFGS
Sbjct: 159 IDSHICTLTKRG-EGACHGDSGGPL---VANGAQI--GIVSFGS 196
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 30/236 (12%)
Query: 195 YGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRY 254
Y S+ L G H CG A I D+ L + + G+++ VG Y
Sbjct: 14 YQVSLRLSGSHRCG--------ASILDNNNVLTAA-----HCVDGLSNLNRLKVHVGTNY 60
Query: 255 SHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVN 314
+ + ++++ L+ + AL+ L+ P D T+ + N
Sbjct: 61 LSESGDVYDVEDAVVNKNYDDFLLRN--DVALVHLTNPIKFNDLVQPIKLSTNDEDLESN 118
Query: 315 PKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVC-RDKYGDSVELHGGHLCGGQLDGF 373
P C TGWG + G+ + L++I + +H C RD++ + H+C G
Sbjct: 119 P---CTLTGWGSTRLGGNTPNALQEIELIVHPQKQCERDQW----RVIDSHICTLTKRG- 170
Query: 374 SGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
GAC GDSGGPL + +G GI SFGS CA G PDVYT++S ++ WI +
Sbjct: 171 EGACHGDSGGPL---VANGAQI--GIVSFGSPCAL-GEPDVYTRVSSFVSWINANL 220
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 68.6 bits (166), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 71/241 (29%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G ES + P+ L+++ +CG LI ++V+TAAHC I
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGP--SKFCGGFLIRRNFVLTAAHCAGRSI------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
T LG + TEEE + ++ V + H +++ HHDI LLKL S
Sbjct: 52 --TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASL--TLAVGT 107
Query: 145 CLTDADKRPVNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+ V P + C GWGR +KP D L+++++ L + C + D
Sbjct: 108 LPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD-- 161
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC---GVGIRYSHRQ 258
H LC G A GDSGGPL C+ GI S+G V R SH +
Sbjct: 162 HNLQLCVGNPRKTKSAFKGDSGGPLLCA-----GVAQGIVSYGRSDAKPPAVFTRISHYR 216
Query: 259 P 259
P
Sbjct: 217 P 217
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 56/118 (47%), Gaps = 16/118 (13%)
Query: 313 VNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQ 369
V P + C GWGR +KP D L+++++ L + C + D H LC G
Sbjct: 117 VPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD--HNLQLCVGN 170
Query: 370 LDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
A GDSGGPL C+ GI S+G AK P V+T++S Y PWI +
Sbjct: 171 PRKTKSAFKGDSGGPLLCA-----GVAQGIVSYGRSDAKP--PAVFTRISHYRPWINQ 221
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 41/281 (14%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG+ R + R+ G+++ G +PWQV L L L++ +WV+TAAH
Sbjct: 76 CGLSARTTGG--RIYGGQKAKPGDFPWQV--------LILGGTTAAGALLYDNWVLTAAH 125
Query: 74 CIH---NDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN---YHHDIAL 127
++ +D +L I +G R ++ E + +HE + + + +DIAL
Sbjct: 126 AVYEQKHDASALDIR------MGTLKRLSPHYTQAW--SEAVFIHEGYTHDAGFDNDIAL 177
Query: 128 LKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQIRVPLH 186
+KL+ + + +CL + A+GWG + +G L L + +P+
Sbjct: 178 IKLNNKV-VINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIPIV 235
Query: 187 NISVCRDKYGDSVELHG----GHLCGGQLDGFSGACIGDSGGPLQ-CSLKDGRWYLAGIT 241
+ C Y G LC G G +C GDSGG L + RW++ GI
Sbjct: 236 DHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIV 295
Query: 242 SFGSGYCGVGIRYSHRQPRLINGKESIRGAWPW-QNLITSF 281
S+GS CG +Y ++IN PW +N+I+ F
Sbjct: 296 SWGSMNCGEAGQYG-VYTKVIN-------YIPWIENIISDF 328
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQIRVP 343
AL+KL+ + + +CL + A+GWG + +G L L + +P
Sbjct: 176 ALIKLNNKV-VINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIP 233
Query: 344 LHNISVCRDKYGDSVELHG----GHLCGGQLDGFSGACIGDSGGPLQ-CSLKDGRWYLAG 398
+ + C Y G LC G G +C GDSGG L + RW++ G
Sbjct: 234 IVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGG 293
Query: 399 ITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+GS C ++G VYTK+ Y+PWI I+
Sbjct: 294 IVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS 326
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 22/225 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ A P+ S+Q+ H CG VL+ WV++AAHC+ +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGA------HLCGGVLVAEQWVLSAAHCLEDAADG----- 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
+LG ++ E S+ V R H ++ HD+ LL+LS + VR +
Sbjct: 50 KVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDYQPDTIDHDLLLLQLSEKATL-GPAVRPL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
D R V P C GWG V G L+ + +P+ + + C + +
Sbjct: 109 PWQRVD-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITER 167
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+C +C GDSGGPL C L G+ S+GS CG
Sbjct: 168 LMCAES--NRRDSCKGDSGGPLVCG-----GVLEGVVSWGSRVCG 205
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 64/238 (26%), Positives = 92/238 (38%), Gaps = 35/238 (14%)
Query: 195 YGDSVELHGGHLCGGQLDG----FSGA-CIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y SV+L+G HLCGG L S A C+ D+ DG+ + G+
Sbjct: 14 YMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAA--------DGKVQVL----LGA---- 57
Query: 250 VGIRYSHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSAR-DKGVRAVCLTDA 308
+S QP + A P + + LL L A VR +
Sbjct: 58 ----HSLSQPEPSKRLYDVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRV 113
Query: 309 DKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGG 368
D R V P C GWG V G L+ + +P+ + + C + + +C
Sbjct: 114 D-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE 172
Query: 369 QLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWI 425
+C GDSGGPL C L G+ S+GS C P +YT+++ Y WI
Sbjct: 173 S--NRRDSCKGDSGGPLVCG-----GVLEGVVSWGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+I GKE + P+ S+Q H CG VLI P WV+TAAHC +
Sbjct: 2 EIIGGKEVSPHSRPFMASIQYGGH------HVCGGVLIDPQWVLTAAHC----QYRFTKG 51
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERI----RVHEEFHNYHHDIALLKLSRPTSAR-DKG 140
+ T VLG ++ E S+ + +++ RV + + +DI L+KL T+A+ +K
Sbjct: 52 QSPTVVLGAHSLSKNEASKQTLEIKKFIPFSRVTSDPQS--NDIMLVKLQ--TAAKLNKH 107
Query: 141 VRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCRDK--YGD 197
V+ + + K + +C TGWG P S LR++ V + + +C + Y
Sbjct: 108 VKMLHI--RSKTSLRSGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNG 165
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQC 228
+ +C G G +C GD+GGPL C
Sbjct: 166 DPFITKDMVCAGDAKGQKDSCKGDAGGPLIC 196
Score = 49.7 bits (117), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 56/245 (22%), Positives = 97/245 (39%), Gaps = 36/245 (14%)
Query: 195 YGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGI---TSFGSGYCGVG 251
+ S++ G H+CGG L D +W L F G
Sbjct: 16 FMASIQYGGHHVCGG-------------------VLIDPQWVLTAAHCQYRFTKGQSPTV 56
Query: 252 IRYSHRQPRLINGKES--IRGAWPWQNLITSFLSAALLKLSRPTSAR-DKGVRAVCLTDA 308
+ +H + K++ I+ P+ + + S ++ + T+A+ +K V+ + +
Sbjct: 57 VLGAHSLSKNEASKQTLEIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHI--R 114
Query: 309 DKRPVNPKQQCVATGWGRVKPKGDLVS-KLRQIRVPLHNISVCRDK--YGDSVELHGGHL 365
K + +C TGWG P S LR++ V + + +C + Y + +
Sbjct: 115 SKTSLRSGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMV 174
Query: 366 CGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLS-FYLPW 424
C G G +C GD+GGPL C + I S G C + P +YT L+ Y W
Sbjct: 175 CAGDAKGQKDSCKGDAGGPLIC-----KGVFHAIVSGGHECGVATKPGIYTLLTKKYQTW 229
Query: 425 IRKQI 429
I+ +
Sbjct: 230 IKSNL 234
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 68.2 bits (165), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 41/281 (14%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG+ R + Q + G+++ G +PWQV L L L++ +WV+TAAH
Sbjct: 151 CGLSARTTGGQ--IYGGQKAKPGDFPWQV--------LILGGTTAAGALLYDNWVLTAAH 200
Query: 74 CIH---NDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN---YHHDIAL 127
++ +D +L I +G R ++ E + +HE + + + +DIAL
Sbjct: 201 AVYEQKHDASALDI------RMGTLKRLSPHYTQAW--SEAVFIHEGYTHDAGFDNDIAL 252
Query: 128 LKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQIRVPLH 186
+KL+ + + +CL + A+GWG + +G L L + +P+
Sbjct: 253 IKLNNKV-VINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIPIV 310
Query: 187 NISVCRDKYGDSVELHG----GHLCGGQLDGFSGACIGDSGGPLQ-CSLKDGRWYLAGIT 241
+ C Y G LC G G +C GDSGG L + RW++ GI
Sbjct: 311 DHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIV 370
Query: 242 SFGSGYCGVGIRYSHRQPRLINGKESIRGAWPW-QNLITSF 281
S+GS CG +Y ++IN PW +N+I+ F
Sbjct: 371 SWGSMNCGEAGQYGVYT-KVIN-------YIPWIENIISDF 403
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQIRVP 343
AL+KL+ + + +CL + A+GWG + +G L L + +P
Sbjct: 251 ALIKLNNKV-VINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIP 308
Query: 344 LHNISVCRDKYGDSVELHG----GHLCGGQLDGFSGACIGDSGGPLQ-CSLKDGRWYLAG 398
+ + C Y G LC G G +C GDSGG L + RW++ G
Sbjct: 309 IVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGG 368
Query: 399 ITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+GS C ++G VYTK+ Y+PWI I+
Sbjct: 369 IVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS 401
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 65/244 (26%), Positives = 110/244 (45%), Gaps = 26/244 (10%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG + ++ R+I G+++ G +PWQV + H R G L+ W++TAAH
Sbjct: 77 CGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNI-HGR-------GGGALLGDRWILTAAH 128
Query: 74 CIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVH-----EEFHNYHHDIALL 128
++ LG + EE P+ R+ VH +E +N+ DIALL
Sbjct: 129 TLYPKEHEAQSNASLDVFLGHTN-VEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALL 187
Query: 129 KLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNI 188
+L + + +CL D D + +G+G ++ K + LR +R+P+ N
Sbjct: 188 ELENSVTL-GPNLLPICLPDNDTF-YDLGLMGYVSGFGVMEEK--IAHDLRFVRLPVANP 243
Query: 189 SVCRD--KYGDSVELHGGHL-CGGQLDGFSGACIGDSGGPLQCSLKD---GRWYLAGITS 242
C + + + +++ ++ C G AC GDSGG +++D RW GI S
Sbjct: 244 QACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVF--AVRDPNTDRWVATGIVS 301
Query: 243 FGSG 246
+G G
Sbjct: 302 WGIG 305
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
ALL+L + + +CL D D + +G+G ++ K + LR +R+P+
Sbjct: 185 ALLELENSVTL-GPNLLPICLPDNDTF-YDLGLMGYVSGFGVMEEK--IAHDLRFVRLPV 240
Query: 345 HNISVCRD--KYGDSVELHGGHL-CGGQLDGFSGACIGDSGGPLQCSLKD---GRWYLAG 398
N C + + + +++ ++ C G AC GDSGG +++D RW G
Sbjct: 241 ANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVF--AVRDPNTDRWVATG 298
Query: 399 ITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
I S+G GC++ GY YTK+ Y+ WI+K++
Sbjct: 299 IVSWGIGCSR-GY-GFYTKVLNYVDWIKKEM 327
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 71/241 (29%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E + P+ L+++ +CG LI ++V+TAAHC I
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGP--SKFCGGFLIRRNFVLTAAHCAGRSI------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
T LG + TEEE + ++ V + H +++ HHDI LLKL S
Sbjct: 52 --TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASL--TLAVGT 107
Query: 145 CLTDADKRPVNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+ V P + C GWGR +KP D L+++++ L + C + D
Sbjct: 108 LPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD-- 161
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC---GVGIRYSHRQ 258
H LC G A GDSGGPL C+ GI S+G V R SH Q
Sbjct: 162 HNLQLCVGNPRKTKSAFKGDSGGPLLCA-----GAAQGIVSYGRSDAKPPAVFTRISHYQ 216
Query: 259 P 259
P
Sbjct: 217 P 217
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 56/118 (47%), Gaps = 16/118 (13%)
Query: 313 VNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQ 369
V P + C GWGR +KP D L+++++ L + C + D H LC G
Sbjct: 117 VPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD--HNLQLCVGN 170
Query: 370 LDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
A GDSGGPL C+ GI S+G AK P V+T++S Y PWI +
Sbjct: 171 PRKTKSAFKGDSGGPLLCA-----GAAQGIVSYGRSDAKP--PAVFTRISHYQPWINQ 221
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ A P+ S+QV H CG VL+ WV++AAHC+ +
Sbjct: 1 ILGGREAEAHARPYMASVQVNGE------HLCGGVLVAEQWVLSAAHCLEDAADG----- 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
+LG ++ E S+ V R H + HD+ LL+LS + VR +
Sbjct: 50 KVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSRPDTIDHDLLLLQLSEKATL-GPAVRPL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
D R V P C GWG V G +L+ + +P+ + + C + +
Sbjct: 109 PWQRVD-RDVEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGAITQR 167
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+C +C GDSGGPL C L G+ + GS CG
Sbjct: 168 MMCAES--NRRDSCKGDSGGPLVCG-----GVLEGVVTSGSRVCG 205
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 8/116 (6%)
Query: 311 RPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL 370
R V P C GWG V G +L+ + +P+ + + C + + +C
Sbjct: 115 RDVEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGAITQRMMCAES- 173
Query: 371 DGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWI 425
+C GDSGGPL C L G+ + GS C P +YT+++ Y WI
Sbjct: 174 -NRRDSCKGDSGGPLVCG-----GVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 25/220 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + +G +P+ V L + CG L V+TAAHC+ + I
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM----------GCGGALYAQDIVLTAAHCVSGSGNNTSI-- 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
TA G D + S V++ ++ ++ D AL+KL++P + L
Sbjct: 49 --TATGGVVDL--QSSSAVKVRSTKVLQAPGYNGTGKDWALIKLAQP-------INQPTL 97
Query: 147 TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHL 206
A N VA GWG + G L + VP + + CR YG+ + + +
Sbjct: 98 KIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL-VANEEI 155
Query: 207 CGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G G C GDSGGP+ W GI S+G G
Sbjct: 156 CAGYDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGEG 195
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 45/141 (31%), Positives = 63/141 (44%), Gaps = 9/141 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KL++P + L A N VA GWG + G L + VP
Sbjct: 84 ALIKLAQP-------INQPTLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPF 135
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ + CR YG+ + + +C G G C GDSGGP+ W GI S+G
Sbjct: 136 VSDAACRSAYGNEL-VANEEICAGYDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGE 194
Query: 405 GCAKSGYPDVYTKLSFYLPWI 425
GCA+ G VYT++S + I
Sbjct: 195 GCARKGKYGVYTEVSTFASAI 215
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 21/198 (10%)
Query: 57 WCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHE 116
+CG LI+P WVVTAAHC + F + + VL E + R P E+
Sbjct: 25 FCGGTLINPEWVVTAAHCDSTN-FQMQLGVHSKKVL-------NEDEQTRNPKEKFICPN 76
Query: 117 EFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDL 174
+ +N DI L+KL +P S + + P + C GWG + P +
Sbjct: 77 KNNNEVLDKDIMLIKLDKPISNS----KHIAPLSLPSSPPSVGSVCRIMGWGSITPVKET 132
Query: 175 VSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDG 233
+ + L + +VC+ Y + + + LC G + G C GDSGGPL C+ +
Sbjct: 133 FPDVPYCANINLLDHAVCQAGYPELLAEY-RTLCAGIVQGGKDTCGGDSGGPLICNGQ-- 189
Query: 234 RWYLAGITSFGSGYCGVG 251
GI S+G+ CG G
Sbjct: 190 ---FQGIVSYGAHPCGQG 204
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 8/113 (7%)
Query: 319 CVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C GWG + P + + + L + +VC+ Y + + + LC G + G C
Sbjct: 118 CRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYR-TLCAGIVQGGKDTC 176
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQI 429
GDSGGPL C+ + GI S+G+ C + P +YT + Y WI++ I
Sbjct: 177 GGDSGGPLICNGQ-----FQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNI 224
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 26/244 (10%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG + ++ R+I G+++ G +PWQV + H R G L+ W++TAAH
Sbjct: 77 CGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNI-HGR-------GGGALLGDRWILTAAH 128
Query: 74 CIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVH-----EEFHNYHHDIALL 128
++ LG + EE P+ R+ VH +E +N+ DIALL
Sbjct: 129 TLYPKEHEAQSNASLDVFLGHTN-VEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALL 187
Query: 129 KLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNI 188
+L + + +CL D D + +G+G ++ K + LR +R+P+ N
Sbjct: 188 ELENSVTL-GPNLLPICLPDNDTF-YDLGLMGYVSGFGVMEEK--IAHDLRFVRLPVANP 243
Query: 189 SVCRD--KYGDSVELHGGHL-CGGQLDGFSGACIGDSGGPLQCSLKD---GRWYLAGITS 242
C + + + +++ ++ C G AC GD+GG +++D RW GI S
Sbjct: 244 QACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDAGGVF--AVRDPNTDRWVATGIVS 301
Query: 243 FGSG 246
+G G
Sbjct: 302 WGIG 305
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
ALL+L + + +CL D D + +G+G ++ K + LR +R+P+
Sbjct: 185 ALLELENSVTL-GPNLLPICLPDNDTF-YDLGLMGYVSGFGVMEEK--IAHDLRFVRLPV 240
Query: 345 HNISVCRD--KYGDSVELHGGHL-CGGQLDGFSGACIGDSGGPLQCSLKD---GRWYLAG 398
N C + + + +++ ++ C G AC GD+GG +++D RW G
Sbjct: 241 ANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDAGGVF--AVRDPNTDRWVATG 298
Query: 399 ITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
I S+G GC++ GY YTK+ Y+ WI+K++
Sbjct: 299 IVSWGIGCSR-GY-GFYTKVLNYVDWIKKEM 327
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 48/142 (33%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KL++P + L A N VA GWG + G L + VP
Sbjct: 84 ALIKLAQP-------INQPTLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPF 135
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLD-GFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ + CR YG+ + + +C G D G C GDSGGP+ W GI S+G
Sbjct: 136 VSDAACRSAYGNEL-VANEEICAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWG 194
Query: 404 SGCAKSGYPDVYTKLSFYLPWI 425
GCA+ GYP VYT++S + I
Sbjct: 195 YGCARPGYPGVYTEVSTFASAI 216
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 26/221 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + +G +P+ V L + CG L V+TAAHC+ + I
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM----------GCGGALYAQDIVLTAAHCVSGSGNNTSI-- 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
TA G D + S V++ ++ ++ D AL+KL++P + L
Sbjct: 49 --TATGGVVDL--QSSSAVKVRSTKVLQAPGYNGTGKDWALIKLAQP-------INQPTL 97
Query: 147 TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHL 206
A N VA GWG + G L + VP + + CR YG+ + + +
Sbjct: 98 KIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL-VANEEI 155
Query: 207 CGGQLD-GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G D G C GDSGGP+ W GI S+G G
Sbjct: 156 CAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYG 196
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 48/142 (33%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KL++P + L A N VA GWG + G L + VP
Sbjct: 84 ALIKLAQP-------INQPTLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPF 135
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLD-GFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ + CR YG+ + + +C G D G C GDSGGP+ W GI S+G
Sbjct: 136 VSDAACRSAYGNEL-VANEEICAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWG 194
Query: 404 SGCAKSGYPDVYTKLSFYLPWI 425
GCA+ GYP VYT++S + I
Sbjct: 195 YGCARPGYPGVYTEVSTFASAI 216
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 26/221 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + +G +P+ V L + CG L V+TAAHC+ + I
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM----------GCGGALYAQDIVLTAAHCVSGSGNNTSI-- 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
TA G D + + V++ ++ ++ D AL+KL++P + L
Sbjct: 49 --TATGGVVDL--QSGAAVKVRSTKVLQAPGYNGTGKDWALIKLAQP-------INQPTL 97
Query: 147 TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHL 206
A N VA GWG + G L + VP + + CR YG+ + + +
Sbjct: 98 KIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL-VANEEI 155
Query: 207 CGGQLD-GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G D G C GDSGGP+ W GI S+G G
Sbjct: 156 CAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYG 196
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 22/226 (9%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
R++ G+E+ A P+ S+Q+ H CG VL+ WV++AAHC+ +
Sbjct: 7 RILGGREAEAHARPYMASVQLNGA------HLCGGVLVAEQWVLSAAHCLEDAADG---- 56
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRA 143
+LG ++ E S+ V R H + HD+ LL+LS + VR
Sbjct: 57 -KVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATL-GPAVRP 114
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
+ D R V P C GWG V G L+ + +P+ + + C + +
Sbjct: 115 LPWQRVD-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITE 173
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+C +C GDSGGPL C L G+ + GS CG
Sbjct: 174 RLMCAES--NRRDSCKGDSGGPLVCG-----GVLEGVVTSGSRVCG 212
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 91/238 (38%), Gaps = 35/238 (14%)
Query: 195 YGDSVELHGGHLCGGQLDG----FSGA-CIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y SV+L+G HLCGG L S A C+ D+ DG+ + G+
Sbjct: 21 YMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAA--------DGKVQVL----LGA---- 64
Query: 250 VGIRYSHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSAR-DKGVRAVCLTDA 308
+S QP + A P + + LL L A VR +
Sbjct: 65 ----HSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRV 120
Query: 309 DKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGG 368
D R V P C GWG V G L+ + +P+ + + C + + +C
Sbjct: 121 D-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE 179
Query: 369 QLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWI 425
+C GDSGGPL C L G+ + GS C P +YT+++ Y WI
Sbjct: 180 S--NRRDSCKGDSGGPLVCG-----GVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWI 230
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 48/142 (33%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KL++P + L A N VA GWG + G L + VP
Sbjct: 84 ALIKLAQP-------INQPTLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPF 135
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLD-GFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ + CR YG+ + + +C G D G C GDSGGP+ W GI S+G
Sbjct: 136 VSDAACRSAYGNEL-VANEEICAGYPDTGGVDPCQGDSGGPMFRKDNADEWIQVGIVSWG 194
Query: 404 SGCAKSGYPDVYTKLSFYLPWI 425
GCA+ GYP VYT++S + I
Sbjct: 195 YGCARPGYPGVYTEVSTFASAI 216
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 26/221 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + +G +P+ V L + CG L V+TAAHC+ + I
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM----------GCGGALYAQDIVLTAAHCVSGSGNNTSI-- 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
TA G D + S V++ ++ ++ D AL+KL++P + L
Sbjct: 49 --TATGGVVDL--QSSSAVKVRSTKVLQAPGYNGTGKDWALIKLAQP-------INQPTL 97
Query: 147 TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHL 206
A N VA GWG + G L + VP + + CR YG+ + + +
Sbjct: 98 KIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL-VANEEI 155
Query: 207 CGGQLD-GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
C G D G C GDSGGP+ W GI S+G G
Sbjct: 156 CAGYPDTGGVDPCQGDSGGPMFRKDNADEWIQVGIVSWGYG 196
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 26/244 (10%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CG + ++ ++I G+++ G +PWQV + H R G L+ W++TAAH
Sbjct: 145 CGKPVNPVEQRQQIIGGQKAKMGNFPWQVFTNI-HGR-------GGGALLGDRWILTAAH 196
Query: 74 CIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVH-----EEFHNYHHDIALL 128
++ LG + EE P+ R+ VH +E +N+ DIALL
Sbjct: 197 TLYPKEHEAQSNASLDVFLGHTN-VEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALL 255
Query: 129 KLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNI 188
+L + + +CL D D + +G+G ++ K + LR +R+P+ N
Sbjct: 256 ELENSVTL-GPNLLPICLPDNDTF-YDLGLMGYVSGFGVMEEK--IAHDLRFVRLPVANP 311
Query: 189 SVCRD--KYGDSVELHGGHL-CGGQLDGFSGACIGDSGGPLQCSLKD---GRWYLAGITS 242
C + + + +++ ++ C G AC GDSGG +++D RW GI S
Sbjct: 312 QACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVF--AVRDPNTDRWVATGIVS 369
Query: 243 FGSG 246
+G G
Sbjct: 370 WGIG 373
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
ALL+L + + +CL D D + +G+G ++ K + LR +R+P+
Sbjct: 253 ALLELENSVTL-GPNLLPICLPDNDTF-YDLGLMGYVSGFGVMEEK--IAHDLRFVRLPV 308
Query: 345 HNISVCRD--KYGDSVELHGGHL-CGGQLDGFSGACIGDSGGPLQCSLKD---GRWYLAG 398
N C + + + +++ ++ C G AC GDSGG +++D RW G
Sbjct: 309 ANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVF--AVRDPNTDRWVATG 366
Query: 399 ITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
I S+G GC++ GY YTK+ Y+ WI+K++
Sbjct: 367 IVSWGIGCSR-GY-GFYTKVLNYVDWIKKEM 395
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 70/242 (28%), Positives = 101/242 (41%), Gaps = 32/242 (13%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+I G E + P+ L+++ +CG LI ++V+TAAHC I
Sbjct: 2 EIIGGTECKPHSRPYMAYLEIVTSNGP--SKFCGGFLIRRNFVLTAAHCAGRSI------ 53
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRA 143
T LG + TEEE + ++ V + H +++ HHDI LLKL S
Sbjct: 54 ---TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASL--TLAVG 108
Query: 144 VCLTDADKRPVNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVE 200
+ V P + C GWGR +KP D L+++++ L + C + D
Sbjct: 109 TLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD- 163
Query: 201 LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC---GVGIRYSHR 257
H LC G A GDSGGPL C+ GI S+G V R SH
Sbjct: 164 -HNLQLCVGNPRKTKSAFKGDSGGPLLCA-----GVAQGIVSYGRSDAKPPAVFTRISHY 217
Query: 258 QP 259
+P
Sbjct: 218 RP 219
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 56/118 (47%), Gaps = 16/118 (13%)
Query: 313 VNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQ 369
V P + C GWGR +KP D L+++++ L + C + D H LC G
Sbjct: 119 VPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD--HNLQLCVGN 172
Query: 370 LDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
A GDSGGPL C+ GI S+G AK P V+T++S Y PWI +
Sbjct: 173 PRKTKSAFKGDSGGPLLCA-----GVAQGIVSYGRSDAKP--PAVFTRISHYRPWINQ 223
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 70/241 (29%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E + P+ L+++ +CG LI ++V+TAAHC I
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGP--SKFCGGFLIRRNFVLTAAHCAGRSI------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
T LG + TEEE + ++ V + H +++ HHDI LLKL S
Sbjct: 52 --TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASL--TLAVGT 107
Query: 145 CLTDADKRPVNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 201
+ V P + C GWGR +KP D L+++++ L + C + D
Sbjct: 108 LPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD-- 161
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYC---GVGIRYSHRQ 258
H LC G A GDSGGPL C+ GI S+G V R SH +
Sbjct: 162 HNLQLCVGNPRKTKSAFKGDSGGPLLCA-----GVAQGIVSYGRSDAKPPAVFTRISHYR 216
Query: 259 P 259
P
Sbjct: 217 P 217
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 56/118 (47%), Gaps = 16/118 (13%)
Query: 313 VNPKQQCVATGWGR---VKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQ 369
V P + C GWGR +KP D L+++++ L + C + D H LC G
Sbjct: 117 VPPGRMCRVAGWGRTGVLKPGSD---TLQEVKLRLMDPQAC-SHFRDFD--HNLQLCVGN 170
Query: 370 LDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
A GDSGGPL C+ GI S+G AK P V+T++S Y PWI +
Sbjct: 171 PRKTKSAFKGDSGGPLLCA-----GVAQGIVSYGRSDAKP--PAVFTRISHYRPWINQ 221
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 40/235 (17%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E + P+ V L + + C LI WV+TAAHC N +
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTI------CAGALIAKDWVLTAAHCNLN--------K 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF-------HNYHHDIALLKLSRPTSARDK 139
+LG T EE ++ + + V +EF D+ LL+L+ + K
Sbjct: 47 RSQVILGAHSITREEPTK-----QIMLVKKEFPYPCYDPATREGDLKLLQLTE----KAK 97
Query: 140 GVRAVCLTDADKR--PVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDK--Y 195
+ V + K+ V P C GWGR LR++ + + + VC D+ Y
Sbjct: 98 INKYVTILHLPKKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHY 157
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG-SGYCG 249
+ + +C G L G +C GDSG PL C G+TSFG CG
Sbjct: 158 NFNPVIGMNMVCAGSLRGGRDSCNGDSGSPLLC-----EGVFRGVTSFGLENKCG 207
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/126 (33%), Positives = 55/126 (43%), Gaps = 10/126 (7%)
Query: 313 VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDK--YGDSVELHGGHLCGGQL 370
V P C GWGR LR++ + + + VC D+ Y + + +C G L
Sbjct: 114 VKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGSL 173
Query: 371 DGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG--SGCAKSGYPDVYTKLS-FYLPWIRK 427
G +C GDSG PL C G+TSFG + C P VY LS +L WI
Sbjct: 174 RGGRDSCNGDSGSPLLC-----EGVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIM 228
Query: 428 QINIAV 433
I AV
Sbjct: 229 TIKGAV 234
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 40/235 (17%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E + P+ V L + + C LI WV+TAAHC N +
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTI------CAGALIAKDWVLTAAHCNLN--------K 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF-------HNYHHDIALLKLSRPTSARDK 139
+LG T EE ++ + + V +EF D+ LL+L+ + K
Sbjct: 47 RSQVILGAHSITREEPTK-----QIMLVKKEFPYPCYDPATREGDLKLLQLTE----KAK 97
Query: 140 GVRAVCLTDADKR--PVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDK--Y 195
+ V + K+ V P C GWGR LR++ + + + VC D+ Y
Sbjct: 98 INKYVTILHLPKKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHY 157
Query: 196 GDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG-SGYCG 249
+ + +C G L G +C GDSG PL C G+TSFG CG
Sbjct: 158 NFNPVIGMNMVCAGSLRGGRDSCNGDSGSPLLC-----EGVFRGVTSFGLENKCG 207
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 42/126 (33%), Positives = 55/126 (43%), Gaps = 10/126 (7%)
Query: 313 VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDK--YGDSVELHGGHLCGGQL 370
V P C GWGR LR++ + + + VC D+ Y + + +C G L
Sbjct: 114 VKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSL 173
Query: 371 DGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG--SGCAKSGYPDVYTKLS-FYLPWIRK 427
G +C GDSG PL C G+TSFG + C P VY LS +L WI
Sbjct: 174 RGGRDSCNGDSGSPLLC-----EGVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIM 228
Query: 428 QINIAV 433
I AV
Sbjct: 229 TIKGAV 234
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ A P+ S+Q+ H CG VL+ WV++AAHC+ +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGA------HLCGGVLVAEQWVLSAAHCLEDAADG----- 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
+LG ++ E S+ V R H + HD+ LL+LS + VR +
Sbjct: 50 KVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATL-GPAVRPL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
D R V P C GWG V G L+ + +P+ + + C + +
Sbjct: 109 PWQRVD-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITER 167
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+C +C GDSGGPL C L G+ + GS CG
Sbjct: 168 LMCAES--NRRDSCKGDSGGPLVCG-----GVLEGVVTSGSAVCG 205
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 91/238 (38%), Gaps = 35/238 (14%)
Query: 195 YGDSVELHGGHLCGGQLDG----FSGA-CIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y SV+L+G HLCGG L S A C+ D+ DG+ + G+
Sbjct: 14 YMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAA--------DGKVQVL----LGA---- 57
Query: 250 VGIRYSHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSAR-DKGVRAVCLTDA 308
+S QP + A P + + LL L A VR +
Sbjct: 58 ----HSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRV 113
Query: 309 DKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGG 368
D R V P C GWG V G L+ + +P+ + + C + + +C
Sbjct: 114 D-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE 172
Query: 369 QLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWI 425
+C GDSGGPL C L G+ + GS C P +YT+++ Y WI
Sbjct: 173 S--NRRDSCKGDSGGPLVCG-----GVLEGVVTSGSAVCGNRKKPGIYTRVASYAAWI 223
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 35/92 (38%), Positives = 56/92 (60%), Gaps = 5/92 (5%)
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 395
KL+Q +P+ + + C+ +G ++ C G G +C+GDSGGPL C KDG W
Sbjct: 8 KLQQAALPIVSEADCKKSWGS--KITDVMTCAGA-SGVD-SCMGDSGGPLVCQ-KDGVWT 62
Query: 396 LAGITSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
LAGI S+GSG + P VY++++ +PW+++
Sbjct: 63 LAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQ 94
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/72 (43%), Positives = 43/72 (59%), Gaps = 5/72 (6%)
Query: 177 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 236
KL+Q +P+ + + C+ +G ++ C G G +C+GDSGGPL C KDG W
Sbjct: 8 KLQQAALPIVSEADCKKSWGS--KITDVMTCAGA-SGVD-SCMGDSGGPLVCQ-KDGVWT 62
Query: 237 LAGITSFGSGYC 248
LAGI S+GSG C
Sbjct: 63 LAGIVSWGSGVC 74
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+ING + PWQ +L + +L +CGAVL+HP W++TAAHC +
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPNQL-----YCGAVLVHPQWLLTAAHCRK---------K 46
Query: 87 LWTAVLGDWDRTE--EEKSEVRIPVERIRVHEEFHNYH-HDIALLKLSRPTSARDKGVRA 143
++ LG + + E ++ V+ I H H +D+ L+KL+R R + +
Sbjct: 47 VFRVRLGHYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNR----RIRPTKD 102
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVK-PKGDLVSKLRQIRVPLHNISVCRDKYGDSVELH 202
V + + +C+ +GWG K P+ L+ + + + + C D Y ++
Sbjct: 103 VRPINVSSHCPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQID-- 160
Query: 203 GGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
C G G +C GDSGGP+ C+ L G+ S+G C
Sbjct: 161 DTMFCAGDKAG-RDSCQGDSGGPVVCNGS-----LQGLVSWGDYPCA 201
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 17/131 (12%)
Query: 309 DKRPVNPKQ-------QCVATGWGRVK-PKGDLVSKLRQIRVPLHNISVCRDKYGDSVEL 360
D RP+N +C+ +GWG K P+ L+ + + + + C D Y ++
Sbjct: 102 DVRPINVSSHCPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQID- 160
Query: 361 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS-GCAKSGYPDVYTKLS 419
C G G +C GDSGGP+ C+ L G+ S+G CA+ P VYT L
Sbjct: 161 -DTMFCAGDKAG-RDSCQGDSGGPVVCNGS-----LQGLVSWGDYPCARPNRPGVYTNLC 213
Query: 420 FYLPWIRKQIN 430
+ WI++ I
Sbjct: 214 KFTKWIQETIQ 224
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 39/268 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIH---NDIFSLP 83
+ G+++ G +PWQV L L L++ +WV+TAAH ++ +D +L
Sbjct: 1 IYGGQKAKPGDFPWQV--------LILGGTTAAGALLYDNWVLTAAHAVYEQKHDASALD 52
Query: 84 IPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN---YHHDIALLKLSRPTSARDKG 140
I +G R ++ E + +HE + + + +DIAL+KL+ +
Sbjct: 53 IR------MGTLKRLSPHYTQAW--SEAVFIHEGYTHDAGFDNDIALIKLNNKV-VINSN 103
Query: 141 VRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSV 199
+ +CL + A+GWG + +G L L + +P+ + C Y
Sbjct: 104 ITPICLPRKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIPIVDHQKCTAAYEKPP 162
Query: 200 ELHG----GHLCGGQLDGFSGACIGDSGGPLQ-CSLKDGRWYLAGITSFGSGYCGVGIRY 254
G LC G G +C GDSGG L + RW++ GI S+GS CG +Y
Sbjct: 163 YPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQY 222
Query: 255 SHRQPRLINGKESIRGAWPW-QNLITSF 281
++IN PW +N+I+ F
Sbjct: 223 G-VYTKVIN-------YIPWIENIISDF 242
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQIRVP 343
AL+KL+ + + +CL + A+GWG + +G L L + +P
Sbjct: 90 ALIKLNNKV-VINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIP 147
Query: 344 LHNISVCRDKYGDSVELHG----GHLCGGQLDGFSGACIGDSGGPLQ-CSLKDGRWYLAG 398
+ + C Y G LC G G +C GDSGG L + RW++ G
Sbjct: 148 IVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGG 207
Query: 399 ITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+GS C ++G VYTK+ Y+PWI I+
Sbjct: 208 IVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS 240
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ A P+ S+Q+ H CG VL+ WV++AAHC+ +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGA------HLCGGVLVAEQWVLSAAHCLEDAADG----- 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
+LG ++ E S+ V R H + HD+ LL+LS + VR +
Sbjct: 50 KVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATL-GPAVRPL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
D R V P C GWG V G L+ + +P+ + + C + +
Sbjct: 109 PWQRVD-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITER 167
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+C +C GDSGGPL C L G+ + GS CG
Sbjct: 168 LMCAES--NRRDSCKGDSGGPLVCG-----GVLEGVVTSGSRVCG 205
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 91/238 (38%), Gaps = 35/238 (14%)
Query: 195 YGDSVELHGGHLCGGQLDG----FSGA-CIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y SV+L+G HLCGG L S A C+ D+ DG+ + G+
Sbjct: 14 YMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAA--------DGKVQVL----LGA---- 57
Query: 250 VGIRYSHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSAR-DKGVRAVCLTDA 308
+S QP + A P + + LL L A VR +
Sbjct: 58 ----HSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRV 113
Query: 309 DKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGG 368
D R V P C GWG V G L+ + +P+ + + C + + +C
Sbjct: 114 D-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE 172
Query: 369 QLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWI 425
+C GDSGGPL C L G+ + GS C P +YT+++ Y WI
Sbjct: 173 S--NRRDSCKGDSGGPLVCG-----GVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 69/268 (25%), Positives = 116/268 (43%), Gaps = 39/268 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIH---NDIFSLP 83
+ G+++ G +PWQV L L L++ +WV+TAAH ++ +D +L
Sbjct: 1 IYGGQKAKPGDFPWQV--------LILGGTTAAGALLYDNWVLTAAHAVYEQKHDASALD 52
Query: 84 IPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN---YHHDIALLKLSRPTSARDKG 140
I +G R ++ E + +HE + + + +DIAL+KL+ +
Sbjct: 53 IR------MGTLKRLSPHYTQAW--SEAVFIHEGYTHDAGFDNDIALIKLNNKV-VINSN 103
Query: 141 VRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSV 199
+ +CL + A+GWG + +G L L + +P+ + C Y
Sbjct: 104 ITPICLPRKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIPIVDHQKCTAAYEKPP 162
Query: 200 ELHG----GHLCGGQLDGFSGACIGDSGGPLQ-CSLKDGRWYLAGITSFGSGYCGVGIRY 254
G LC G G +C GD+GG L + RW++ GI S+GS CG +Y
Sbjct: 163 YPRGSVTANMLCAGLESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQY 222
Query: 255 SHRQPRLINGKESIRGAWPW-QNLITSF 281
++IN PW +N+I+ F
Sbjct: 223 G-VYTKVIN-------YIPWIENIISDF 242
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQC-VATGWGRVKPKGDLVSKLRQIRVP 343
AL+KL+ + + +CL + A+GWG + +G L L + +P
Sbjct: 90 ALIKLNNKV-VINSNITPICLPRKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIP 147
Query: 344 LHNISVCRDKYGDSVELHG----GHLCGGQLDGFSGACIGDSGGPLQ-CSLKDGRWYLAG 398
+ + C Y G LC G G +C GD+GG L + RW++ G
Sbjct: 148 IVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDAGGALVFLDSETERWFVGG 207
Query: 399 ITSFGS-GCAKSGYPDVYTKLSFYLPWIRKQIN 430
I S+GS C ++G VYTK+ Y+PWI I+
Sbjct: 208 IVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS 240
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIP 85
+L++G + + P+Q +L L CG VLIHP WV+TAAHC ++
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLL------CGGVLIHPLWVLTAAHCKKPNL------ 48
Query: 86 ELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHH--DIALLKLSRPTSARDKGVRA 143
LG + ++E S+ + V R +H ++ H DI LL+L+RP +
Sbjct: 49 ---QVFLGKHNLRQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPL 105
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
D + + C GWG+ GD ++ + L + C Y + +
Sbjct: 106 PLERDCSAQTTS----CHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHAYPGQITQN- 159
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
LC G +C GDSGGPL C +L G+ S+G+ CG
Sbjct: 160 -MLCAGDEKYGKDSCQGDSGGPLVCGD-----HLRGLVSWGNIPCG 199
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 41/146 (28%), Positives = 60/146 (41%), Gaps = 13/146 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
LL+L+RP + D + + C GWG+ GD ++ + L
Sbjct: 89 LLRLARPAKLSELIQPLPLERDCSAQTTS----CHILGWGKTA-DGDFPDTIQCAYIHLV 143
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS- 404
+ C Y + + LC G +C GDSGGPL C +L G+ S+G+
Sbjct: 144 SREECEHAYPGQITQN--MLCAGDEKYGKDSCQGDSGGPLVCGD-----HLRGLVSWGNI 196
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQIN 430
C P VYT + Y WI+K I
Sbjct: 197 PCGSKEKPGVYTNVCRYTNWIQKTIQ 222
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 63.9 bits (154), Expect = 2e-10, Method: Composition-based stats.
Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSG--ACIGDSGGPLQCSLKDGR 393
KL+Q +P+ + + C+ +G + C G SG +C+GDSGGPL C KDG
Sbjct: 8 KLQQAALPIVSEADCKKSWGSKIT--DVMTCAGA----SGVDSCMGDSGGPLVCQ-KDGV 60
Query: 394 WYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
W LAGI S+GSG + P VY++++ +PW+++
Sbjct: 61 WTLAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQ 94
Score = 50.4 bits (119), Expect = 2e-06, Method: Composition-based stats.
Identities = 32/74 (43%), Positives = 43/74 (58%), Gaps = 9/74 (12%)
Query: 177 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSG--ACIGDSGGPLQCSLKDGR 234
KL+Q +P+ + + C+ +G + C G SG +C+GDSGGPL C KDG
Sbjct: 8 KLQQAALPIVSEADCKKSWGSKIT--DVMTCAGA----SGVDSCMGDSGGPLVCQ-KDGV 60
Query: 235 WYLAGITSFGSGYC 248
W LAGI S+GSG C
Sbjct: 61 WTLAGIVSWGSGVC 74
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+E+ A P+ S+Q+ H CG VL+ WV++AAHC+ +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGA------HLCGGVLVAEQWVLSAAHCLEDAADG----- 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
+LG ++ E S+ V R H + HD+ LL+LS + VR +
Sbjct: 50 KVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATL-GPAVRPL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
D R V P C GWG V G L+ + +P+ + + C + +
Sbjct: 109 PWQRVD-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITER 167
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
+C +C GD+GGPL C L G+ + GS CG
Sbjct: 168 LMCAES--NRRDSCKGDAGGPLVCG-----GVLEGVVTSGSRVCG 205
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 62/238 (26%), Positives = 91/238 (38%), Gaps = 35/238 (14%)
Query: 195 YGDSVELHGGHLCGGQLDG----FSGA-CIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
Y SV+L+G HLCGG L S A C+ D+ DG+ + G+
Sbjct: 14 YMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAA--------DGKVQVL----LGA---- 57
Query: 250 VGIRYSHRQPRLINGKESIRGAWPWQNLITSFLSAALLKLSRPTSAR-DKGVRAVCLTDA 308
+S QP + A P + + LL L A VR +
Sbjct: 58 ----HSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRV 113
Query: 309 DKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGG 368
D R V P C GWG V G L+ + +P+ + + C + + +C
Sbjct: 114 D-RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE 172
Query: 369 QLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWI 425
+C GD+GGPL C L G+ + GS C P +YT+++ Y WI
Sbjct: 173 S--NRRDSCKGDAGGPLVCG-----GVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 27/245 (11%)
Query: 14 CGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAH 73
CGV + R+I G ++ +PWQV +P W G LI+ WV+TAAH
Sbjct: 70 CGVPREPFEEKQRIIGGSDADIKNFPWQVFFD--NP-------WAGGALINEYWVLTAAH 120
Query: 74 CIHND---IFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKL 130
+ + + + T+ L E + + + V E N+ +DIAL++L
Sbjct: 121 VVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDNDIALVRL 180
Query: 131 SRPTSARDKGVRAVCL--TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNI 188
P V +CL T +D ++ + +GWGR + K D +L+ R+P+ +
Sbjct: 181 KDPVKM-GPTVSPICLPGTSSDYNLMDGDLGLI-SGWGRTE-KRDRAVRLKAARLPVAPL 237
Query: 189 SVCRD-------KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPL--QCSLKDGRWYLAG 239
C++ ++ +C G G +C GDSGG Q ++Y AG
Sbjct: 238 RKCKEVKVEKPTADAEAYVFTPNMICAGGEKGMD-SCKGDSGGAFAVQDPNDKTKFYAAG 296
Query: 240 ITSFG 244
+ S+G
Sbjct: 297 LVSWG 301
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 18/156 (11%)
Query: 285 ALLKLSRPTSARDKGVRAVCL--TDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRV 342
AL++L P V +CL T +D ++ + +GWGR + K D +L+ R+
Sbjct: 176 ALVRLKDPVKM-GPTVSPICLPGTSSDYNLMDGDLGLI-SGWGRTE-KRDRAVRLKAARL 232
Query: 343 PLHNISVCRD-------KYGDSVELHGGHLCGGQLDGFSGACIGDSGGPL--QCSLKDGR 393
P+ + C++ ++ +C G G +C GDSGG Q +
Sbjct: 233 PVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGMD-SCKGDSGGAFAVQDPNDKTK 291
Query: 394 WYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
+Y AG+ S+G C G +YT++ Y+ WI K +
Sbjct: 292 FYAAGLVSWGPQCGTYG---LYTRVKNYVDWIMKTM 324
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 29/225 (12%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
L++G + + P+Q +L L CG VLIHP WV+TAAHC ++
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLL------CGGVLIHPLWVLTAAHCKKPNL------- 47
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHH--DIALLKLSRPTSARDKGVRAV 144
LG + ++E S+ + V R +H ++ H DI LL+L+RP +
Sbjct: 48 --QVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLP 105
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
D + + C GWG+ GD ++ + L + C Y + +
Sbjct: 106 LERDCSAQTTS----CHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHAYPGQITQN-- 158
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCG 249
LC G +C GDSGGPL C +L G+ S+G+ CG
Sbjct: 159 MLCAGDEKYGKDSCQGDSGGPLVCGD-----HLRGLVSWGNIPCG 198
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 41/146 (28%), Positives = 60/146 (41%), Gaps = 13/146 (8%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLH 345
LL+L+RP + D + + C GWG+ GD ++ + L
Sbjct: 88 LLRLARPAKLSELIQPLPLERDCSAQTTS----CHILGWGKTA-DGDFPDTIQCAYIHLV 142
Query: 346 NISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS- 404
+ C Y + + LC G +C GDSGGPL C +L G+ S+G+
Sbjct: 143 SREECEHAYPGQITQN--MLCAGDEKYGKDSCQGDSGGPLVCGD-----HLRGLVSWGNI 195
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQIN 430
C P VYT + Y WI+K I
Sbjct: 196 PCGSKEKPGVYTNVCRYTNWIQKTIQ 221
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 23/198 (11%)
Query: 57 WCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLG-DWDRTEEEKSEVRIPVERIRV- 114
+CG LI+ WV+TAAHC + + LG + E + R+P E+
Sbjct: 27 FCGGTLINQEWVLTAAHCDRKN---------FRIKLGMHSKKVPNEDEQTRVPKEKFFCL 77
Query: 115 -HEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKP-KG 172
+ + + DI L++L P K + + P + C GWGR+ P +G
Sbjct: 78 SSKNYTLWDKDIMLIRLDSPV----KNSKHIAPFSLPSSPPSVGSVCRIMGWGRISPTEG 133
Query: 173 DLVSKLRQIRVPLHNISVCRDKYGD-SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLK 231
+ + L +CR Y + + LC G L+G C GDSGGPL C+ +
Sbjct: 134 TYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCKGDSGGPLICNGQ 193
Query: 232 DGRWYLAGITSFGSGYCG 249
GI S+G C
Sbjct: 194 -----FQGIASWGDDPCA 206
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 39/114 (34%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 319 CVATGWGRVKP-KGDLVSKLRQIRVPLHNISVCRDKYGD-SVELHGGHLCGGQLDGFSGA 376
C GWGR+ P +G + + L +CR Y + + LC G L+G
Sbjct: 120 CRIMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDT 179
Query: 377 CIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWIRKQI 429
C GDSGGPL C+ + GI S+G CA+ P YTK+ +L WI I
Sbjct: 180 CKGDSGGPLICNGQ-----FQGIASWGDDPCAQPHKPAAYTKVFDHLDWIENII 228
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 32/234 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ +P+ S+Q H+CG LIH +V+TAA C F P
Sbjct: 1 IVGGRKARPRQFPFLASIQ------NQGRHFCGGALIHARFVMTAASC-----FQSQNPG 49
Query: 87 LWTAVLGDWD-RTEEEKSEVRIPVERIRVH-EEFHNYHHDIALLKLSRPTSARDK-GVRA 143
+ T VLG +D R E +S + + + + +D+ LL+L R + +
Sbjct: 50 VSTVVLGAYDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILP 109
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
+ L +A V +C GWG + G L R + V + CR
Sbjct: 110 LPLQNAT---VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPN--------- 157
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
++C G L G C GD G PL C G+ SF G CG G + R
Sbjct: 158 -NVCTGVLTRRGGICNGDQGTPLVCE-----GLAHGVASFSLGPCGRGPDFFTR 205
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 61/244 (25%), Positives = 87/244 (35%), Gaps = 53/244 (21%)
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVG------ 251
S++ G H CGG +L R+ + + F S GV
Sbjct: 17 SIQNQGRHFCGG-------------------ALIHARFVMTAASCFQSQNPGVSTVVLGA 57
Query: 252 --IRYSHRQPRLINGKESI--RGAWPWQNLITSFLSAALLKLSRPTSARDK-GVRAVCLT 306
+R RQ R S+ G P QNL LL+L R + + + L
Sbjct: 58 YDLRRRERQSRQTFSISSMSENGYDPQQNLN----DLMLLQLDREANLTSSVTILPLPLQ 113
Query: 307 DADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLC 366
+A V +C GWG + G L R + V + CR ++C
Sbjct: 114 NAT---VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPN----------NVC 160
Query: 367 GGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
G L G C GD G PL C G+ SF G G PD +T+++ + WI
Sbjct: 161 TGVLTRRGGICNGDQGTPLVCE-----GLAHGVASFSLGPCGRG-PDFFTRVALFRDWID 214
Query: 427 KQIN 430
+N
Sbjct: 215 GVLN 218
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 22/229 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+++ G +PWQV + H R G L+ W++TAAH ++
Sbjct: 1 IIGGQKAKMGNFPWQVFTNI-HGR-------GGGALLGDRWILTAAHTLYPKEHEAQSNA 52
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVH-----EEFHNYHHDIALLKLSRPTSARDKGV 141
LG EE P+ R+ VH +E +N+ DIALL+L + +
Sbjct: 53 SLDVFLGH-TNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTL-GPNL 110
Query: 142 RAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRD--KYGDSV 199
+CL D D + +G+G ++ K + LR +R+P+ N C + + + +
Sbjct: 111 LPICLPDNDTF-YDLGLMGYVSGFGVMEEK--IAHDLRFVRLPVANPQACENWLRGKNRM 167
Query: 200 ELHGGHL-CGGQLDGFSGACIGDSGGPLQC-SLKDGRWYLAGITSFGSG 246
++ ++ C G AC GDSGG RW GI S+G G
Sbjct: 168 DVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIG 216
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
ALL+L + + +CL D D + +G+G ++ K + LR +R+P+
Sbjct: 96 ALLELENSVTL-GPNLLPICLPDNDTF-YDLGLMGYVSGFGVMEEK--IAHDLRFVRLPV 151
Query: 345 HNISVCRD--KYGDSVELHGGHL-CGGQLDGFSGACIGDSGGPLQC-SLKDGRWYLAGIT 400
N C + + + +++ ++ C G AC GDSGG RW GI
Sbjct: 152 ANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIV 211
Query: 401 SFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
S+G GC++ GY YTK+ Y+ WI+K++
Sbjct: 212 SWGIGCSR-GY-GFYTKVLNYVDWIKKEM 238
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 32/234 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ +P+ S+Q H+CG LIH +V+TAA C F P
Sbjct: 1 IVGGRKARPRQFPFLASIQ------NQGRHFCGGALIHARFVMTAASC-----FQSQNPG 49
Query: 87 LWTAVLGDWD-RTEEEKSEVRIPVERIRVH-EEFHNYHHDIALLKLSRPTSARDK-GVRA 143
+ T VLG +D R E +S + + + + +D+ LL+L R + +
Sbjct: 50 VSTVVLGAYDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILP 109
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
+ L +A V +C GWG + G L R + V + CR
Sbjct: 110 LPLQNAT---VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPN--------- 157
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
++C G L G C GD G PL C G+ SF G CG G + R
Sbjct: 158 -NVCTGVLTRRGGICNGDGGTPLVCE-----GLAHGVASFSLGPCGRGPDFFTR 205
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 61/244 (25%), Positives = 87/244 (35%), Gaps = 53/244 (21%)
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVG------ 251
S++ G H CGG +L R+ + + F S GV
Sbjct: 17 SIQNQGRHFCGG-------------------ALIHARFVMTAASCFQSQNPGVSTVVLGA 57
Query: 252 --IRYSHRQPRLINGKESI--RGAWPWQNLITSFLSAALLKLSRPTSARDK-GVRAVCLT 306
+R RQ R S+ G P QNL LL+L R + + + L
Sbjct: 58 YDLRRRERQSRQTFSISSMSENGYDPQQNLN----DLMLLQLDREANLTSSVTILPLPLQ 113
Query: 307 DADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLC 366
+A V +C GWG + G L R + V + CR ++C
Sbjct: 114 NAT---VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPN----------NVC 160
Query: 367 GGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
G L G C GD G PL C G+ SF G G PD +T+++ + WI
Sbjct: 161 TGVLTRRGGICNGDGGTPLVCE-----GLAHGVASFSLGPCGRG-PDFFTRVALFRDWID 214
Query: 427 KQIN 430
+N
Sbjct: 215 GVLN 218
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 335 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRW 394
S L+ ++ P+ + S C+ Y ++ G +C G L+G +C GDSGGP+ C+ +
Sbjct: 8 SLLQCLKAPVLSDSSCKSSYPG--QITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ---- 61
Query: 395 YLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L GI S+G GCA+ P VYTK+ Y+ WI++ I
Sbjct: 62 -LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTI 95
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 40/71 (56%), Gaps = 7/71 (9%)
Query: 176 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRW 235
S L+ ++ P+ + S C+ Y ++ G +C G L+G +C GDSGGP+ C+ +
Sbjct: 8 SLLQCLKAPVLSDSSCKSSYPG--QITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ---- 61
Query: 236 YLAGITSFGSG 246
L GI S+G G
Sbjct: 62 -LQGIVSWGYG 71
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 62/234 (26%), Positives = 94/234 (40%), Gaps = 32/234 (13%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G+++ +P+ S+Q H CG LIH +V+TAA C F P
Sbjct: 1 IVGGRKARPRQFPFLASIQ------NQGSHECGGALIHARFVMTAASC-----FQSQNPG 49
Query: 87 LWTAVLGDWD-RTEEEKSEVRIPVERIRVH-EEFHNYHHDIALLKLSRPTSARDK-GVRA 143
+ T VLG +D R E +S + + + + +D+ LL+L R + +
Sbjct: 50 VSTVVLGAYDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILP 109
Query: 144 VCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHG 203
+ L +A V +C GWG + G L R + V + CR
Sbjct: 110 LPLQNAT---VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPN--------- 157
Query: 204 GHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVGIRYSHR 257
++C G L G C GD G PL C G+ SF G CG G + R
Sbjct: 158 -NVCTGVLTRRGGICNGDGGTPLVCE-----GLAHGVASFSLGPCGRGPDFFTR 205
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 61/244 (25%), Positives = 87/244 (35%), Gaps = 53/244 (21%)
Query: 198 SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGYCGVG------ 251
S++ G H CGG +L R+ + + F S GV
Sbjct: 17 SIQNQGSHECGG-------------------ALIHARFVMTAASCFQSQNPGVSTVVLGA 57
Query: 252 --IRYSHRQPRLINGKESI--RGAWPWQNLITSFLSAALLKLSRPTSARDK-GVRAVCLT 306
+R RQ R S+ G P QNL LL+L R + + + L
Sbjct: 58 YDLRRRERQSRQTFSISSMSENGYDPQQNLN----DLMLLQLDREANLTSSVTILPLPLQ 113
Query: 307 DADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLC 366
+A V +C GWG + G L R + V + CR ++C
Sbjct: 114 NAT---VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPN----------NVC 160
Query: 367 GGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIR 426
G L G C GD G PL C G+ SF G G PD +T+++ + WI
Sbjct: 161 TGVLTRRGGICNGDGGTPLVCE-----GLAHGVASFSLGPCGRG-PDFFTRVALFRDWID 214
Query: 427 KQIN 430
+N
Sbjct: 215 GVLN 218
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 7/95 (7%)
Query: 335 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRW 394
S L+ ++ P+ + S C+ Y ++ G +C G L G +C GDSGGP+ C+ +
Sbjct: 8 SLLQCLKAPVLSNSSCKSSYPG--QITGNMICVGFLQGGKDSCQGDSGGPVVCNGQ---- 61
Query: 395 YLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L GI S+G GCA+ P VYTK+ Y+ WI++ I
Sbjct: 62 -LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTI 95
Score = 37.7 bits (86), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 39/71 (54%), Gaps = 7/71 (9%)
Query: 176 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRW 235
S L+ ++ P+ + S C+ Y ++ G +C G L G +C GDSGGP+ C+ +
Sbjct: 8 SLLQCLKAPVLSNSSCKSSYPG--QITGNMICVGFLQGGKDSCQGDSGGPVVCNGQ---- 61
Query: 236 YLAGITSFGSG 246
L GI S+G G
Sbjct: 62 -LQGIVSWGYG 71
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 57 WCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHE 116
+C LI+ WV+TAAHC N F + + VL + ++T K + P ++ ++
Sbjct: 25 FCSGTLINEEWVLTAAHC-DNTNFQMKLGVHSKKVLNEDEQTRNPKEKFICPNKK---ND 80
Query: 117 EFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVS 176
E + DI L+KL S + V P + C GWG + P
Sbjct: 81 EVLD--KDIMLIKLDSRVSNSEHIVPLS----LPSSPPSVGSVCHIMGWGSITP-----I 129
Query: 177 KLRQIRVP------LHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSL 230
K+ VP L + +VC+ Y + + + LC G L+G C GDSGGPL C+
Sbjct: 130 KVTYPDVPYCAYINLLDDAVCQAGYPELLTEYR-TLCAGILEGGKDTCGGDSGGPLICNG 188
Query: 231 KDGRWYLAGITSFGSGYCGVGIR---------YSHRQPRLINGKESI 268
+ GI SFG+ CG G++ Y+H +I G ++
Sbjct: 189 Q-----FQGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSIIAGNTTV 230
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 56/118 (47%), Gaps = 18/118 (15%)
Query: 319 CVATGWGRVKPKGDLVSKLRQIRVP------LHNISVCRDKYGDSVELHGGHLCGGQLDG 372
C GWG + P K+ VP L + +VC+ Y + + + LC G L+G
Sbjct: 118 CHIMGWGSITP-----IKVTYPDVPYCAYINLLDDAVCQAGYPELLTEYR-TLCAGILEG 171
Query: 373 FSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWIRKQI 429
C GDSGGPL C+ + GI SFG+ C + P VYTK+ Y WI+ I
Sbjct: 172 GKDTCGGDSGGPLICNGQ-----FQGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSII 224
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 48/150 (32%), Positives = 67/150 (44%), Gaps = 12/150 (8%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
LLKL R + + V +CL + V P +C GWG K G+ + V L
Sbjct: 87 VLLKLERSVTLNQR-VALICL-PPEWYVVPPGTKCEIAGWGETKGTGNDTV----LNVAL 140
Query: 345 HNI---SVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
N+ C K+ V +C L GAC GD GGPL C W L GI
Sbjct: 141 LNVISNQECNIKHRGRVR--ESEMCTEGLLAPVGACEGDYGGPLAC-FTHNSWVLEGIII 197
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQINI 431
CA+S +P V+T++S ++ WI K + +
Sbjct: 198 PNRVCARSRWPAVFTRVSVFVDWIHKVMRL 227
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 84/208 (40%), Gaps = 22/208 (10%)
Query: 36 GAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDW 95
G PW VSL+ + H+CG L+ W++TA C + L E+W L
Sbjct: 7 GNSPWTVSLRNRQGQ-----HFCGGSLVKEQWILTARQCFSSCHMPLTGYEVWLGTLFQ- 60
Query: 96 DRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVN 155
+ E S R+PV ++ + LLKL R + + V +CL + V
Sbjct: 61 NPQHGEPSLQRVPVAKMVCGPS----GSQLVLLKLERSVTLNQR-VALICL-PPEWYVVP 114
Query: 156 PKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNI---SVCRDKYGDSVELHGGHLCGGQLD 212
P +C GWG K G+ + V L N+ C K+ V +C L
Sbjct: 115 PGTKCEIAGWGETKGTGNDTV----LNVALLNVISNQECNIKHRGRVR--ESEMCTEGLL 168
Query: 213 GFSGACIGDSGGPLQCSLKDGRWYLAGI 240
GAC GD GGPL C W L GI
Sbjct: 169 APVGACEGDYGGPLAC-FTHNSWVLEGI 195
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 26/238 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G E A P+ L+++ P L C LI ++V+TAAHC I
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHL--SACSGFLIRRNFVMTAAHCAGRSI------- 51
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAV 144
T +LG ++ +E + ++ VE+ H ++ + +DI LLKL + GV +
Sbjct: 52 --TVLLGAHNKKVKEDTWQKLEVEKQFPHPKYDDRLVLNDIMLLKLKEKANL-TLGVGTL 108
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
++ A + P + C A GWGR L+++++ + + C+ E
Sbjct: 109 PIS-AKSNSIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKHFEDFHQE---P 164
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSF---GSGYCGVGIRYSHRQP 259
LC G GDSGGPL C+ GI S+ + V R SH +P
Sbjct: 165 QLCVGNPKKIRNVYKGDSGGPLLCA-----GIAQGIASYVLRNAKPPSVFTRISHYRP 217
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/120 (30%), Positives = 51/120 (42%), Gaps = 10/120 (8%)
Query: 308 ADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCG 367
A + P + C A GWGR L+++++ + + C+ E LC
Sbjct: 112 AKSNSIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKHFEDFHQE---PQLCV 168
Query: 368 GQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRK 427
G GDSGGPL C+ GI S+ AK P V+T++S Y PWI K
Sbjct: 169 GNPKKIRNVYKGDSGGPLLCA-----GIAQGIASYVLRNAKP--PSVFTRISHYRPWINK 221
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 395
+L+Q +PL + + C+ +G ++ +C G G S +C+GDSGGPL C K+G W
Sbjct: 5 RLQQASLPLLSNTNCKKYWG--TKIKDAMICAGA-SGVS-SCMGDSGGPLVCK-KNGAWT 59
Query: 396 LAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L GI S+GS + P VY +++ + W+++ +
Sbjct: 60 LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 93
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 29/72 (40%), Positives = 43/72 (59%), Gaps = 5/72 (6%)
Query: 177 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 236
+L+Q +PL + + C+ +G ++ +C G G S +C+GDSGGPL C K+G W
Sbjct: 5 RLQQASLPLLSNTNCKKYWG--TKIKDAMICAGA-SGVS-SCMGDSGGPLVCK-KNGAWT 59
Query: 237 LAGITSFGSGYC 248
L GI S+GS C
Sbjct: 60 LVGIVSWGSSTC 71
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 43 SLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEK 102
SL VL G + CG LI+ WVVTAAHC N+ F L +L + ++T + K
Sbjct: 14 SLVVLFNSNGFL---CGGTLINQDWVVTAAHCDSNN-FQLLFGVHSKKILNEDEQTRDPK 69
Query: 103 SEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVA 162
+ P R + E DI L+KL S + + P + C
Sbjct: 70 EKFFCP-NRKKDDE----VDKDIMLIKLDSSVSNSEH----IAPLSLPSSPPSVGSVCRI 120
Query: 163 TGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGD 221
GWG+ P ++ + + + + +VCR Y ++ LC G L G C D
Sbjct: 121 MGWGKTIPTKEIYPDVPHCANINILDHAVCRTAYS-WRQVANTTLCAGILQGGRDTCHFD 179
Query: 222 SGGPLQCSLKDGRWYLAGITSFGSGYCG 249
SGGPL C+ GI S+G CG
Sbjct: 180 SGGPLICN-----GIFQGIVSWGGHPCG 202
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 53/113 (46%), Gaps = 8/113 (7%)
Query: 319 CVATGWGRVKPKGDLVSKLRQ-IRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGAC 377
C GWG+ P ++ + + + + +VCR Y ++ LC G L G C
Sbjct: 118 CRIMGWGKTIPTKEIYPDVPHCANINILDHAVCRTAYS-WRQVANTTLCAGILQGGRDTC 176
Query: 378 IGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWIRKQI 429
DSGGPL C+ GI S+G C + G P VYTK+ YL WI+ I
Sbjct: 177 HFDSGGPLICN-----GIFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKSII 224
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 46/142 (32%), Positives = 63/142 (44%), Gaps = 10/142 (7%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KL++P + L A N VA GWG + G L + VP
Sbjct: 91 ALIKLAQP-------INQPTLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPF 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLD-GFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 403
+ + CR + + +C G D G C GDSGGP+ W GI S+G
Sbjct: 143 VSDAACRSS-SSFILVANEMICAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWG 201
Query: 404 SGCAKSGYPDVYTKLSFYLPWI 425
GCA+ GYP VYT++S + I
Sbjct: 202 YGCARPGYPGVYTEVSTFASAI 223
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 90/223 (40%), Gaps = 23/223 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + +G +P+ V L + G +CG L V+TAAHC+ + I
Sbjct: 1 VVGGTRAAQGEFPFMVRL-INEENEG----FCGGALYAQDIVLTAAHCVSGSGNNTSI-- 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
TA G D + S V++ ++ F Y D AL+KL++P +
Sbjct: 54 --TATGGVVDL--QSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQP-------INQP 102
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L A N VA GWG + G L + VP + + CR + +
Sbjct: 103 TLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPFVSDAACRSS-SSFILVANE 160
Query: 205 HLCGGQLD-GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G D G C GDSGGP+ W GI S+G G
Sbjct: 161 MICAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYG 203
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+ + E
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTE 56
Query: 87 LWTAV-LGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKGV 141
V +G RT E++ +I + E+I +H ++ N DIAL+KL +P + D +
Sbjct: 57 NDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-I 115
Query: 142 RAVCLTDADKRP--VNPKQQCVATGWGRVK 169
VCL D + + + TGWG +K
Sbjct: 116 HPVCLPDRETAASLLQAGYKGRVTGWGNLK 145
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 58.2 bits (139), Expect = 1e-08, Method: Composition-based stats.
Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 336 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 395
+L+Q +PL + + C+ +G ++ +C G G S +C+GDSGGPL C K+G W
Sbjct: 6 RLQQASLPLLSNTNCKKYWGTKIK--DAMICAGA-SGVS-SCMGDSGGPLVCK-KNGAWT 60
Query: 396 LAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
L GI S+GS + P VY +++ + W+++ +
Sbjct: 61 LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 94
Score = 48.9 bits (115), Expect = 6e-06, Method: Composition-based stats.
Identities = 29/72 (40%), Positives = 43/72 (59%), Gaps = 5/72 (6%)
Query: 177 KLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWY 236
+L+Q +PL + + C+ +G ++ +C G G S +C+GDSGGPL C K+G W
Sbjct: 6 RLQQASLPLLSNTNCKKYWGTKIK--DAMICAGA-SGVS-SCMGDSGGPLVCK-KNGAWT 60
Query: 237 LAGITSFGSGYC 248
L GI S+GS C
Sbjct: 61 LVGIVSWGSSTC 72
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 88/222 (39%), Gaps = 22/222 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + +G +P+ V L + G +CG L V+TAAHC+ + I
Sbjct: 1 VVGGTRAAQGEFPFMVRL-INEENEG----FCGGALYAQDIVLTAAHCVSGSGNNTSI-- 53
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
TA G D + S V++ ++ F Y D AL+KL++P +
Sbjct: 54 --TATGGVVDL--QSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQP-------INQP 102
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L A N VA GWG + G L + VP + + CR + +
Sbjct: 103 TLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPFVSDAACRSS-SSFILVANE 160
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G C GDSGGP+ W GI S+G G
Sbjct: 161 MICAGYDTKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEG 202
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/141 (29%), Positives = 59/141 (41%), Gaps = 9/141 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KL++P + L A N VA GWG + G L + VP
Sbjct: 91 ALIKLAQP-------INQPTLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPF 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ + CR + + +C G C GDSGGP+ W GI S+G
Sbjct: 143 VSDAACRSS-SSFILVANEMICAGYDTKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGE 201
Query: 405 GCAKSGYPDVYTKLSFYLPWI 425
GCA+ G VYT++S + I
Sbjct: 202 GCARKGKYGVYTEVSTFASAI 222
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ES + P+ LQ+ P CG L+ +V+TAAHC ++I
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSP---AGQSRCGGFLVREDFVLTAAHCWGSNI------- 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHN--YHHDIALLKLSRPTSARDKGVRAV 144
LG + E ++ I R H +++ +DI LL+LS R++ V V
Sbjct: 51 --NVTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLS-RRVRRNRNVNPV 107
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L A + + P C GWGRV + LR++++ + C +G
Sbjct: 108 ALPRAQE-GLRPGTLCTVAGWGRVSMRRG-TDTLREVQLRVQRDRQCLRIFGSYDPRR-- 163
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
+C G A GDSGGPL C+ GI S+G
Sbjct: 164 QICVGDRRERKAAFKGDSGGPLLCN-----NVAHGIVSYG 198
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/117 (29%), Positives = 52/117 (44%), Gaps = 10/117 (8%)
Query: 313 VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDG 372
+ P C GWGRV + LR++++ + C +G +C G
Sbjct: 116 LRPGTLCTVAGWGRVSMRRG-TDTLREVQLRVQRDRQCLRIFGSYDPRR--QICVGDRRE 172
Query: 373 FSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
A GDSGGPL C+ GI S+G P+V+T++S +LPWIR +
Sbjct: 173 RKAAFKGDSGGPLLCN-----NVAHGIVSYGKSSGVP--PEVFTRVSSFLPWIRTTM 222
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/222 (26%), Positives = 86/222 (38%), Gaps = 27/222 (12%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + +G +P+ V L + CG L V+TAAHC+ + I
Sbjct: 1 VVGGTRAAQGEFPFMVRLSM----------GCGGALYAQDIVLTAAHCVSGSGNNTSI-- 48
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
TA G D + S V++ ++ F Y D AL+KL++P +
Sbjct: 49 --TATGGVVDL--QSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQP-------INQP 97
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L A N VA GWG + G L + VP + + CR + +
Sbjct: 98 TLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPFVSDAACRSS-SSFILVANE 155
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG 246
+C G C GDSGGP+ W GI S+G G
Sbjct: 156 MICAGYDTKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEG 197
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/141 (29%), Positives = 59/141 (41%), Gaps = 9/141 (6%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
AL+KL++P + L A N VA GWG + G L + VP
Sbjct: 86 ALIKLAQP-------INQPTLKIATTTAYNQGTFTVA-GWGANREGGSQQRYLLKANVPF 137
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
+ + CR + + +C G C GDSGGP+ W GI S+G
Sbjct: 138 VSDAACRSS-SSFILVANEMICAGYDTKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGE 196
Query: 405 GCAKSGYPDVYTKLSFYLPWI 425
GCA+ G VYT++S + I
Sbjct: 197 GCARKGKYGVYTEVSTFASAI 217
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 24/220 (10%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I G+ES + P+ LQ+ P CG L+ +V+TAAHC ++I
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSP---AGQSRCGGFLVREDFVLTAAHCWGSNI------- 50
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFH--NYHHDIALLKLSRPTSARDKGVRAV 144
LG + E ++ I R H +++ +DI LL+LSR R++ V V
Sbjct: 51 --NVTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSR-RVRRNRNVNPV 107
Query: 145 CLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGG 204
L A + + P C GWGRV + LR++++ + C +G
Sbjct: 108 ALPRAQE-GLRPGTLCTVAGWGRVSMRRG-TDTLREVQLRVQRDRQCLRIFGSYDPRR-- 163
Query: 205 HLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFG 244
+C G A GDSGGPL C+ GI S+G
Sbjct: 164 QICVGDRRERKAAFKGDSGGPLLCN-----NVAHGIVSYG 198
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/117 (29%), Positives = 52/117 (44%), Gaps = 10/117 (8%)
Query: 313 VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDG 372
+ P C GWGRV + LR++++ + C +G +C G
Sbjct: 116 LRPGTLCTVAGWGRVSMRRG-TDTLREVQLRVQRDRQCLRIFGSYDPRR--QICVGDRRE 172
Query: 373 FSGACIGDSGGPLQCSLKDGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
A GDSGGPL C+ GI S+G P+V+T++S +LPWIR +
Sbjct: 173 RKAAFKGDSGGPLLCN-----NVAHGIVSYGKSSGVP--PEVFTRVSSFLPWIRTTM 222
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 43/145 (29%), Positives = 62/145 (42%), Gaps = 4/145 (2%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
L+KL+RP + D V + L + + K C GWG + LR + +
Sbjct: 86 VLMKLARP-AVLDDFVSTIDLPNYGST-IPEKTSCSVYGWGYTGLI-NYDGLLRVAHLYI 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
C + V L+ +C G SG C GD GGPL C R L G+ G
Sbjct: 143 MGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVL-GVIVPGR 201
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA P ++ ++++Y WI K I
Sbjct: 202 GCAIPNRPGIFVRVAYYAKWIHKII 226
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 81/202 (40%), Gaps = 16/202 (7%)
Query: 40 WQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTE 99
W VSL+ + H CG LI SWV+TA C + L E W + R +
Sbjct: 13 WMVSLRYRNK------HICGGSLIKESWVLTARQCFPSR--DLKDYEAWLGIHDVHGRGD 64
Query: 100 EEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQ 159
E+ +V + V ++ E D+ L+KL+RP + D V + L + + K
Sbjct: 65 EKCKQV-LNVSQLVYGPE----GSDLVLMKLARP-AVLDDFVSTIDLPNYGST-IPEKTS 117
Query: 160 CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACI 219
C GWG + LR + + C + V L+ +C G SG C
Sbjct: 118 CSVYGWGYTGLI-NYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCE 176
Query: 220 GDSGGPLQCSLKDGRWYLAGIT 241
GD GGPL C R L I
Sbjct: 177 GDYGGPLVCEQHKMRMVLGVIV 198
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 43/145 (29%), Positives = 62/145 (42%), Gaps = 4/145 (2%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
L+KL+RP + D V + L + + K C GWG + LR + +
Sbjct: 86 VLMKLARP-AVLDDFVSTIDLPNYGST-IPEKTSCSVYGWGYTGLI-NYDGLLRVAHLYI 142
Query: 345 HNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 404
C + V L+ +C G SG C GD GGPL C R L G+ G
Sbjct: 143 MGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVL-GVIVPGR 201
Query: 405 GCAKSGYPDVYTKLSFYLPWIRKQI 429
GCA P ++ ++++Y WI K I
Sbjct: 202 GCAIPNRPGIFVRVAYYAKWIHKII 226
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 81/202 (40%), Gaps = 16/202 (7%)
Query: 40 WQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTE 99
W VSL+ + H CG LI SWV+TA C + L E W + R +
Sbjct: 13 WMVSLRYRNK------HICGGSLIKESWVLTARQCFPSR--DLKDYEAWLGIHDVHGRGD 64
Query: 100 EEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQ 159
E+ +V + V ++ E D+ L+KL+RP + D V + L + + K
Sbjct: 65 EKCKQV-LNVSQLVYGPE----GSDLVLMKLARP-AVLDDFVSTIDLPNYGST-IPEKTS 117
Query: 160 CVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACI 219
C GWG + LR + + C + V L+ +C G SG C
Sbjct: 118 CSVYGWGYTGLI-NYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCE 176
Query: 220 GDSGGPLQCSLKDGRWYLAGIT 241
GD GGPL C R L I
Sbjct: 177 GDYGGPLVCEQHKMRMVLGVIV 198
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 95/238 (39%), Gaps = 41/238 (17%)
Query: 26 RLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIH----NDIFS 81
R++ G +G++PWQ + + H L GA LI+ W++T A + ND +
Sbjct: 102 RIMGGSLDAKGSFPWQAKM-ISHHNLT-----SGATLINEQWLLTTAKNLRLGHKNDTKA 155
Query: 82 LPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGV 141
I +G +K EV I E++ H + N DI L+KL + ++ V
Sbjct: 156 KDIAPTLRLYVG-------KKQEVEI--EKVIFHPD--NSTVDIGLIKLKQKVPVNER-V 203
Query: 142 RAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKY-GDSVE 200
+CL D VN +GWGR + L+ + +P+ + C Y G +V
Sbjct: 204 MPICLPSKDY--VNVGLVGYVSGWGR-NANLNFTEHLKYVMLPVADQEKCVQYYEGSTVP 260
Query: 201 --------------LHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDG-RWYLAGITSF 243
L+ C G C GD+G KD WY AGI SF
Sbjct: 261 EKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDAGSAFAVHDKDDDTWYAAGILSF 318
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/167 (26%), Positives = 65/167 (38%), Gaps = 21/167 (12%)
Query: 279 TSFLSAALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLR 338
S + L+KL + ++ V +CL D VN +GWGR + L+
Sbjct: 183 NSTVDIGLIKLKQKVPVNER-VMPICLPSKDY--VNVGLVGYVSGWGR-NANLNFTEHLK 238
Query: 339 QIRVPLHNISVCRDKY-GDSVE--------------LHGGHLCGGQLDGFSGACIGDSGG 383
+ +P+ + C Y G +V L+ C G C GD+G
Sbjct: 239 YVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDAGS 298
Query: 384 PLQCSLKDG-RWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQI 429
KD WY AGI SF C + Y VY +++ L WI+ I
Sbjct: 299 AFAVHDKDDDTWYAAGILSFDKSCRTAEY-GVYVRVTSILDWIQTTI 344
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 14/148 (9%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIF--SLPI 84
++ G+++ G PWQV L P+ L CGA LI WV+TAAHC+ + + +
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCLLYPPWDKNFTV 56
Query: 85 PELWTAVLGDWDRTEEEKSEVRIPV-ERIRVHEEFH---NYHHDIALLKLSRPTSARDKG 140
+L + G RT E+ +I + ++I +H ++ N DIALLKL RP D
Sbjct: 57 DDLLVRI-GKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDY- 114
Query: 141 VRAVCLTDADK--RPVNPKQQCVATGWG 166
+ VCL D + ++ + TGWG
Sbjct: 115 IHPVCLPDKQTAAKLLHAGFKGRVTGWG 142
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 56/199 (28%), Positives = 78/199 (39%), Gaps = 31/199 (15%)
Query: 58 CGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVR-IPVERIRVHE 116
CG LI+ WV+TA HC ++ LG + K +R P E+
Sbjct: 25 CGGTLINQEWVLTARHCDRGNM---------RIYLGMHNLKVLNKDALRRFPKEKYFCLN 75
Query: 117 EFHN--YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQ---CVATGWGRV-KP 170
++ + DI L++L+RP VR P NP C GWG + P
Sbjct: 76 TRNDTIWDKDIMLIRLNRP-------VRNSAHIAPLSLPSNPPSVGSVCRIMGWGTITSP 128
Query: 171 KGDLVSKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSL 230
L + + + +VC+ Y L LC G L+G C GDSGGPL C+
Sbjct: 129 NATLPDVPHCANINILDYAVCQAAYKG---LAATTLCAGILEGGKDTCKGDSGGPLICNG 185
Query: 231 KDGRWYLAGITSFGSGYCG 249
+ GI S G C
Sbjct: 186 Q-----FQGILSVGGNPCA 199
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/154 (31%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 286 LLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQ---CVATGWGRV-KPKGDLVSKLRQIR 341
L++L+RP VR P NP C GWG + P L
Sbjct: 88 LIRLNRP-------VRNSAHIAPLSLPSNPPSVGSVCRIMGWGTITSPNATLPDVPHCAN 140
Query: 342 VPLHNISVCRDKYGDSVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
+ + + +VC+ Y L LC G L+G C GDSGGPL C+ + GI S
Sbjct: 141 INILDYAVCQAAYKG---LAATTLCAGILEGGKDTCKGDSGGPLICNGQ-----FQGILS 192
Query: 402 FGSG-CAKSGYPDVYTKLSFYLPWIRKQINIAVD 434
G CA+ P +YTK+ Y WI+ I+ D
Sbjct: 193 VGGNPCAQPRKPGIYTKVFDYTDWIQSIISGNTD 226
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 31/199 (15%)
Query: 58 CGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVER-IRVHE 116
C LI+ WV+TAAHC +I + + R E+E ++R+P + ++
Sbjct: 28 CAGALINREWVLTAAHCDRRNI------RIKLGMHSKNIRNEDE--QIRVPRGKYFCLNT 79
Query: 117 EFHN-YHHDIALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLV 175
+F N DI L++L RP + + R +C GWG++
Sbjct: 80 KFPNGLDKDIMLIRLRRPVTYSTH----IAPVSLPSRSRGVGSRCRIMGWGKI------- 128
Query: 176 SKLRQIRVP-LHNISVCRDKYGDS----VELHGGHLCGGQLDGFSGACIGDSGGPLQCSL 230
S VP NI + + K+ + V LC G L G C GDSGGPL C+
Sbjct: 129 STTTYPDVPHCTNIFIVKHKWCEPLYPWVPADSRTLCAGILKGGRDTCHGDSGGPLICNG 188
Query: 231 KDGRWYLAGITSFGSGYCG 249
+ + GI + GS CG
Sbjct: 189 E-----MHGIVAGGSEPCG 202
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 39/119 (32%), Positives = 53/119 (44%), Gaps = 18/119 (15%)
Query: 317 QQCVATGWGRVKPKGDLVSKLRQIRVP-LHNISVCRDKYGDS----VELHGGHLCGGQLD 371
+C GWG++ S VP NI + + K+ + V LC G L
Sbjct: 118 SRCRIMGWGKI-------STTTYPDVPHCTNIFIVKHKWCEPLYPWVPADSRTLCAGILK 170
Query: 372 GFSGACIGDSGGPLQCSLKDGRWYLAGITSFGSG-CAKSGYPDVYTKLSFYLPWIRKQI 429
G C GDSGGPL C+ + + GI + GS C + P VYTK+ Y WI+ I
Sbjct: 171 GGRDTCHGDSGGPLICNGE-----MHGIVAGGSEPCGQHLKPAVYTKVFDYNNWIQSII 224
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 51.2 bits (121), Expect = 1e-06, Method: Composition-based stats.
Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 22/145 (15%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
++ G + P+QVSL H+CG LI+ WVV+AAHC + I
Sbjct: 1 IVGGYTCAANSIPYQVSLNS-------GSHFCGGSLINSQWVVSAAHCYKSRI------- 46
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEF--HNYHHDIALLKLSRPTSARDKGVRAV 144
LG+ + E +E I +I H F + +DI L+KLS P + + V
Sbjct: 47 --QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR----V 100
Query: 145 CLTDADKRPVNPKQQCVATGWGRVK 169
+ +C+ +GWG K
Sbjct: 101 ATVSLPRSCAAAGTECLISGWGNTK 125
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 335 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLK 390
S L+ + +P+ VC+D + + C G +G G AC GDSGGP S
Sbjct: 4 SVLQVVNLPIVERPVCKDS--TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 61
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
+ RWY GI S+G GC + G YT + WI+K I+
Sbjct: 62 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 101
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 6/75 (8%)
Query: 176 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLK 231
S L+ + +P+ VC+D + + C G +G G AC GDSGGP S
Sbjct: 4 SVLQVVNLPIVERPVCKDS--TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 61
Query: 232 DGRWYLAGITSFGSG 246
+ RWY GI S+G G
Sbjct: 62 NNRWYQMGIVSWGEG 76
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 335 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLK 390
S L+ + +P+ VC+D + + C G +G G AC GDSGGP S
Sbjct: 4 SVLQVVNLPIVERPVCKDS--TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 61
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
+ RWY GI S+G GC + G YT + WI+K I+
Sbjct: 62 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 101
Score = 37.0 bits (84), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 6/75 (8%)
Query: 176 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQL--DGFSG-ACIGDSGGPL-QCSLK 231
S L+ + +P+ VC+D + + C G +G G AC GDSGGP S
Sbjct: 4 SVLQVVNLPIVERPVCKDS--TRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 61
Query: 232 DGRWYLAGITSFGSG 246
+ RWY GI S+G G
Sbjct: 62 NNRWYQMGIVSWGEG 76
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 46/100 (46%), Gaps = 6/100 (6%)
Query: 335 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS---GACIGDSGGPL-QCSLK 390
S L+ + +PL VC K + + C G G AC GDSGGP S
Sbjct: 8 SVLQVVNLPLVERPVC--KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPY 65
Query: 391 DGRWYLAGITSFGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
+ RWY GI S+G GC + G YT + WI+K I+
Sbjct: 66 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 105
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 27/75 (36%), Positives = 34/75 (45%), Gaps = 6/75 (8%)
Query: 176 SKLRQIRVPLHNISVCRDKYGDSVELHGGHLCGGQLDGFS---GACIGDSGGPL-QCSLK 231
S L+ + +PL VC K + + C G G AC GDSGGP S
Sbjct: 8 SVLQVVNLPLVERPVC--KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPY 65
Query: 232 DGRWYLAGITSFGSG 246
+ RWY GI S+G G
Sbjct: 66 NNRWYQMGIVSWGEG 80
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/195 (23%), Positives = 80/195 (41%), Gaps = 28/195 (14%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHND-----IFSLPIPELWTAVLG 93
PW V+++ L CG ++ +V+TAAHC+ + + LW
Sbjct: 12 PWTVAVRTYPGEESLT---CGGAILSQWFVLTAAHCVFDQKPETIVIQYESTNLWE---- 64
Query: 94 DWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADKRP 153
D +++ S V + R E +DIA+L+LSRP + L D + RP
Sbjct: 65 DPGKSDPYVSHVYLSFYRQETME------NDIAILELSRPLKLDGLKSKPAKLPDIEFRP 118
Query: 154 VNPKQQCVATGWGRVKPKGDLVSKLRQIRVPLHNISVCRDKYGD---SVELHGGHLCGGQ 210
+ +G+G + L+ ++ + ++ CR KYG S+++ G
Sbjct: 119 -KTGSDVLVSGYGDGQTMDPKDHDLKSAQLTVVDLDECRTKYGPIFLSLQVFCAQKVGVS 177
Query: 211 LDGFSGACIGDSGGP 225
L+ GD+G P
Sbjct: 178 LES------GDAGDP 186
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 16/149 (10%)
Query: 285 ALLKLSRPTSARDKGVRAVCLTDADKRPVNPKQQCVATGWGRVKPKGDLVSKLRQIRVPL 344
A+L+LSRP + L D + RP + +G+G + L+ ++ +
Sbjct: 91 AILELSRPLKLDGLKSKPAKLPDIEFRP-KTGSDVLVSGYGDGQTMDPKDHDLKSAQLTV 149
Query: 345 HNISVCRDKYGD---SVELHGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITS 401
++ CR KYG S+++ G L+ GD+G P + L G+ +
Sbjct: 150 VDLDECRTKYGPIFLSLQVFCAQKVGVSLES------GDAGDPTV-----QQDTLVGVAA 198
Query: 402 FGSGCAKSGYPDVYTKLSFYLPWIRKQIN 430
+ + G P+V+TK+ Y+ WI+ I
Sbjct: 199 YFPKRPE-GAPEVFTKVGSYVSWIQDIIK 226
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization,
Patterson Search, Structure Determination, Refinement,
Structure And Comparison With Its Components And With
The Bovine Trypsin- Pancreatic Trypsin Inhibitor
Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 42.7 bits (99), Expect = 4e-04, Method: Composition-based stats.
Identities = 20/52 (38%), Positives = 32/52 (61%), Gaps = 6/52 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHND 78
+I G+E + + PWQV+ + H CG VL++P WV+TAAHC +++
Sbjct: 1 IIGGRECEKNSHPWQVA--IYH----YSSFQCGGVLVNPKWVLTAAHCKNDN 46
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 25/224 (11%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPE 86
+I GK+S PW V + V +CG ++ ++V+TAA C+ P
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKP------FCGGSILTANFVITAAQCVDG-----TKPS 49
Query: 87 LWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
+ G RT + S + + +R H ++ A+++ P DK + + L
Sbjct: 50 DISIHYGSSYRTTKGTSVMAKKIYIVRYHP--LTMQNNYAVIETEMPIKLDDKTTKKIEL 107
Query: 147 TDADKRPVNPKQQCVATGWGRVKPKG-DLVSKLRQIRVPLHNISVCRDKY----GDSVEL 201
P P + +GWG K + L + + + C ++Y D
Sbjct: 108 PSLLYDP-EPDTSVLVSGWGSTNFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEADKYIY 166
Query: 202 HGGHLCGGQLDGFSGACIGDSGGPLQCSLKDGRWYLAGITSFGS 245
G GG+ D + GD+G P ++++G L G+ S+ S
Sbjct: 167 DGVFCAGGEYDE-TYIGYGDAGDP---AVQNGT--LVGVASYIS 204
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 4/49 (8%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCI 75
++ G ++ G PWQV L P+ L CGA LI WV+TAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELL----CGASLISDRWVLTAAHCL 45
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 32/133 (24%), Positives = 61/133 (45%), Gaps = 20/133 (15%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHC--IHNDIFSLPIPELWTAVLGDWD 96
PWQV L + +CG V+I ++V+T A C +H +I V ++
Sbjct: 106 PWQVKLTNSEGK-----DFCGGVIIRENFVLTTAKCSLLHRNI----------TVKTYFN 150
Query: 97 RTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDAD--KRPV 154
RT ++ ++I + + + +D++LL+L P G+ VC + D + +
Sbjct: 151 RTSQDPLMIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGL-PVCTPEKDFAEHLL 209
Query: 155 NPKQQCVATGWGR 167
P+ + + +GW R
Sbjct: 210 IPRTRGLLSGWAR 222
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 93/244 (38%), Gaps = 55/244 (22%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
PWQ + V+ P G C ++ +V+TAAHC D I +V G+
Sbjct: 460 PWQAKISVIRPSKG--HESCMGAVVSEYFVLTAAHCFTVDDKEHSIK---VSVGGEKRDL 514
Query: 99 EEE------------KSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
E E K E IP EF++Y D+AL+KL + +R +CL
Sbjct: 515 EIEVVLFHPNYNINGKKEAGIP--------EFYDY--DVALIKLKNKLKY-GQTIRPICL 563
Query: 147 --TDADKRPVN-PKQQCVATGWGRVKPKGDLVS--------KLRQIRVPLHN-------- 187
T+ R + P + P D+ + KL + V + N
Sbjct: 564 PCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCE 623
Query: 188 ----ISVCRDKYGDSVE-LHGGHLCGGQLDGFS--GACIGDSGGPLQCSLKDGRWYLAGI 240
+ DK D E + LC G + ++ C GDSGGPL K R+ G+
Sbjct: 624 RDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGV 682
Query: 241 TSFG 244
S+G
Sbjct: 683 ISWG 686
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 93/244 (38%), Gaps = 55/244 (22%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
PWQ + V+ P G C ++ +V+TAAHC D I +V G+
Sbjct: 469 PWQAKISVIRPSKGH--ESCMGAVVSEYFVLTAAHCFTVDDKEHSIK---VSVGGEKRDL 523
Query: 99 EEE------------KSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
E E K E IP EF++Y D+AL+KL + +R +CL
Sbjct: 524 EIEVVLFHPNYNINGKKEAGIP--------EFYDY--DVALIKLKNKLKY-GQTIRPICL 572
Query: 147 --TDADKRPVN-PKQQCVATGWGRVKPKGDLVS--------KLRQIRVPLHN-------- 187
T+ R + P + P D+ + KL + V + N
Sbjct: 573 PCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCE 632
Query: 188 ----ISVCRDKYGDSVE-LHGGHLCGGQLDGFS--GACIGDSGGPLQCSLKDGRWYLAGI 240
+ DK D E + LC G + ++ C GDSGGPL K R+ G+
Sbjct: 633 RDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGV 691
Query: 241 TSFG 244
S+G
Sbjct: 692 ISWG 695
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 32/133 (24%), Positives = 61/133 (45%), Gaps = 20/133 (15%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHC--IHNDIFSLPIPELWTAVLGDWD 96
PWQV L + +CG V+I ++V+T A C +H +I V ++
Sbjct: 65 PWQVKLTNSEGK-----DFCGGVIIRENFVLTTAKCSLLHRNI----------TVKTYFN 109
Query: 97 RTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDAD--KRPV 154
RT ++ ++I + + + +D++LL+L P G+ VC + D + +
Sbjct: 110 RTSQDPLMIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGL-PVCTPEKDFAEHLL 168
Query: 155 NPKQQCVATGWGR 167
P+ + + +GW R
Sbjct: 169 IPRTRGLLSGWAR 181
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 93/244 (38%), Gaps = 55/244 (22%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
PWQ + V+ P G C ++ +V+TAAHC D I +V G+
Sbjct: 227 PWQAKISVIRPSKG--HESCMGAVVSEYFVLTAAHCFTVDDKEHSIK---VSVGGEKRDL 281
Query: 99 EEE------------KSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
E E K E IP EF++Y D+AL+KL + +R +CL
Sbjct: 282 EIEVVLFHPNYNINGKKEAGIP--------EFYDY--DVALIKLKNKLKY-GQTIRPICL 330
Query: 147 --TDADKRPVN-PKQQCVATGWGRVKPKGDLVS--------KLRQIRVPLHN-------- 187
T+ R + P + P D+ + KL + V + N
Sbjct: 331 PCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCE 390
Query: 188 ----ISVCRDKYGDSVE-LHGGHLCGGQLDGFS--GACIGDSGGPLQCSLKDGRWYLAGI 240
+ DK D E + LC G + ++ C GDSGGPL K R+ G+
Sbjct: 391 RDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGV 449
Query: 241 TSFG 244
S+G
Sbjct: 450 ISWG 453
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 36.6 bits (83), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 93/244 (38%), Gaps = 55/244 (22%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
PWQ + V+ P G C ++ +V+TAAHC D I +V G+
Sbjct: 479 PWQAKISVIRPSKGH--ESCMGAVVSEYFVLTAAHCFTVDDKEHSIK---VSVGGEKRDL 533
Query: 99 EEE------------KSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
E E K E IP EF++Y D+AL+KL + +R +CL
Sbjct: 534 EIEVVLFHPNYNINGKKEAGIP--------EFYDY--DVALIKLKNKLKY-GQTIRPICL 582
Query: 147 --TDADKRPVN-PKQQCVATGWGRVKPKGDLVS--------KLRQIRVPLHN-------- 187
T+ R + P + P D+ + KL + V + N
Sbjct: 583 PCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCE 642
Query: 188 ----ISVCRDKYGDSVE-LHGGHLCGGQLDGFS--GACIGDSGGPLQCSLKDGRWYLAGI 240
+ DK D E + LC G + ++ C GDSGGPL K R+ G+
Sbjct: 643 RDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGV 701
Query: 241 TSFG 244
S+G
Sbjct: 702 ISWG 705
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 93/244 (38%), Gaps = 55/244 (22%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
PWQ + V+ P G C ++ +V+TAAHC D I +V G+
Sbjct: 28 PWQAKISVIRPSKGH--ESCMGAVVSEYFVLTAAHCFTVDDKEHSIK---VSVGGEKRDL 82
Query: 99 EEE------------KSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
E E K E IP EF++Y D+AL+KL + +R +CL
Sbjct: 83 EIEVVLFHPNYNINGKKEAGIP--------EFYDY--DVALIKLKNKLKY-GQTIRPICL 131
Query: 147 --TDADKRPVN-PKQQCVATGWGRVKPKGDLVS--------KLRQIRVPLHN-------- 187
T+ R + P + P D+ + KL + V + N
Sbjct: 132 PCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCE 191
Query: 188 ----ISVCRDKYGDSVE-LHGGHLCGGQLDGFS--GACIGDSGGPLQCSLKDGRWYLAGI 240
+ DK D E + LC G + ++ C GDSGGPL K R+ G+
Sbjct: 192 RDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGV 250
Query: 241 TSFG 244
S+G
Sbjct: 251 ISWG 254
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 93/244 (38%), Gaps = 55/244 (22%)
Query: 39 PWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHCIHNDIFSLPIPELWTAVLGDWDRT 98
PWQ + V+ P G C ++ +V+TAAHC D I +V G+
Sbjct: 235 PWQAKISVIRPSKG--HESCMGAVVSEYFVLTAAHCFTVDDKEHSIK---VSVGGEKRDL 289
Query: 99 EEE------------KSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCL 146
E E K E IP EF++Y D+AL+KL + +R +CL
Sbjct: 290 EIEVVLFHPNYNINGKKEAGIP--------EFYDY--DVALIKLKNKLKY-GQTIRPICL 338
Query: 147 --TDADKRPVN-PKQQCVATGWGRVKPKGDLVS--------KLRQIRVPLHN-------- 187
T+ R + P + P D+ + KL + V + N
Sbjct: 339 PCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCE 398
Query: 188 ----ISVCRDKYGDSVE-LHGGHLCGGQLDGFS--GACIGDSGGPLQCSLKDGRWYLAGI 240
+ DK D E + LC G + ++ C GDSGGPL K R+ G+
Sbjct: 399 RDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGV 457
Query: 241 TSFG 244
S+G
Sbjct: 458 ISWG 461
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 18/48 (37%), Positives = 25/48 (52%), Gaps = 7/48 (14%)
Query: 27 LINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLIHPSWVVTAAHC 74
++ G + P+QVSL H+CG LI+ WVV+AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSLNS-------GSHFCGGSLINSQWVVSAAHC 41
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 33.9 bits (76), Expect = 0.17, Method: Composition-based stats.
Identities = 21/66 (31%), Positives = 34/66 (51%), Gaps = 6/66 (9%)
Query: 109 VERIRVHEEFH---NYHHDIALLKLSRPTSARDKGVRAVCLTDADKRP--VNPKQQCVAT 163
+E+I +H ++ N DIAL+KL +P + D + VCL D + + + T
Sbjct: 8 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY-IHPVCLPDRETAASLLQAGYKGRVT 66
Query: 164 GWGRVK 169
GWG +K
Sbjct: 67 GWGNLK 72
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 42/152 (27%), Positives = 59/152 (38%), Gaps = 36/152 (23%)
Query: 4 LCDTVTFARDCGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLI 63
L DT+ CGVG ++ S + PW V+++ P+ C LI
Sbjct: 223 LTDTI-----CGVGN---------MSANASDQERTPWHVTIK---PK---SQETCRGALI 262
Query: 64 HPSWVVTAAHCIH--NDIFSLPIPELWTAVLGD----WDRTEEEKSEVRIPVERIRVHEE 117
WV+TAAHC ND LW +GD W + + V P + +
Sbjct: 263 SDQWVLTAAHCFRDGND------HSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKN 316
Query: 118 ---FHNYHHDIALLKLSRPTSARDKGVRAVCL 146
Y DIALLKL++ R +CL
Sbjct: 317 QGILEFYGDDIALLKLAQKVKMSTHA-RPICL 347
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 32.3 bits (72), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 42/152 (27%), Positives = 59/152 (38%), Gaps = 36/152 (23%)
Query: 4 LCDTVTFARDCGVGIRYSHRQPRLINGKESIRGAWPWQVSLQVLHPRLGLMPHWCGAVLI 63
L DT+ CGVG ++ S + PW V+++ P+ C LI
Sbjct: 215 LTDTI-----CGVGN---------MSANASDQERTPWHVTIK---PK---SQETCRGALI 254
Query: 64 HPSWVVTAAHCIH--NDIFSLPIPELWTAVLGD----WDRTEEEKSEVRIPVERIRVHEE 117
WV+TAAHC ND LW +GD W + + V P + +
Sbjct: 255 SDQWVLTAAHCFRDGND------HSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKN 308
Query: 118 ---FHNYHHDIALLKLSRPTSARDKGVRAVCL 146
Y DIALLKL++ R +CL
Sbjct: 309 QGILEFYGDDIALLKLAQKVKMSTHA-RPICL 339
>pdb|3K3T|A Chain A, E185a Mutant Of Peptidoglycan Hydrolase From Sphingomonas
Sp. A1
Length = 170
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 15/63 (23%), Positives = 29/63 (46%)
Query: 78 DIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSAR 137
++F++ WT + + E E + ++ VER R ++ + D A L + P A+
Sbjct: 52 NLFNIKAGSNWTGKVVEARTVEYENGQRKVRVERFRAYDSYEQAFQDYADLVGNSPRYAK 111
Query: 138 DKG 140
G
Sbjct: 112 VAG 114
>pdb|3EZL|A Chain A, Crystal Structure Of Acetyacetyl-Coa Reductase From
Burkholderia Pseudomallei 1710b
Length = 256
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 19/77 (24%), Positives = 32/77 (41%), Gaps = 3/77 (3%)
Query: 92 LGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSARDKGVRAVCLTDADK 151
+GDWD T++ +V+ V I V D+ K++R L + K
Sbjct: 72 VGDWDSTKQAFDKVKAEVGEIDVLVNNAGITRDVVFRKMTREDWQAVIDTNLTSLFNVTK 131
Query: 152 RPVNPKQQCVATGWGRV 168
+ ++ V GWGR+
Sbjct: 132 QVIDG---MVERGWGRI 145
>pdb|2ZYC|A Chain A, Crystal Structure Of Peptidoglycan Hydrolase From
Sphingomonas Sp. A1
Length = 170
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 15/63 (23%), Positives = 29/63 (46%)
Query: 78 DIFSLPIPELWTAVLGDWDRTEEEKSEVRIPVERIRVHEEFHNYHHDIALLKLSRPTSAR 137
++F++ WT + + E E + ++ VER R ++ + D A L + P A+
Sbjct: 52 NLFNIKAGSNWTGKVVEARTVEYENGQRKVRVERFRAYDSYEQAFQDYADLVGNSPRYAK 111
Query: 138 DKG 140
G
Sbjct: 112 VAG 114
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.140 0.465
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 14,583,022
Number of Sequences: 62578
Number of extensions: 654781
Number of successful extensions: 3383
Number of sequences better than 100.0: 362
Number of HSP's better than 100.0 without gapping: 327
Number of HSP's successfully gapped in prelim test: 35
Number of HSP's that attempted gapping in prelim test: 1292
Number of HSP's gapped (non-prelim): 810
length of query: 436
length of database: 14,973,337
effective HSP length: 102
effective length of query: 334
effective length of database: 8,590,381
effective search space: 2869187254
effective search space used: 2869187254
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 53 (25.0 bits)